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Abstract 
 
Ovarian cystectomy is commonly performed to treat benign ovarian cysts, but might 
cause inadvertent damage to normal ovarian tissue, thereby influencing Ă ǁŽŵĂŶ ?Ɛ
ovarian reserve. Ovarian reserve is defined as the existent quantitative and qualitative 
supply of follicles which are found in the ovaries that can potentially develop into mature 
follicles which in effect determine a ǁŽŵĂŶ ?Ɛ ƌĞƉƌŽĚƵĐƚŝǀĞ ƉŽƚĞŶƚŝĂů ? It is commonly 
quantified by the levels of serum FSH and recently by total antral follicle count (2.0-10.0 
mm follicles in both ovaries) and AMH levels. These tests however have inherent 
biological variation in relation to menstrual cycle and ageing; and are also influenced by 
the intra- and inter-observer variations. The aim of this thesis was to develop a reliable 
method of examining the effect of ovarian cystectomy on ovarian reserve.  
 I began by examining the ultrasound markers of ovarian reserve. AFC is measured using 
2D ultrasound and there is some evidence that 3D ultrasound can make more reliable 
counts than 2D. I examined the reliability of these two methods and compared them to a 
new 3D assisted method, SonoAVC which is designed to make automated AFC. I found 
that the intra- and inter-observer reliability of SonoAVC in counting the number of antral 
follicles was superior to 2D and 3D manual methods. It however required post-processing 
of the counts by manually clicking on the antral follicles initially missed in the automated 
version, thereby making it a semi-automated method. 
I then compared 2D ultrasound to SonoAVC in measuring the size of antral follicles as 
there is increasing evidence that the small antral follicles might be more predictive of 
ovarian reserve. I found that SonoAVC measured the size of antral follicles significantly 
quicker than 2D and also that the number of small follicles measured by 2D were more 
S h i l p a  D e b   P a g e  | 21 
 
 
than SonoAVC, thereby raising the possibility that 2D might overestimate the number of 
small antral follicles. 
I then studied the ability of antral follicle counts stratified by size in prediction of ovarian 
response and pregnancy. I found that the small antral follicles measuring between 2.0-4.0 
mm were independent predictors of clinical pregnancy and ovarian response to assisted 
reproduction treatment.  
I then examined the AFCs of different sizes made by SonoAVC and 2D in bovine ovaries 
and compared to the follicles obtained by manually dissecting the follicles. I found that 
SonoAVC with post-processing significantly underestimated and 2D overestimated the 
number of antral follicles measuring 4.0mm or less, but both made comparable counts of 
follicles measuring more than 4.0mm when compared with the antral follicles dissected 
manually. However, the agreement with SonoAVC with post-processing was more than 
that with 2D. 
Having established that SonoAVC albeit with post-processing was the most reliable 
method in measuring the size of antral follicles, I began to examine the intra- and inter-
cycle variation and compared to AMH. I found that the small antral follicle measuring 2.0-
6.0 mm showed least intra-and inter-cycle variation and that it was comparable to AMH. 
The larger antral follicles showed significant intra-cycle variation but a non-significant 
inter-cycle variation in the early follicular phase of menstrual cycle.  
I also examined the inter-ŽǀĂƌŝĂŶǀĂƌŝĂƚŝŽŶ ŝŶ ƚŚĞ& ?s and found that the small antral 
follicles measuring 2.0-6.0 mm again showed the least variation between ovaries within 
an individual. I was finally able to conclude that small antral follicles  ?A? ? ? ?ŵŵ ? measured 
using SonoAVC were the most reliable in prediction of ovarian reserve, and showed 
excellent correlation with AMH. 
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Finally, I examined the effect of laparoscopic ovarian cystectomy on the ovarian reserve 
for up to 6 months post-operatively using AMH and small AFC measured by SonoAVC. I 
found that ovarian cystectomy significantly reduces ovarian reserve and that this effect 
may be more pronounced with cysts of endometriotic nature, followed by dermoid cysts. 
In summary, the effect of ovarian cystectomy on ovarian reserve is best quantified using 
AFC of small follicles measuring less than 6.0 mm as it provides reliable measures of 
ovarian reserve, has minimal biological variation and is comparable to AMH. 
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CHAPTER 1.  Background and Hypothesis 
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Benign ovarian cysts develop within the ovarian parenchyma and are often removed 
either using a minimally invasive procedure such as laparoscopy or an open abdominal 
procedure called the laparotomy. Both, the cyst in itself and the cystectomy i.e. excision 
and enucleating of cyst from the ovary can influence the ovarian reserve. Ovarian reserve 
is an important concept widely used in the field of reproductive medicine, especially when 
planning assisted reproduction treatments. It is defined as the existent quantitative and 
qualitative supply of follicles which are found in the ovaries that can potentially develop 
into mature follicles which in effect determine ĂǁŽŵĂŶ ?ƐƌĞƉƌŽĚƵĐƚŝǀĞƉŽƚĞŶƚŝĂů ?/ƚŝƐĂůƐŽ
used as a term to determine the capacity of the ovary to develop oocytes capable of 
fertilisation, resulting in a healthy and successful pregnancy.  
This chapter is an introduction to reproductive physiology, ovarian reserve and methods 
used for its evaluation; and management of benign ovarian cysts and its effect on ovarian 
reserve. 
 
1.1 Introduction to reproductive physiology 
 
1.1.1 Folliculogenesis 
 
From birth, the ovaries of the human females contain primordial follicles with immature 
oocytes. In the adult ovary, a clutch of follicles leave the pool of resting follicles to begin 
folliculogenesis, entering the growth phase that will end in atresia or in ovulation 
(Gougeon 1998). The factors controlling this initial recruitment is still unclear but may be 
mediated by the counterbalance of various stimulatory and inhibitory hormones and 
locally expressed growth factors (Fortune, Cushman et al. 2000). The process of 
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folliculogenesis, from primordial to preovulatory follicle takes approximately 6 months. It 
is a continuous process, and therefore at any time, the ovary contains follicles in all stages 
of development. 
 
Morphology and function of follicles 
During the basal follicular growth the mitotic activity of the granulosa cells progressively 
increases but is only slightly susceptible to gonadotrophins which are attributed to the 
number of receptors for gonadotrophins present on the follicle cells and the transducing 
mechanisms coupling with these receptors (Jonassen, Bose et al. 1982). In vitro studies 
have shown that the pre antral follicles produce very low amounts of progesterone and 
androstenedione and undetectable amounts of Oestradiol (Roy and Treacy 1993).  
Granulosa cells cultured from these follicles have low aromatizing capacity (McNatty, 
Makris et al. 1979; McNatty, Makris et al. 1979).  
Once the primordial follicle is initiated, it is irreversibly committed to enter into the 
growing follicular pool and cannot return to the resting state (McNatty, Reader et al. 
2007). The stromal cells further differentiate into an outer theca externa and an inner 
theca interna. Secondary follicles grow into preantral follicles when the theca interna 
commences its epithelioid differentiation, and constitutes the first category of growing 
follicles in a classification based on morphology and number of granulosa cells in each 
individual follicle. From the follicular diameter of 0.15mm, the preantral follicles increase 
in size to 0.18  W 0.25mm and are called early antral follicles. Certain local factors including 
GDF-9, BMP-15, basic fibroblast growth factor (bFGF) and EGF might be responsible for 
this initial initiation of primordial follicles (Webb and Campbell 2007). Activin is shown to 
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promote granulosa cell proliferation in the pre-antral follicles (Findlay 1993) and Inhibin A, 
expressed by the dominant follicles exhibits an inhibitory effect on the neighbouring early 
growing follicles thereby playing an important role in follicle selection (Vitale, Gonzalez et 
al. 2002). The role of Inhibin B is unclear on pre-antral follicle development (McNatty, 
Heath et al. 1999). These early pre-antral follicles are independent of gonadotrophins 
(Webb, Campbell et al. 1999), although FSH receptor mRNA is detected in secondary 
follicles and beyond (Webb and Campbell 2007). In vitro animal studies have shown that 
FSH alone may not be sufficient in the growth of primary and secondary follicles (Fortune, 
Kito et al. 1998; Liu, Andoh et al. 1998), and that addition of local factors such as IGF-1 
and activin might assist the growth of follicles (Liu, Andoh et al. 1998; Webb and Campbell 
2007).  
Through the accumulation of fluid in the antral cavity and proliferation of granulosa cells 
and theca interna cells, the follicle reaches a size of 2mm when it is called tertiary follicle 
or a Graffian follicle or an antral follicle. The stage of folliculogenesis when follicles grow 
from the pre antral stage to a size of 2mm is called basal follicular growth, which takes 
about 70 days, during which time they become gonadotrophin responsive (Gougeon 
1996). During the follicular phase of the menstrual cycle, the final stages of follicular 
growth occur with the development of gonadotrophin dependent antral and preovulatory 
follicles. The selectable follicles constitute the pool of follicles from which the one 
destined to ovulate in the subsequent cycle will be selected (Gougeon and Lefevre 1983). 
Selectable follicles are present throughout the menstrual cycle. During the late luteal 
phase following the disintegration of corpus luteum and consequent rise in pituitary 
follicle stimulating hormone (FSH), the 2  W 5 mm follicles, which have entered the 
preantral stage 70 days earlier, are recruited into gonadotrophin dependent selectable 
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follicles, competing with each other for growth inducing FSH. They exhibit a significant 
increase in the rate of cell proliferation, becoming more dependent on FSH (Gougeon 
1984). In vitro studies have shown that these follicles become responsive to 
gonadotrophins in terms of quality and growth rate but that their FSH-induced aromatase 
remains poorly expressed (McNatty, Makris et al. 1979; Sasano, Okamoto et al. 1989; 
Tamura, Kitawaki et al. 1992; Gougeon 1996). Once these follicles are selected for further 
growth, continued gonadotrophins support is essential for their survival and further 
development through the enlargement of the antrum to pre-ovulatory follicle stage 
(McGee and Hsueh 2000).  
AMH expression begins in the primary follicles with highest levels present in secondary, 
pre-antral and small antral follicles measuring 4 mm or less in diameter (Weenen, Laven 
et al. 2004) and may have a role in regulation of follicular growth at this stage through an 
inhibitory effect on the sensitivity of follicles to FSH (Visser and Themmen 2005).  They 
become responsive to gonadotrophins but are not completely dependent on them for 
their growth (McGee and Hsueh 2000). Animal studies have shown that follicles 
measuring >100 µm in diameter demonstrate significant steroid production in response to 
gonadotrophins in sheep (Scaramuzzi, Adams et al. 1993) and that FSH can accelerate the 
growth of pre-antral follicles through proliferation of granulosa cells (Campbell, Telfer et 
al. 2000; Campbell, Telfer et al. 2004). As they enlarge they become increasingly 
responsive to gonadotrophins due to acquisition of FSH and LH receptors (McGee and 
Hsueh 2000; Webb and Campbell 2007) progressing to a gonadotrophin-dependent 
phase. Transient increases in FSH levels that follows luteolysis in the late luteal phase of 
menstrual cycle after the onset of puberty is the key for cyclical recruitment of the follicle 
that express the FSH receptors maximally (McGee and Hsueh 2000).  
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An atretic follicle usually fails to develop beyond the size of 10mm (Gougeon and Lefevre 
1983) (Figure 1.1). Only about 0.1% of follicles reach the mature pre-ovulatory stage and 
ŽǀƵůĂƚĞ ŝŶ Ă ǁŽŵĂŶ ?Ɛ ůŝĨĞƚŝŵĞ ĂŶĚ ƚŚĞ ƌĞŵĂŝŶŝŶŐ  ? ? ? ?A? ŽĨĨŽůůŝĐůĞƐ ƵŶĚĞƌŐŽ ĂƚƌĞƐŝĂ
(Markstrom, Svensson et al. 2002). Follicular atresia is a hormonally controlled apoptotic 
process through which the degenerating follicles are eliminated in a coordinated fashion. 
Although apoptosis can occur at all stages of follicle development, the most susceptible 
phase to atresia is the pre-antral to early antral transition and the subordinate follicles 
during selection for dominance (McGee and Hsueh 2000). The FSH requirement of the 
gonadotrophin dependent follicles is higher than that for the gonadotrophin responsive or 
ovulatory follicles and therefore, they are more vulnerable to atresia once the 
gonadotrophin level falls (Scaramuzzi, Adams et al. 1993). With increasing size of the 
follicles and the theca cells, the amount of estrogen increases sharply, mainly due to 
aromatization of theca derived androgen into estrogen by the granulosa cells. Generally 
single follicle gains dominance and this is invariably the one from the cohort with the 
largest number of granulosa cells as it demonstrates an increased sensitivity to FSH. Once 
the largest follicle reaches 10 mm or more in diameter, it starts to express LH receptors in 
the granulosa cells, a critical step in the selection of the dominant follicle as these 
ƌĞĐĞƉƚŽƌƐĞŶĂďůĞƚŚĞĨŽůůŝĐůĞƚŽƐǁŝƚĐŚŝƚƐ ?ŐŽŶĂĚŽƚƌŽƉŚŝŶ-dependence from FSH to LH and 
thereby reach dominance over the other FSH-dependent follicles (Webb and Campbell 
2007). Oestradiol and later inhibin secreted by these follicles progressively begin to 
suppress FSH, causing the follicles with lower amount of FSH receptors to become atretic. 
As more Oestradiol is secreted, more LH receptors are made by the theca cells, inciting 
theca cells to create more androgen that will become oestrogen. This positive feedback 
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loop causes LH to spike sharply causing ovulation (Gougeon 1996; van den Hurk and Zhao 
2005).  
 
Figure 1.1 Process of folliculogenesis 
A fixed number of primordial follicles are present at birth and majority of them remain in the 
resting state. A proportion of these follicles undergo initiation of growth (initial recruitment) both 
before and during reproductive life and develop through primary, secondary and antral stages, at 
which majority of them undergo atretic changes. After puberty, a cohort of the antral follicles is 
rescued by an increase in gonadotrophin levels to develop into pre-ovulatory follicles (cyclic 
recruitment). However, only one of them emerges as the dominant follicle to grow into ovulatory 
stage and the remaining cohort of antral follicles subsequently undergoes atresia. 
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1.1.2 Bio-physiology of reproductive ageing 
 
Reproductive ageing is thought to be due to a gradual decrease in both the quantity and 
quality of the oocytes contained within the follicles present in the ovarian cortex (te Velde 
and Pearson 2002). By the fourth month of foetal development, the ovaries contain 6-7 
million oocytes within primordial follicles, which are surrounded by a layer of flat 
granulosa cells. This population reduces to 1-2 million primordial follicles by means of 
apoptosis at birth (Markstrom, Svensson et al. 2002). This process of apoptosis slows 
down till the age of menarche when approximately 300,000 to 400,000 primordial follicles 
remain. During the reproductive years, the decline in the number of primordial follicles 
continues, however at a steady rate of about 1000 follicles per month, accelerating 
further after the age of 37 years. With the onset of menopause, the population of 
primordial follicles drops below 1000 (Faddy and Gosden 1996). During the reproductive 
life, the number of all follicles in different stages of development decrease with an abrupt 
fall beyond the age of 40 years. This evolution parallels the number of resting follicles, 
suggesting that the number of growing follicles is positively correlated to the size of 
primordial follicles (Gougeon, Ecochard et al. 1994).  
With the decline in the number of primordial follicles, oocyte quality also diminishes, 
especially after the age of 31 years, when fecundity gradually starts to decrease. The loss 
of oocyte quality is believed to be the result of an increase in meiotic nondisjunction, 
leading to an increasing rate of aneuploidy in the early embryo at higher female ages. 
Several factors might be responsible for this age related decline in the quality of oocytes. 
These may relate to differences between germ cells at the time they are formed during 
ĨŽĞƚĂů ůŝĨĞ ? ĚĂŵĂŐĞ ƚŽ ŽŽĐǇƚĞƐ ĚƵƌŝŶŐ ƚŚĞ ĐŽƵƌƐĞ ŽĨ Ă ǁŽŵĂŶ ?Ɛ ůŝĨĞ Žƌ ĐŚĂŶŐĞƐ ŝŶ ƚŚĞ
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quality of granulosa cells surrounding the primordial follicles (te Velde and Pearson 2002). 
Oxidative stress associated with ageing could increase the meiotic nondisjunction  leading 
to accumulated damage to oocytes (Tarin 1995), impaired perifollicular microcirculation 
resulting in low oxygen levels and a  concomitant increase in anaerobic products in the 
follicular fluid (Gaulden 1992). Also, endocrine imbalance caused due to increase in levels 
of FSH and altered FSH: LH ratio is associated with decline in oocytes quality. 
Natural population studies have shown that by a mean age of 41 years, the natural 
fecundity has already reached its nadir (Broekmans, Faddy et al. 2004). A similar pattern 
of decline in female fecundity has been reported from studies where coital behaviour and 
male factor have been controlled for, suggesting that this decline in fecundity is mainly 
accounted for by the ovarian factor (van Noord-Zaadstra, Looman et al. 1991). This age 
related decline in fertility is also seen in couples undergoing assisted reproduction 
treatments (2003 CDC ART report) (Figure 1.2).  
A poor response to ovarian stimulation in such treatment programmes is a strong 
predictor of poor prospects of becoming pregnant, and also of spontaneous fecundity and 
early menopause (de Boer, den Tonkelaar et al. 2003; Lawson, El-Toukhy et al. 2003; 
Klinkert, Broekmans et al. 2004) 
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Figure 1.2 EffĞĐƚŽĨǁŽŵĞŶ ?ƐĂŐĞŽŶůŝǀĞďŝƌƚŚƌĂƚĞƐƉĞƌĞŵďƌǇŽƚƌĂŶƐĨĞƌ ? 
The live birth rate following IVF using own eggs is above 40% in women up to 34 years of age, then 
ƐŚŽǁƐĂŐƌĂĚƵĂůĚƌŽƉǁŝƚŚŝŶĐƌĞĂƐŝŶŐĂŐĞƚŽďĞůŽǁ ?A?ŝŶǁŽŵĞŶĂŐĞĚA? ? ?ǇĞĂƌƐ ?/ŶĐŽŶƚƌĂƐƚ ?ƚŚĞ
live birth rate per embryo transfer in IVF cycles using donor eggs remains constant even up to the 
age of 47 years. This indicates that the ovarian ageing and not the uterine function is primarily 
responsible for the decline in live birth rates. (2003 Assisted reproductive technology report. 
Atlanta: Centers for Disease Control and Prevention, 2003; http://www.cdc.gov).    
 
1.2 Ovarian reserve and ovarian response 
 
Ovarian reserve is defined as the existent quantitative and qualitative supply of follicles 
which are found in the ovaries that can potentially develop into mature follicles which in 
ĞĨĨĞĐƚ ĚĞƚĞƌŵŝŶĞƐ Ă ǁŽŵĂŶ ?Ɛ ƌĞƉƌŽĚƵĐƚŝǀĞ ƉŽƚĞŶƚŝĂů ? /ƚ ŝƐ ĂůƐŽ ƵƐĞĚ ĂƐ Ă ƚĞƌŵ ƚŽ
determine the capacity of the ovary to provide eggs that are capable of fertilisation 
resulting in a healthy and successful pregnancy. Since true ovarian reserve cannot be 
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determined directly as it would entail performing ovarian biopsy to establish the number 
of primordial follicles, markers of ovarian reserve that can estimate the reserve have 
evolved.  
Ovarian response is dependent on ovarian reserve thereby allowing the use of markers of 
ovarian reserve in prediction of ovarian response. It is clinically an important concept 
when evaluating the outcomes following assisted reproduction treatment (ART). Ovarian 
response to ART includes outcomes such as the number of stimulated follicles following 
controlled ovarian stimulation, number of oocytes retrieved, number of mature oocytes, 
fertilisation rate and formation of embryos. 
Follicular exhaustion is a known fact in the fourth decade of reproductive life. With 
increasing levels of female education, their participation in the labour force, 
postponement of childbearing has lead to a so called sexual revolution causing an 
increasing incidence of subfertility due to ovarian ageing. This perhaps reflects on the 
increasing number of IVF cycles performed as reflected in the national U.K. statistics on 
live births following IVF and ICSI between 1992 and 2006.  The evaluations of ovarian 
reserve have therefore arisen to better counsel couples and guide the assisted 
reproduction protocols.                                                                                                                                                                           
1.2.1 Evaluation of ovarian reserve 
 
The commonly employed tests of ovarian reserve can be divided into static markers 
(oestradiol, FSH, inhibin-B, and AMH), dynamic markers (tests of stimulation with 
clomiphene citrate, gonadotrophins, and gonadotrophin releasing hormone analogue), 
and ultrasonographic markers (antral follicle count, ovarian volume and ovarian blood 
flow) 
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1.2.1.a  Static markers 
 
Oestradiol 
Basal serum oestradiol is mainly produced by the ovulatory follicles and therefore can 
only be used in estimating the number of ovulatory follicles. The levels produced are also 
dependent on the LH levels in the cycle. It is an indirect marker of ovarian reserve as it is 
proposed to predict ovarian response in assisted reproduction cycles (Evers, Slaats et al. 
1998).  In a few studies, a higher rate of cycle cancellation was seen among patients with 
basal levels of <20 or >80 pg/ml (Evers, Slaats et al. 1998; Frattarelli, Bergh et al. 2000). 
Other studies have failed to support its clinical application as they were unable to 
correlate it with follicular development (Frattarelli, Bergh et al. 2000) or predict 
pregnancy (Scott, Toner et al. 1989; Licciardi, Liu et al. 1995; Smotrich, Widra et al. 1995). 
Basal E2 levels do not differ significantly between poor and normal responders to assisted 
reproduction cycles (Lee, Lenton et al. 1988; Ficicioglu, Kutlu et al. 2006). The use of E2 as 
a marker of ovarian reserve therefore is no longer recommended (Broekmans, Kwee et al. 
2006).  
Follicle stimulating hormone (FSH) 
Basal FSH is the most widely used test to assess ovarian reserve. It is secreted by the 
anterior pituitary and acts on the receptors expressed by the granulosa cells of 
gonadotrophin responsive antral follicles. Increasing levels of basal FSH is the earliest sign 
of human reproductive aging (Reame, Wyman et al. 1998; van Zonneveld, Scheffer et al. 
2003). Inhibin B is assumed to suppress pituitary FSH secretion. Reduction in the 
production of inhibin B from a decreasing population of growing follicles may elevate FSH 
secretion (Klein, Battaglia et al. 1996). A poor outcome to assisted reproduction 
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treatment can be expected in women with high levels of basal FSH; however the cut-off 
levels reported differ in different studies, ranging from 8 to 15 IU/mL (Watt, Legedza et al. 
2000; Ashrafi, Madani et al. 2005; Klinkert, Broekmans et al. 2005). Although, studies have 
reported lower chances of pregnancy with higher levels of basal FSH, there is no 
association established with lower levels of FSH (van der Steeg, Steures et al. 2007). 
Contrary to this study, Luna et al reported a higher pregnancy rate in women younger 
than 35 years and with high FSH levels high when compared to older women with normal 
levels (Luna, Grunfeld et al. 2007). In view of this, there is a search for more predictive 
markers of ovarian reserve. 
Inhibin-B 
Inhibin B is a glycoprotein hormŽŶĞ ŽĨ ƚŚĞ ƚƌĂŶƐĨŽƌŵŝŶŐ ŐƌŽǁƚŚ ĨĂĐƚŽƌ ɴ  ?d'&-ɴ ? ĨĂŵŝůǇ
(Kingsley 1994). It is secreted by the granulosa cells of the growing follicles, and is 
selectively responsible for pituitary inhibition of FSH secretion (Klein, Illingworth et al. 
1996; Hayes, Hall et al. 1998). In normal ovulatory cycles, serum concentration of Inhibin 
B is inversely correlated with FSH concentration and increases up to the mid follicular 
phase, when it reaches a maximum peak reflective of the mass of granulosa cells within 
recruited antral follicles, after which it progressively decreases (Groome, Illingworth et al. 
1996). Studies have reported significant positive correlation between higher levels of 
Inhibin B and number of oocytes collected after stimulation (Fowler, Fahy et al. 1995; 
Seifer, Lambert-Messerlian et al. 1997). Tinkanen et al found a negative correlation 
between serum inhibin B and FSH levels, and a positive correlation between inhibin B 
levels and antral follicle counts (Tinkanen, Blauer et al. 2001). However, the predictive 
value of inhibin B in predicting ovarian response is only modest with high false positive 
rates (Broekmans, Kwee et al. 2006). 
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Anti-Müllerian hormone (AMH) 
AMH is a glycoprotein hormone of TGF-ɴĨamily. AMH also known as Müllerian inhibiting 
substance is one of the best markers of ovarian reserve (Dehghani-Firouzabadi, Tayebi et 
al. 2008; Nelson, Yates et al. 2009). AMH is thought to be expressed by the granulosa cells 
of pre-antral and small antral follicles measuring 6.0 mm or less (Modi, Bhartiya et al. 
2006). The biological role of AMH is still unclear, but rodent data suggest that it acts as a 
modulator of follicle recruitment and ovarian steroidogenesis (Durlinger, Kramer et al. 
1999; Durlinger, Gruijters et al. 2001; Fanchin, Schonauer et al. 2003). It is considered to 
be a marker that can estimate the quantity and activity of recruitable follicles in early 
stages of growth, thus being more reliable for the prediction of ovarian reserve (te Velde 
and Pearson 2002; van Rooij, Broekmans et al. 2002; Fanchin, Schonauer et al. 2003; 
Gruijters, Visser et al. 2003; Muttukrishna, McGarrigle et al. 2005; Visser and Themmen 
2005).  
Studies have shown reduced variability in the levels of AMH as compared to other 
endocrine markers of ovarian reserve (Fanchin, Taieb et al. 2005; La Marca, Stabile et al. 
2006; Elgindy, El-Haieg et al. 2008). AMH has also been suggested as an important 
predictor of response to ovarian stimulation. Ficicioglu et al., for example, found that 
levels of AMH predict the number of oocytes retrieved with a positive predictive value of 
96% (Ficicioglu, Kutlu et al. 2006) and other groups have reported a strong correlation 
between the number of oocytes retrieved and both AMH levels and the total number of 
antral follicles (de Vet, Laven et al. 2002; van Rooij, Broekmans et al. 2005; Fanchin, 
Mendez Lozano et al. 2007; Dehghani-Firouzabadi, Tayebi et al. 2008). AMH is expressed 
by the granulosa cells of the early growing, pre-antral and small antral follicles, which 
measure less than 6 mm,, but not by non-atretic, larger antral follicles or those that have 
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become atretic, and may reflect or represent the population of smaller antral follicles 
more than the overall number (Baarends, Hoogerbrugge et al. 1995; Gruijters, Visser et al. 
2003; Weenen, Laven et al. 2004; Skalba, Cygal et al. 2008). Whilst serum levels of AMH 
correlate with the total number of antral follicles (de Vet, Laven et al. 2002; van Rooij, 
Broekmans et al. 2005; Fanchin, Mendez Lozano et al. 2007), it is likely that the smaller 
antral follicles more accurately reflect ovarian reserve than the total population of 
follicles.  
1.2.1.b   Ultrasonographic markers 
 
Transvaginal ultrasonographic assessment of the ovaries for ovarian volume, AFC and 
stromal blood flow has been described in relation to the assessment of ovarian reserve.  
2D ultrasound is widely used for this application. 3D ultrasound has been more recently 
introduced for assessment of ovarian reserve and might have a role in improving the 
predictive accuracy of tests of ovarian reserve.  2D ultrasound can display images in two 
planes, the sagittal and the transverse and often make the imaginative 3D interpretation 
of objects difficult (Nelson and Pretorius 1998). 3D ultrasound overcomes this problem by 
displaying the object in the coronal plane as well and also when required create a 3D 
rendered image of the object (Merz 1999).  
Ovarian volume 
Ovarian volume as measured by ultrasound has been assessed in studies as a potential 
marker of ovarian reserve. Syrop et al, in their study found a reduction in E2 levels, 
number of oocytes collected and pregnancy rates with decreasing volume of ovary in 
women undergoing assisted reproduction cycles (Syrop, Dawson et al. 1999). Bowen et al 
found a significant correlation between reduced ovarian volume, increasing age and FSH 
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levels (Bowen, Norian et al. 2007). Other studies did not detect a significant difference in 
ovarian volume between normal and poor responders in women aged less than 37 years 
(Elgindy, El-Haieg et al. 2008) and when evaluating women at high risk for cancellation of 
assisted reproduction cycles (McIlveen, Skull et al. 2007). Broekmans et al in their recent 
systematic review concluded that ovarian volume has little clinical application in 
prediction of poor pregnancy response (Broekmans, Kwee et al. 2006). However, de 
Carvalho et al in their recent review commented on the value of ovarian volume with 
regards to its easy execution, and therefore could be included in preparatory protocols 
providing data for continuity of research (de Carvalho, Rosa e Silva et al. 2008).  
tŚĞŶƵƐŝŶŐ ?ƵůƚƌĂƐŽƵŶĚ ?ƚŚĞĨŽƌŵƵůĂĨŽƌǀŽůƵŵĞŽĨĂŶĞůůŝƉƐŽŝĚ ? ‘ůĞŶŐƚŚA?ǁŝĚƚŚA?ĚĞƉƚŚ
× S ? ? ?ŝƐƵƐĞĚƚŽĐĂůĐƵůĂƚĞƚŚĞǀŽůƵŵĞŽĨŽǀĂƌǇ ?tŚĞŶƵƐŝŶg 3D ultrasound, there are two 
ďĂƐŝĐ ŵĞƚŚŽĚƐ ĞŵƉůŽǇĞĚ ƚŽ ĐĂůĐƵůĂƚĞ ǀŽůƵŵĞ ĨƌŽŵ Ă  ? ĚĂƚĂƐĞƚ P ƚŚĞ ĐŽŶǀĞŶƚŝŽŶĂů  ‘ĨƵůů
ƉůĂŶĂƌ ? Žƌ  ‘ĐŽŶƚŽƵƌ ? ŵĞƚŚŽĚ ĂŶĚ ƚŚĞ ƌĞĐĞŶƚůǇ ŝŶƚƌŽĚƵĐĞĚ  ‘ƌŽƚĂƚŝŽŶĂů ? ŵĞƚŚŽĚ ƉŽƐƐŝďůĞ
through Virtual Organ Computer-aided AnaLysis (VOCAL¥) which also generates a 3D 
model of the object of interest (Bordes, Bory et al. 2002). Both techniques involve manual 
delineation of the object of interest in the multiplanar display that shows the three 
perpendicular planes characteristic of 3D ultrasound. The reproducibility and validity of 
ovarian volume measurements made from 3D ultrasound data using the trapezoid 
formula were shown better than that those obtained by 2D ultrasound (Bonilla-Musoles, 
Raga et al. 1995; Kyei-Mensah, Maconochie et al. 1996). Whilst volume measurements 
using both the methods have been shown to be more reproducible than 2D 
measurements (Yaman, Sommergruber et al. 1999; Raine-Fenning, Campbell et al. 2003), 
the VOCAL technique is less time consuming (Bordes, Bory et al. 2002). VOCAL allows 
rotation of the 3D dataset about a central axis through a number of pre-defined rotation 
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steps (Bordes, Bory et al. 2002; Raine-Fenning, Campbell et al. 2002). The most 
appropriate rotation step for its use in a clinical or research setting recommended by the 
authors was 9° as it provided the best compromise between the reliability, validity and 
time taken for measurement (Raine-Fenning, Clewes et al. 2003). Another study by the 
same authors have shown that rotational measurement of ovarian volume from 3D data is 
significantly more reliable than volume estimation from 2D measurements using the 
ellipsoid formula (Raine-Fenning, Campbell et al. 2003). Ng et al. examined the predictive 
value of ovarian volume measured with the VOCAL imaging programme on datasets 
obtained from 3D ultrasound performed prior to ovarian stimulation but after down-
regulation in 111 women undergoing their first cycle of IVF (Ng, Tang et al. 2006). Multiple 
regression analysis was applied to evaluate the predictive value of age, basal FSH, BMI, 
and various ultrasound markers including ovarian volume, AFC and ovarian stromal 
vascularity, with the number of oocytes as the dependant variable. AFC achieved the best 
predictive value with the largest R
2
 change of 0.17 (P<0.001). Ovarian volume was 
excluded from the equation indicating that it was not a significant predictor. Furthermore, 
there was no statistically significant difference in the mean ovarian volume between 
pregnant and non-pregnant women. Recent meta-analyses did not find a significant 
impact on the predictive performance of ovarian volume regardless of whether it was 
measured by 2D or 3D ultrasonography. As an individual marker of ovarian reserve, the 
performance of ovarian volume in the prediction of non-conception is poor (Hendriks, 
Kwee et al. 2007; Verhagen, Hendriks et al. 2008). 
Ovarian stromal blood flow using Doppler ultrasound 
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Of the four types of Doppler ultrasound described (continuous wave, spectral  also known 
as pulsed wave Doppler, colour Doppler and power Doppler, pulsed wave and power 
Doppler are commonly used when assessing ovarian blood flow (Whittingham 2007).  
With pulsed wave Doppler the Doppler signals from a specific location can be isolated and 
ĂƐƐĞƐƐĞĚďǇƉůĂĐŝŶŐĂ ‘ƌĂŶŐĞŐĂƚĞ ?ĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞůŝŵƚƐŽĨƐĂŵƉůĞǀŽůƵŵĞ ?WƵůƐĞƐ
rather than continuous waves are transmitted successively and it allows the use of a 
single transducer for both transmission and reception of the signals. A wave form is 
displayed against time as the Doppler frequency shifts are electronically converted by a 
mathematical technique, fast Fourier transformation. These waveforms can be analysed 
and quantified to generate indices of blood flow in terms of the absolute flow velocities 
during peak systole and during diastole as well as providing an indication of the resistance 
to flow over the whole cardiac cycle. Two formulae are used to calculate the degree of 
resistance to flow: the Resistance Index (RI) and the Pulsatility Index (PI) (Gosling and King 
1974).  The resistance index is calculated by dividing the systolic peak velocity minus the 
end-diastolic velocity by the peak systolic velocity (Pourcelot, Arbeille et al. 1985). The 
index varies from zero to 1.00 with the latter indicating absence of end-diastolic flow. The 
resistance index is easily measured by defining the maximal systolic flow velocity and the 
end-diastolic flow velocity as two separate points whilst the pulsatility index is calculated 
by the on-board computer following manual delineation of the complete waveform over 
three to four consecutive and comparable cardiac cycles. The pulsatility index has the 
advantage therefore of taking into consideration more of the frequencies within any given 
waveform and is calculated by dividing the systolic peak velocity minus the end-diastolic 
velocity by the mean velocity. The pulsatility index has a distinct advantage in that it can 
produce variable values even when end-diastolic flow is reversed or absent, conditions 
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where the resistance index only records a negative value or a value of one respectively.  
The two main limitations of pulsed wave Doppler are that it is dependent on the angle of 
insonation (Rubin, Bude et al. 1994) and that it cannot differentiate between background 
noise and true flow (Jaffe 1992). 
Power Doppler is a variant of colour Doppler that utilises the amplitude or power of the 
Doppler signal to display the total integrated Doppler power from a Doppler shifted 
ultrasound signal in colour rather than the mean Doppler frequency shift (Rubin, Adler et 
al. 1995). Power Doppler signal depends on the density as opposed to the velocity of 
scatterers with the signal amplitude determined by the total energy or power within the 
returning signal. This allows a much greater sensitivity in detecting small vessels and slow-
moving blood. The number of colour-containing pixels and their hue depend 
approximately on the log of reflector concentration rather than on velocity (Adler, Rubin 
et al. 1995). The colour scale range from black for zero power to orange for high power. 
This range of colours depends on the density of blood cells (scatterers) within the area 
being examined by Doppler and represents a complex interaction between the 
haematocrit, shear stress, vascular diameter and flow velocity (Martinoli, Derchi et al. 
1998). However, the exact way in which blood and ultrasound interact to produce the 
Doppler signal is still not clearly understood (Paeng, Cao et al. 2001). The main advantages 
of it are that its acquisition is not angle dependent and that true flow is not affected by 
the background noise. Use of 3D ultrasound with power Doppler facilitates the acquisition 
of power Doppler data from a structure of interest as a whole. It is an appropriate method 
for the semi-quantification of the blood supply of an organ particularly ovarian blood flow 
because of the presence of small blood vessels with low velocity flow within an ovary 
within the pelvis (Raine-Fenning, Campbell et al. 2004). Furthermore, reliable acquisition 
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and measurement using VOCAL programme of 3D power Doppler information has been 
reported (Raine-Fenning, Campbell et al. 2003; Raine-Fenning, Campbell et al. 2004). 
There are only a few studies on the predictive capacity of ovarian vascular flow 
parameters for ovarian response or the occurrence of pregnancy using very different 
flow-derived predictors. Few studies have evaluated 2D pulsed wave Doppler in 
assessment of ovarian response (Zaidi, Barber et al. 1996; Zaidi, Collins et al. 1996; 
Engmann, Sladkevicius et al. 1999; Kim, Ku et al. 2002; Kupesic and Kurjak 2002; Kupesic, 
Kurjak et al. 2003). Peak systolic velocity (PSV) and resistance index (RI) were shown to be 
of some value in predicting ovarian response. One study has used 2D power Doppler in 
prediction of ovarian response  (Popovic-Todorovic, Loft et al. 2003). Few studies have 
used 3D power Doppler (Ng, Tang et al. 2006) in the assessment of ovarian reserve. All 
these studies have reported AFC as a superior test of ovarian reserve.  
Antral follicle count 
Ultrasonographic assessment of the total number of antral follicles measuring 2-10 mm is 
generally considered a reliable determinant of ovarian reserve (Scheffer, Broekmans et al. 
2003; Ng, Chan et al. 2005; Jayaprakasan, Campbell et al. 2008). The pool of antral follicles 
comprises of pre-antral and early antral follicles (0.2  W 2.0 mm) that are largely 
gonadotrophin-independent, small antral follicles (2.0-4.0 mm) that are gonadotrophin 
responsive, and larger antral follicles (>4.0 mm) that are gonadotrophin-dependent 
(Gougeon 1989). The follicle destined to become dominant is selected from the pool 
during the early follicular phase. With the exception of this dominant follicle, all other 
healthy follicles showing evidence of granulosa cell activity do not exceed 6 mm 
throughout the cycle (Gougeon 1998). Larger follicles are invariably atretic (Gougeon and 
Lefevre 1983). At any given timepoint during the menstrual cycle, the ovaries contain 
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follicles at different developmental stages and accordingly antral follicle counts are 
commonly made during the early follicular phase (Gougeon 1998). The total antral follicle 
count (tAFC) is made by counting the number of antral follicles measuring 2 to 10 mm in 
both ovaries and can be estimated using two-dimensional (Scheffer, Broekmans et al. 
2002) or three-dimensional ultrasound (Jayaprakasan, Campbell et al. 2008). It is now 
accepted that antral follicle count shows less inter-cycle variation when compared to 
ovarian volume and FSH (Jayaprakasan, Campbell et al. 2008; van Disseldorp, Lambalk et 
al. 2010). AFC made using 3D ultrasound might provide more reproducible counts than 2D 
ultrasound (Jayaprakasan, Hilwah et al. 2007; Jayaprakasan, Walker et al. 2007; 
Jayaprakasan, Campbell et al. 2008). Studies have shown significant correlations with the 
other serum markers (Haadsma, Bukman et al. 2007) and with serum AMH (Fanchin, 
Schonauer et al. 2003; Visser and Themmen 2005).  
The number of small antral follicles is also strongly correlated with other ovarian reserve 
tests, such as AMH, supporting the concept that these smaller follicles represent the 
functional ovarian reserve (Haadsma, Bukman et al. 2007). There is a linear decline in the 
number of antral follicles with age (Gougeon 1994) and this is more  apparent in the 
smaller antral follicles (<6.0 mm) than the larger ones (>6.0 mm) (Scheffer, Broekmans et 
al. 2003; Haadsma, Bukman et al. 2007) and their total number is, therefore, more 
reflective of the primordial follicle pool. Very few studies have considered the size of 
antral follicles other than to define the limits of follicular diameter above and below 
which follicles should not be included in the final count (Chang, Chiang et al. 1998; 
Pellicer, Gaitan et al. 1998; Weenen, Laven et al. 2004). Studies that have considered the 
size of the follicles between and above these extremes suggest that follicles measuring 2-
5mm correlate most strongly with assisted reproduction treatment outcomes (Chang, 
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Chiang et al. 1998). Pellicer et al. used 3D ultrasound to assess the population of these 
 ‘ƐĞůĞĐƚĂďůĞ ?ĨŽůůŝĐůĞƐŝŶǇŽƵŶŐ ?ůŽǁƌĞƐƉŽŶĚĞƌƐĂŶĚĨŽƵŶĚƚŚĂƚƚŚĞŶƵŵďĞƌŽĨĂŶƚƌĂůĨŽůůŝĐůĞƐ
measuring 2-5 mm in diameter was significantly less age-matched normal responders 
(Pellicer, Ardiles et al. 1998). 
The standard technique used to the quantify the size of an antral follicle involves 
calculation of the mean diameter from two measurements of the follicular diameter 
(Haadsma, Bukman et al. 2007). No studies have reported on the intra- or inter-observer 
reliability of quantitative antral follicle counts stratified according to the size of the 
follicle. Measurement reliability is likely to be relatively poor as it will depend on both the 
identification and subsequent measurement of each follicle. There is a natural variation in 
determining the total number of antral follicles, both within and between observers and 
once a follicle has been identified there will be further variability in its measurement. Any 
variability is likely to be exaggerated when there are larger numbers of antral follicles as 
more measures are required overall (Scheffer, Broekmans et al. 2002; Jayaprakasan, 
Campbell et al. 2008). Assessment of follicle size requires measurement of each follicle in 
two dimensions and calculation of the mean diameter (Haadsma, Bukman et al. 2007). 
This can be very labour intensive and the reliability and validity of such measures are 
likely to be reduced when there are numerous follicles as it is difficult to ensure each 
follicle is only measured once and none are missed. Three-dimensional ultrasound allows 
the user to acquire a volume of information which can be examined off-line and facilitates 
the implementation of various software programmes that enhance measurement 
accuracy and both intra- and inter-observer reliability (Raine-Fenning, Campbell et al. 
2003). The most recent development has seen the introduction of automated data 
analysis where mathematical algorithms allow the definition and differentiation of hypo 
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echoic, fluid-filled areas within the acquired volume (Raine-Fenning, Jayaprakasan et al. 
2007). 
SonoAVC (Sonography based automated volume calculation: GE Medical Systems, Zipf, 
Austria) is a new software program that identifies and quantifies hypo echoic regions 
within a three-dimensional dataset and provides automatic estimation of their absolute 
dimensions, mean diameter, and volume (Raine-Fenning 2008). Each individual volume is 
given a specific color and the automated measurements of its mean diameter (relaxed 
sphere diameter), its maximum dimensions (x, y, z diameters), and its volume are 
displayed in descending order from the largest to the smallest (Raine-Fenning 2008). An 
unlimited number of volumes can theoretically be quantified, which makes it an ideal tool 
for follicle tracking. It also identifies small volumes and can theoretically be used to count 
antral follicles. To date SonoAVC has been used to assess stimulated ovaries only (Raine-
Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008). These studies have shown that 
SonoAVC provides automatic measurements of follicular diameter and volume that are 
more reliable and more accurate than comparable estimations made from 2D data (Raine-
Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008). However, its reliability and 
application in assessing antral follicles has not been tested so far. 
 
1.2.2 Physiological variation in the markers of ovarian reserve 
 
The process of folliculogenesis is a continuous process, from the stage of primordial 
follicles to the preovulatory stage, and therefore at any time, the ovary contains follicles 
in all stages of development (Gougeon 1998). Tests evaluating ovarian reserve are 
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classically performed in the early follicular phase and therefore the ranges of normality 
described also relate to the values in that stage of menstrual cycle. The follicular phase of 
the menstrual cycle, also the final stages of follicular growth includes the late tertiary 
antral follicles and preovulatory follicles. During the late luteal phase with the 
disintegration of corpus luteum and consequent rise in pituitary follicle stimulating 
hormone (FSH), the 2  W 5 mm follicles, which have entered the preantral stage 70 days 
earlier, become selectable follicles competing with each other for growth inducing FSH. 
The selectable antral follicles are gonadotrophin dependent and compete with each other 
for growth inducing FSH. Age related increases in gonadotrophins have been 
demonstrated in both basal determinations (Sherman, West et al. 1976; Reyes, Winter et 
al. 1977; Metcalf and Livesey 1985) and in provocative tests such as clomiphene citrate 
challenge test (Navot, Rosenwaks et al. 1987; Loumaye, Billion et al. 1990). Therefore, an 
early serum FSH is commonly determined in the work up of female subfertility. Brown et 
al investigated the intercycle and day to day early follicular variation in the serum levels of 
FSH and found a mean variation of up to 25.6% between cycles and a mean variation of 
up to 15% in the day to day early follicular levels (Brown, Liu et al. 1995). This variation 
was significantly less than that observed in serum E2 levels (Brown, Liu et al. 1995). This 
variation could be reflective of the quantity and quality of selectable follicle. 
AMH which is expressed in the granulosa cells of growing follicles, in the recent years has 
been shown in several studies to be a univariate predictor of outcome after IVF. The pool 
of growing follicles is thought to relate to the number of primordial follicles and therefore 
considered as an indirect marker of ovarian reserve. As AMH is primarily expressed by 
small antral follicles, it is thought to relate closely to primordial follicle number (Kevenaar, 
Meerasahib et al. 2006). Another advantage of using AMH as a marker of ovarian reserve 
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is that the levels do not fluctuate across and between cycles as much as the other 
endocrine markers (E2, Inhibin B, FSH, LH) of ovarian reserve (Hehenkamp, Looman et al. 
2006; La Marca, Stabile et al. 2006; La Marca, Giulini et al. 2007; Tsepelidis, Devreker et al. 
2007).  
The antral follicle count (AFC), an ultrasound marker of ovarian reserve can be measured 
using two-dimensional or three-dimensional ultrasound (Scheffer, Broekmans et al. 2002). 
A recent meta-analysis done on the accuracy of multivariate models predicting ovarian 
reserve and pregnancy following ART, has shown that the performance of multivariate 
models in the prediction of poor ovarian response after IVF is comparable with that of 
AFC (Verhagen, Hendriks et al. 2008). Jayaprakasan et al looked at the intercycle 
variability of AFC, ovarian volume, and basal FSH levels and found least variation in AFC 
(Jayaprakasan, Campbell et al. 2008). Their work also supports the use of 3D ultrasound in 
improving the reliability of the test (Jayaprakasan, Walker et al. 2007; Jayaprakasan, 
Campbell et al. 2008). The small antral follicle population which might be a test of 
functional reserve has not been tested as yet for its physiological variations and its 
reliability as a test of ovarian reserve. 
 
1.3 Benign ovarian cysts 
The most common types of benign ovarian cysts are endometrioma, dermoid, cyst 
adenoma, and functional ovarian cysts.  The incidence rate for developing a simple cyst is 
about 8% per year and is more common in pre-menopausal women (Reynolds, Hill et al. 
1986). They could be either a functional cyst wherein the dominant follicle does not 
release the oocyte and the follicle continues to grow forming a cyst, or a luteal cyst which 
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is formed within the corpus luteum, or a haemorrhagic cyst which is formed by collection 
of blood in either a functional or a luteal cyst. Mature cystic teratomas or dermoids 
represent more than 10% of all ovarian ŶĞŽƉůĂƐŵ ?Ɛ and are the most common benign 
germ cell tumours of the ovary in women of reproductive age.  They arise from 
ectodermal (hair, skin, sweat glands), mesodermal (bone, muscle, cartilage) and 
endodermal tissue elements (neural and vascular tissue lines) in variable amounts. 
Endometriosis affects 3 - 10% of women in their reproductive age and is the leading cause 
of sub fertility, seen in about 25-35% of women with infertility (Jenkins, Olive et al. 1986; 
Mahmood and Templeton 1991). Endometriomas are identified in 17-44% of women with 
endometriosis (Chapron, Vercellini et al. 2002). According to the implantation theory, the 
endometrial implants cause adherence of the ovary to pelvic peritoneum and 
progressively invaginate the ovarian cortex (Hughesdon 1957; Brosens, Puttemans et al. 
1994). Another theory suggests that endometrioma is formed due to the metaplasia of 
coelomic epithelium which invaginate into the ovarian cortex (Donnez, Nisolle et al. 
1996). These theories suggest that an endometrioma is perhaps a pseudo cyst.  
Ovarian cysts can cause pain and discomfort related to pressure on adjacent structures, 
torsion, rupture, haemorrhage (both within and outside of the cyst), and abnormal 
uterine bleeding (Chapron, Vercellini et al. 2002). Rarely, they become malignant. Clear 
cell carcinoma and endometroid adenocarcinoma are the most common type of 
carcinoma associated with endometriosis (Kobayashi, Kajihara et al.). It is hypothesised 
that repeated events of haemorrhage in endometriosis can contribute to carcinogenesis 
and progression via 3 major processes: 1) increasing oxidative stress promotes DNA 
methylation; 2) activating anti-apoptotic pathways supports tumour promotion; and 3) 
aberrant expression of stress signalling pathways (Kobayashi, Kajihara et al.). Malignant 
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transformation in a dermoid cyst of the ovary is a rare complication, occurring in only 1-
2% of cases, with squamous cell carcinoma being the most common type (Powell, Stinson 
et al. 2003; Hurwitz, Fenton et al. 2007). In assisted reproduction treatment, three 
mechanisms are feared to alter the outcome of treatment, one that ovary containing the 
cyst may not respond adequately to COH, second that oocytes collected may get 
contaminated by the cyst fluid, and lastly that inadvertent puncture of cyst during oocyte 
collection might cause subsequent peritonitis and infection.  
Table 1: Ultrasonic diagnostic features of commonly occurring benign cysts.  
Diagnosis of ovarian cysts is predominantly based on the morphologic features of the cyst on 
ultrasound as shown in the table below. 
Functional cysts 
     Follicular cyst 
 
 
    Corpus luteum cysts 
 
hŶŝůŽĐƵůĂƌ ĐǇƐƚ A? ?ĐŵƐ ŝŶ ĚŝĂŵĞƚĞƌ ǁŝƚŚ Ă ƚŚŝŶ ƐŵŽŽƚŚ ǁĂůů ĂŶĚ
echo free fluid within it. Some may undergo haemorrhagic 
change producing echogenic fluid (Reynolds, Hill et al. 1986) 
Hypo echoic cysts with thick walls and varying size although 
usually less than 3cms. Haemorrhage is often seen (Reynolds, Hill 
et al. 1986) 
Endometrioma Thin walled ovoid or round hypo echoic masses containing fluid 
with scattered internal echoes or gravity dependent fluid filled 
levels from layering of haemorrhage. Acoustic enhancement 
through the lesion (Athey and Diment 1989) 
Germ cell tumour  
Dermoid / Teratoma 
Echogenic mass of varying density and shadowing. Echogenic 
particles in a hypo echoic medium (dermoid mesh). Cyst with fat-
fluid level where the uppermost oil layer is echo free (Caspi, 
Appelman et al. 1996).  
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Khamsi et al reported a study of 14 women in whom endometrioma was inadvertently 
entered resulting in retrieved oocytes that were either exposed or not exposed to 
endometrioma fluid. They found no difference in fertilization or early embryo 
development between the two groups. The fertilization rate for oocytes exposed to an 
endometrioma was 60%, versus 56% for controls. The good-quality embryo formation 
rate for oocytes exposed to an endometrioma was 45%, versus 46% for controls. (Khamsi, 
Yavas et al. 2001). In contrast, another study found high concentrations of transforming 
growth factor-B1in the fluid of endometrioma and showed a growth enhancing effect on 
endometrioma cells (Badawy, Cuenca et al. 1998). It is therefore a common practice to 
excise the ovarian cysts especially when measuring more than 4cms.  
Operative laparoscopy compared with laparotomy has been established as the gold 
standard surgical approach in the treatment of ovarian cysts in terms of reduced 
postoperative pain, analgesic requirement, hospitalization, and adhesion formation 
(Pados, Tsolakidis et al. 2006). Potential problems with surgical treatment of ovarian cysts 
are the small risk of post surgical ovarian failure of 2.4% especially when dealing with 
bilateral ovarian cysts (Busacca, Riparini et al. 2006), a moderate 30.4% risk of recurrence 
(Koga, Takemura et al. 2006) and a reduction in ovarian reserve. The principle of 
cystectomy is to either remove or destroy the cyst wall or capsule in order to prevent 
recurrence. The techniques commonly used therefore are stripping of the cyst from 
underlying normal ovarian tissue or drainage of the cyst with ablation of cyst wall. 
Following the excision of the cyst or stripping of the cyst wall from the ovarian cortex, it is 
a normal practice to achieve haemostasis in the cyst bed using some form of coagulation, 
either monopolar, bipolar, laser, or an ultrasonic device. The current body of evidence 
suggests that ovarian cysts especially endometrioma can affect the function of the 
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adjacent normal ovarian tissue (Maneschi, Marasa et al. 1993), and that stripping of 
ovarian cyst is associated with inadvertent loss of normal ovarian tissue attached to it 
(Hachisuga and Kawarabayashi 2002; Muzii, Bianchi et al. 2002; Roman, Tarta et al. 2010). 
Few studies have suggested that damage to ovarian reserve seen with removal of 
endometriomas might be more pronounced than non-endometriotic cysts (Maneschi, 
Marasa et al. 1993; Muzii, Bianchi et al. 2002; Exacoustos, Zupi et al. 2004; Chang, Han et 
al. 2010; Iwase, Hirokawa et al. 2011). There is also suggestion that inexperience of the 
surgeon can increase the damage caused to the normal ovarian tissue and ovarian reserve 
thereby (Yu, Huang et al.). When looking at outcomes following assisted reproduction 
treatment, Esinler et al found that although the ovarian reserve reduces following 
endometrioma cystectomy, it does not translate into impaired pregnancy outcome. 
(Esinler, Bozdag et al. 2006). This finding was in agreement with another study reporting a 
quantitative but not a qualitative damage to ovarian reserve following laparoscopic 
excision of endometrioma. (Ragni, Somigliana et al. 2005). Somigliana et al observed the 
response of operated ovary and the non operated contra lateral ovary during ovarian 
stimulation as part of an IVF cycle, and found a significant reduction in the ovarian reserve 
in the operated ovary, as measured by the number of follicles measuring >15mm on day 
of HCG administration (Somigliana, Ragni et al. 2003). Candiani et al also found a 
reduction in the ultrasound markers of ovarian reserve following ovarian cystectomy for 
benign cysts when compared to the contra lateral normal ovary, however suggested this 
effect due to ovulation in the intact gonad and not due to injury to ovarian 
vascularisation. (Candiani, Barbieri et al. 2005).  
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1.3.1 Systematic review of current literature 
 
Recently a cochrane database systematic review was conducted to determine the 
effectiveness and safety of surgery, medical treatment, combination therapy or no 
treatment for improving reproductive outcomes among women with endometriomata, 
prior to undergoing ART cycles (Benschop, Farquhar et al.). The endometrioma included in 
analysis were those that were diagnosed by laparoscopy or imaging tests including 
ultrasound and magnetic resonance imaging (MRI). The primary outcome evaluated was 
live birth rate and secondary outcomes included ovarian response, clinical pregnancy rate 
ĂŶĚŵŝƐĐĂƌƌŝĂŐĞ ?&ŽƵƌZd ?ƐŝŶĐůƵĚŝŶŐ ? ? ?ƉĂƌƚŝĐŝƉĂŶƚs were further analysed. None of the 
trials reported on the live birth rates and paucity of evidence on this outcome persists. 
None of the trials showed a significant effect on reproductive outcomes including clinical 
pregnancy rate and miscarriage. Laparoscopic aspiration or cystectomy of 
endometriomata prior to ART did not show evidence of benefit over expectant 
management with regard to the clinical pregnancy rate (Benschop, Farquhar et al.).  
When comparing expectant management to surgical approach, the chance of conception 
is not the only issue that has to be considered. Whilst costs and hazard of surgical 
complications support expectant management, oocyte retrieval risks, the possibility of 
missing occult malignancy and endometriosis progression due to ovarian stimulation 
would favour surgical treatment. Alternative therapeutical options include medical 
treatment and ultrasound-guided aspiration. Whereas prolonged GnRH agonist down-
regulation may be beneficial, data on ultrasound aspiration are more controversial 
(Somigliana, Vercellini et al. 2006). The laparoscopic excision of ovarian endometriomas 
appears to increase the chances of spontaneous conception, but the value of this 
treatment in women selected for IVF WICSI cycles is debated. Studies recruiting women 
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with unilateral disease and comparing the ovarian response in the affected ovary to  
contralateral normal ovary indicate that excision of endometriomas is associated with a 
quantitative damage to ovarian reserve (Somigliana, Vercellini et al. 2006).  
Various methods have been reported to evaluate ovarian reserve following ovarian 
cystectomy. These include ovarian response and or pregnancy rate in women undergoing 
assisted reproduction treatment (ART); two Wdimensional ultrasound markers of ovarian 
reserve such as volume, vascularity, and AFC (2.0-10.0mm); ovarian volume as measured 
using 3D ultrasound; and endocrine markers of ovarian reserve including AMH and FSH. 
The ovarian reserve in operated ovary has more commonly been compared to either the 
contra lateral normal ovary or matched controls, and in very few studies to itself in a 
longitudinal study design. Studies that have used outcomes of ovarian response to 
evaluate ovarian reserve have used measures including the duration of ovarian 
stimulation, the number of oocytes collected, fertilisation rate, and clinical pregnancy rate 
when examining the effects of ovarian cystectomy in sub-fertile population undergoing 
assisted reproduction treatment. They have compared the ovarian response of operated 
ovary either to the contra lateral normal ovary or to the matched case-controls (Loh, Tan 
et al. 1999; Canis, Pouly et al. 2001; Marconi, Vilela et al. 2002; Somigliana, Ragni et al. 
2003; Wong, Gillman et al. 2004; Loo, Lin et al. 2005; Alborzi, Zarei et al. 2006; Esinler, 
Bozdag et al. 2006; Somigliana, Vercellini et al. 2006; Alborzi, Ravanbakhsh et al. 2007; 
Nakagawa, Ohgi et al. 2007; Horikawa, Nakagawa et al. 2008; Kahyaoglu, Ertas et al. 2008; 
Somigliana, Arnoldi et al. 2008; Benaglia, Somigliana et al. 2009; Garcia-Velasco and 
Somigliana 2009; Tsoumpou, Kyrgiou et al. 2009; Benaglia, Somigliana et al. 2010). 
Ovarian cystectomy has been shown to impair ovarian reserve following assisted 
reproduction treatment (ART), but reduced ovarian reserve does not seem to translate 
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into impaired pregnancy outcome (Demirol, Guven et al. 2006; Esinler, Bozdag et al. 2006; 
Somigliana, Ragni et al. 2006; Kahyaoglu, Ertas et al. 2008; Garcia-Velasco and Somigliana 
2009). Few studies have reported ovarian volume in conjunction with ovarian response 
and compared to the response in contra lateral ovary (Somigliana, Ragni et al. 2006). Few 
studies have used ultrasound markers such as volume, antral follicle count, and stromal 
blood flow in the operated ovary and compared to the contra lateral ovary (Exacoustos, 
Zupi et al. 2004; Candiani, Barbieri et al. 2005; Benaglia, Somigliana et al. 2010; Coric, 
Barisic et al. 2010; Donnez, Lousse et al. 2010).  One prospective longitudinal studies 
comparing postoperative ovary to the preoperative ovary has used endocrine and 
ultrasound markers of ovarian reserve with post operative follow up (Candiani, Barbieri et 
al. 2005; Chang, Han et al. 2009; Li, Liu et al. 2009; Tsolakidis, Pados et al. 2009; Chang, 
Han et al. 2010; Pados, Tsolakidis et al. 2010; Iwase, Hirokawa et al. 2011)).  Both, 
ultrasound and endocrine markers of ovarian reserve have been used in the literature to 
quantify the impact of pathology and surgery. The endocrine markers such as Follicle 
Stimulating Hormone (FSH), Anti-Müllerian Hormone (AMH), Oestradiol, and Inhibin B 
provide information on ovarian reserve of both ovaries as a combined unit. Ultrasound is 
the only method so far which allows a direct assessment of each ovary as a separate 
entity; however the measures derived are presented either as a mean or total value.  
In clinical practice, assessing both ovaries as a combined unit is of relevance in managing 
sub fertile couples, and the only area where examining each ovary as a single unit 
probably holds its place is when examining the effects of surgery. Majority of the studies 
looking at effect of surgery on ovarian reserve have done so by either comparing the 
operated ovary to the non operated contra lateral gonad, or to a control group. 
  
S h i l p a  D e b   P a g e  | 56 
 
 
1.4. Rationale for the study and Hypothesis 
 
The evidence suggests that ovarian cystectomy may be detrimental to the ovarian 
reserve, however there is wide variation in the methods employed to evaluate this effect. 
The total antral follicle count (2-10mm) and AMH appear to be the two most predictive 
and reliable markers of ovarian reserve, correlating well with each other and also with 
ovarian ageing. There is a suggestion that 3D ultrasound provides more reliable total 
antral follicle counts. Small antral follicle counts (2-6mm) may have a role in prediction of 
ovarian reserve as it correlates better to ovarian ageing than larger antral follicles. Also, 
production of AMH is mainly by pre antral and these small antral follicles, thereby 
providing a possibility of improving upon the predictive ability of total AFC.  
My hypothesis was that small antral follicle counts produce better estimates of ovarian 
reserve and that it would be a reliable test to use when evaluating the effect of ovarian 
cystectomy on ovarian reserve. My specific objectives to examine this hypothesis were to: 
(1)  Determine the intraobserver and interobserver reliability of antral follicle 
counts made using 3D ultrasound assisted SonoAVC and compare to counts 
made using 2D ultrasound and manual 3D ultrasound method. 
(2) Examine the optimum means of quantifying antral follicle number and size by 
comparing 2D and automated 3D ultrasound techniques.  
(3) Validate the antral follicle counts of different follicle size cohorts made using 
2D and 3D ultrasound methods 
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(4) Determine the predictive value of the automated quantification of the number 
and size of small antral follicles in women undergoing assisted reproduction 
treatment. 
(5) Determine the inter-ovarian, intra- and inter-cycle variation in the antral follicle 
counts of different follicle size cohorts made using semi-automated 3D 
ultrasound technique in women with normal menstrual cycles. 
(6) Determine the effect of combined oral contraceptive pill on the markers of 
ovarian reserve in comparison to non pill users.  
(7) Examine the effect of ovarian cystectomy on ovarian reserve using the most 
reliable method. 
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CHAPTER 2.  Materials and Methods 
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This chapter includes the materials and methods used to initially evaluate the reliability 
and validity of method used, followed by methods used to assess factors that could 
influence ovarian reserve, including, the physiological variation in the markers of ovarian 
reserve, effect of combined oral contraceptive pills containing low dose estrogen, and 
effect of ovarian cysts and cystectomy on the markers of ovarian reserve. 
 
2.1  Ultrasound Technique 
 
2.1.1 Data acquisition 
 
All the transvaginal ultrasound examinations were performed using a Voluson Expert 
730
TM 
or Voluson E8 Expert
 
(GE Medical Systems, Zipf, Austria) and a four-dimensional, 5-9 
MHz transvaginal transducer. Scans were performed in the standard manner with the 
patient in a supine position with knees flexed and hips abducted. The assessment 
comprised of a preliminary conventional 2D ultrasound assessment of the pelvis, to 
exclude any obvious pathology, followed by visualization of ovaries in their transverse and 
longitudinal planes and the subsequent acquisition of 3D data using the volume mode. 
The volume mode, which displays a truncated sector, was then adjusted to precisely 
define the area of interest; the sweep angle set to 90
0
 and a 3D dataset acquired using the 
high quality, slow sweep mode, which results in the highest resolution. The resultant 
multiplanar display of the ovary was examined to confirm its inclusion in entirety. 3D 
datasets on the blood flow to the ovaries using 3D power Doppler was again acquired 
using the high quality, and a slow sweep mode with the sweep angle set to 90
0
.  Pulsed 
wave Doppler was used to measure the ovarian blood flow in the stromal blood vessels. 
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Similar acquisitions of 3D grey scale dataset and 3D power Doppler was performed on the 
uterus and cervix, and pulsed wave Doppler of uterine arteries acquired. Datasets from 
each subject was stored on recordable digital video discs (DVDs) for subsequent off line 
analysis under a unique identification code.  
 
2.1.2 Data display and analysis 
 
4D View  (version 7.0, GE Medical Systems) was used for offline data analysis. The 3D 
dataset were opened and displayed using the multiplanar view (Figure 2.1), which shows 
three sectional planes (the A, B, and C plane) simultaneously that are mutually related so 
that movement within one plane produces geometrically equivalent movements in the 
other two planes. These planes can be used to standardize the view of the ovary, or any 
3D dataset, and for this thesis we would ensure that the A plane shows the ovary in its 
longitudinal section with the iliac vessels inferiolaterally and the B plane the transverse 
image orthogonal to this. This orientation automatically ensures the image presented in 
the C plane demonstrates the coronal view of the ovary. This view is described as a 
multiplanar view and was used to measure the number of antral follicles in each ovary. 
This display provides the investigator an  advantage of being able to cross-check the 
number of follicles in any one plane against the two other image planes, which provides 
the observer with more spatial information than conventional imaging and results in more 
reliable and valid qualitative and quantitative measurements (Scheffer, Broekmans et al. 
2002; Jayaprakasan, Campbell et al. 2008). The quality of the image was adjusted and 
optimized, in tĞƌŵƐŽĨŵĂŐŶŝĨŝĐĂƚŝŽŶ ? ĨŽƌ Ăůů ĚĂƚĂƐĞƚƐ ĂŶĚ ƚŚĞ  ‘ƌĞŶĚĞƌŵŽĚĞ ?ĞŶƚĞƌĞĚ ƚŽ
generate a 3D rendered view of the ovary. The render box was adjusted to exclude as 
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much extra-ovarian information as possible and to ensure that the whole ovary was 
included in the volume of interest (VOI). The threshold settings, which assign 
transparency associated with fluid to opaque voxels, was maintained for all datasets.  
Figure 2.1 Multiplanar view of the ovary with a render box defining the region of 
interest. The figure shows the typical display of an image acquired using 3D ultrasound. Three 
planes the longitudinal, transverse and the coronal planes of the image acquired are displayed 
simultaneously on the screen. The render box delineates the area of interest and allows further 
processing of image. 
 
Once the dataset is correctly positioned, SonoAVC was implemented. The individual 
follicles are then displayed with a specific colour and shown together with their 
dimensions and relative sizes (Figure 2.2).  
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Figure 2.2 SonoAVC - automated measurement of antral follicles 
 
Figure 2.3 SonoAVC with post processing  ? semi-automated measurement of 
antral follicles 
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Post-processing, involving the manual identification of follicles not included in the 
automated analysis, was then used to ensure all antral follicles are counted and measured 
(Figure 2.3). Each additional antral follicle identified in this way is given a new colour and 
its dimensions displayed together with those follicles that were originally identified. The 
mean diameter of relaxed sphere of each antral follicle in both ovaries displayed as d (v) 
was recorded.           
Figure 2.4  Ovarian volume calculated with VOCAL 
Volume of each ovary was analysed using virtual organ computer aided analysis (VOCAL) 
on 4D view (Figure 2.4). This is done by delineating the ovarian cortex in one standard 
plane as the volume is rotated 180
0
 through 30
0
 rotational steps.  
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Figure 2.5  3D Power Doppler Indices  
To obtain the power Doppler indices (vascularisation index-VI, flow index-FI, and 
vascularisation flow index-AFI), facility of histogram was applied on the rendered image of 
the ovary obtained using VOCAL.         
 
Figure 2.6  Blood flow in stromal ovarian artery using pulsed wave Doppler 
indices:  Pulsed wave Doppler indices were recorded from the stored dataset for each 
ovary and the uterine arteries.      
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Department of Obstetrics and Gynaecology at Nottingham University Hospitals 
predominantly uses the Voluson series of ultrasound machines manufactured by GE. This 
is perhaps to help with the purchase power and service contracts. Whilst many other 
manufacturers including Medison, Toshiba, Siemens and Hitachi have 3D probe 
incorporated in some of the ultrasound machines, the applications are limited to simply 
the acquisition of 3D data.  “sŽůƵƐŽŶ ?series has the facility to manipulate and process 
images off-line using the software  ‘4D view ?. Whilst 4D view equivalent is available on 
Medison manufactured ultrasound machine, automated volume counts using SonoAVC is 
unique to Voluson series of ultrasound machines manufactured by GE and was therefore 
used for my research project. 
2.2 Subject profile 
The research studies were conducted in accordance with the ethical principles that have 
their origin in the Declaration of Helsinki on Ethical Principles for Medical Research 
Involving Human Subjects, adopted by the General Assembly of the World Medical 
Association (1996), and the principles of the International Conference on Harmonization 
guideline on Good Clinical Practice. Ethical approval was granted by the University of 
Nottingham and Nottingham Research Ethics Committee (REC) (Reference numbers: 
 ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ? Z  ? ? ?, ? ? ? ? ? ? ? ? ĂŶĚ ƚŚĞ EŽƚƚŝŶŐŚĂŵhŶŝǀĞƌƐŝ Ǉ ,ŽƐƉŝƚĂů ?Ɛ
Research and Development Department (Ref: 08GY001). Informed, written consent was 
obtained prior to the enrolment of all subjects.  
2.2.1 Reliability of SonoAVC 
Fifty-five subjects aged less than 40 years with early follicular phase Follicle Stimulating 
Hormone (FSH) below 15 IU/L, planning to undergo treatment for their sub fertility, were 
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prospectively recruited. Ultrasound was performed during the early follicular phase of 
menstrual cycle between days 2-5. The numbers of follicles measuring between 2 to 10 
mm in diameter were counted in each ovary to calculate the total antral follicle count in 
that ovary. Subjects who had had previous ovarian surgery, had one ovary, and those with 
ovarian cysts or follicles measuring more than 10 mm were excluded from the study. 
Three-dimensional datasets were acquired and subsequently analysed. The tAFC (2-10mm 
antral follicles) was calculated by two observers using three independent methods: 2D 
real time equivalent (2DRTE), 3D manual multiplanar view (3DMPV), and SonoAVC. For 
measures made using SonoAVC, the initial automated count (sAVC-AA) was recorded and 
post-processing (sAVC-PP) then applied to identify follicles that had been missed or 
incorrectly included. Intraclass correlation and limits of agreement were used to evaluate 
the methods.  
2.2.2 SonoAVC in prediction of outcome following assisted reproduction 
treatment 
156 consecutive subjects planning to undergo their first treatment cycle of in vitro 
fertilisation (IVF) were prospectively recruited. Inclusion criteria included age less than 40 
years, body mass index (BMI) of less than 30, regular menstrual cycles of 24-32 days 
duration, planned first cycle of IVF with or without ICSI, and an early follicular phase FSH 
level of <15IU/L. All subjects underwent a pre-treatment ultrasound assessment in the 
early follicular phase (cycle day 2-5) of menstrual cycle. Subjects were excluded if they 
were found to have an ovarian follicle or cyst measuring more than 20 mm in diameter. 
Recruited subjects were subsequently excluded if their treatment cycle was cancelled or if 
they had failed fertilisation or embryo cleavage. Subjects wishing to egg share or 
altruistically donate their oocytes were not included. 
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A long protocol, involving pituitary suppression with Gonadotrophin Releasing Hormone 
(GnRH) agonists (500 mcg/day of Buserelin; Suprefact®, Aventis Pharma, Kent, UK or 800 
mcg/day of Nafarelin; Synarel®, Pharmacia, Milton Keynes, UK) started in the mid-luteal 
phase of the menstrual cycle, was used in all subjects. Ovarian stimulation was 
commenced once down regulation was confirmed with a daily dose of either 225 IU of 
recombinant Follicle Stimulating Hormone (FSH; Gonal-F; Serono Pharmaceuticals Ltd, 
Feltham, UK) or 225 IU of human menopausal gonadotrophin (hMG; Menopur; Ferring 
Pharmaceuticals Ltd, UK). The response to ovarian stimulation was monitored by 
ultrasound and serum oestradiol levels on an alternate day basis from the fifth day of FSH 
administration and human Chorionic Gonadotrophin (hCG; 6500 IU of Ovitrelle; Serono 
Pharmaceuticals Ltd, Feltham, UK when using recombinant FSH or 5000 IU of Pregnyl; 
Organon Laboratories Ltd when using Menopur) administered when there were at least 
three follicles measuring 18 mm or more in diameter with transvaginal, ultrasound-guided 
oocyte retrieval scheduled 36 hours later. One or two embryos were replaced according 
to the wishes of the couple and the number of embryos available 48 hours later. From the 
day of embryo transfer, luteal support was provided through the self-administration of 
progestogen pessaries (Cyclogest; Shire Pharmaceuticals Ltd, Basingstoke, Hants, UK). 
Clinical pregnancy, as confirmed by a transvaginal ultrasound scan performed 5 weeks 
following embryo transfer assessing the fetal viability, was taken as the primary outcome 
measure for analysis. Secondary outcome measures assessed included the number of 
mature oocytes, fertilised oocytes and cleaved embryos. 
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2.2.3 Physiological variation in ovarian reserve 
Healthy volunteers were recruited prospectively through local advertisement. The 
inclusion criteria included was subjects with regular periods aged between 18 to 45 years, 
and with no previous history of ovarian surgery. 
To assess the intracycle variation in ovarian reserve, assessments were planned for early 
follicular, mid follicular, peri-ovulatory and mid to late luteal phases of menstrual cycle. 
The assessments involved transvaginal ultrasound scans for the three-dimensional 
ultrasound markers and a blood test for endocrine markers of ovarian reserve each visit.   
To assess the intercycle variation in ovarian reserve, assessments were planned in the 
early follicular phase of menstrual cycle at 0, 1, 3, 6 and 12 months.  The assessments 
involved transvaginal ultrasound scans for the three-dimensional ultrasound markers and 
a blood test for endocrine markers of ovarian reserve each visit.   
2.2.4 Effect of combined oral contraceptive pills 
Healthy volunteers were prospectively recruited with the help of local advertisement. The 
inclusion criteria included subjects with regular periods aged between 18 and 45 years, 
with no previous history of surgery on the ovaries, and who were taking combined oral 
contraceptive pills containing low dose estrogen for more than one year. The control 
group included subjects with regular periods aged between 18 and 45 years, with no 
previous history of ovarian surgery, and who had not taken hormonal contraceptive in the 
last one year. 
Assessments involved a transvaginal ultrasound scan for three dimensional ultrasound 
markers of ovarian reserve and blood test for endocrine markers of ovarian reserve in the 
early follicular phase of the menstrual cycle.  
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2.2.5 Effect of ovarian cyst and cystectomy  
Subjects with regular periods aged between 18 and 45 years planned to have an ovarian 
cystectomy for benign ovarian cyst were prospectively identified and recruited from the 
out patients department, gynaecology wards, preoperative clinics, patient waiting lists 
ĂŶĚ ŽƉĞƌĂƚŝŶŐ ĚŝĂƌǇ ŽĨ ƚŚĞ ŐǇŶĂĞĐŽůŽŐŝƐƚ Ăƚ YƵĞĞŶ ?Ɛ ŵĞĚŝĐĂůĞŶƚƌĞ ?The assessments 
involved a transvaginal ultrasound scan and a blood test for the markers of ovarian 
reserve in the early follicular phase of menstrual cycle pre operatively and 1, 3, and 6 
months post operatively. 
2.3 Statistical analysis 
 
Statistical analysis was performed using the Statistical Package for the Social Sciences 
(version 15; SPSS, Chicago, IL, USA). Distribution of data was assessed using Kolmigrov-
Smirnov test. For un-paired analysis, ƐƚƵĚĞŶƚ ?Ɛ ƚ ƚĞƐƚwas used for parametric data and 
Mann-WhiƚŶĞǇƚĞƐƚĨŽƌŶŽŶƉĂƌĂŵĞƚƌŝĐĚĂƚĂ ?&ŽƌƉĂŝƌĞĚĂŶĂůǇƐŝƐ ?ƐƚƵĚĞŶƚ ?ƐƚƚĞƐƚwas used 
for parametric data and Wilcoxon signed rank test for non-parametric data. A P value of 
<0.05 was considered as significant. A general linear model with repeated measures was 
used to determine differences with time within each group and the interaction between 
them.   
Linear regression analysis was used to assess the value of different variables for the 
prediction of the outcome following assisted reproduction treatment. Binary logistic 
regression analysis was used to evaluate the effect of the same variables on the 
prediction of pregnancy. Receiver operating characteristic (ROC) curve analysis was 
performed to quantify the ability of any significant predictors to discriminate between 
pregnant and non-pregnant subjects. Areas under the ROC curves (AUCROC) were 
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compared using the MEDCALC software package (version 9.5.2.0; MedCalc Software, 
Mariakerke, Belgium).  
Interobserver reliability was assessed by two-way mixed Intraclass Correlation 
Coefficients (ICCs) with absolute agreement and their 95% confidence intervals. Limits of 
agreement, as described by Bland and Altman, were used to express inter- and intra 
observer reliability and to compare the different methods (Bland and Altman 1995; Khan 
and Chien 2001). Intraclass correlation coefficient (ICC) is a measure of reliability which 
evaluates the proportion of variance between observations (McGraw 1996). The scale 
from Altman was used in classification of the reliability values (Altman 1999). ICC values 
under 0.20 were considered poor, 0.21- 0.40 fair, 0.41-0.60 moderate, 0.61-0.80 good, 
and 0.81-1.00 very good. Limits of agreement are estimated from the mean and standard 
deviation of the differences with 95% of the differences lying within two standard 
deviations either side of mean. These limits, like confidence intervals, give an idea of the 
spread of variance between the methods.  
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CHAPTER 3. The intra-observer and inter-observer reliability 
of automated follicle counts made using three-dimensional 
ultrasound and SonoAVC  
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3.1 Abstract 
 
Objective: To assess the reliability of automated measurements of the total antral follicle 
count (tAFC) made using Sono-Automatic Volume Count (SonoAVC), and to compare 
these to two-dimensional (2D) and manual three-dimensional (3D) techniques.  
Methods: 55 subjects aged <40 who had 3D transvaginal ultrasound (Voluson 730 Expert, 
GE Medical Systems) in early follicular phase of menstrual cycle were prospectively 
recruited. Three-dimensional datasets were acquired and subsequently analysed. The 
tAFC (2-10mm antral follicles) was calculated by two observers using three independent 
methods: 2D real time equivalent (2DRTE), 3D manual multiplanar view (3DMPV), and 
SonoAVC. For measures made using SonoAVC, the initial automated count (sAVC-AA) was 
recorded and post-processing (sAVC-PP) then applied to identify follicles that had been 
missed or incorrectly included. Intraclass correlation and limits of agreement were used to 
evaluate the methods.  
Results: The intra- and inter-observer reliability of measurements of tAFC was best with 
SonoAVC followed by 3D MPV and 2D RTE. The initial count calculated by sAVC-AA missed 
follicles reflecting in the significantly lower mean tAFC (6.51±4.79) than that made after 
post-processing (sAVC-PP; 18.42±10.53, p<0.001), 3D-MPV (19.38±10.85, p<0.001) and 2D 
RTE (19.26±10.55, p<0.001) techniques. The mean tAFC became more comparable with 
post-processing (sAVC-PP) but still remained significantly lower than counts made with 2D 
RTE and 3D MPV (P<0.05).  
Conclusion: SonoAVC is a reliable method for measuring the tAFC. The tAFC made with 
SonoAVC following post processing although lower are more comparable to 2D and 3D 
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MPV but at the expense of time. This may have been observed because SonoAVC 
measures and colour codes each follicle preventing re-counting.  
 
3.2 Introduction 
 
Ovarian reserve is estimated by combining certain clinical parameters and a variety of 
endocrinological or ultrasonographic measurements (Scheffer, Broekmans et al. 1999; 
Merce, Gomez et al. 2005; Jayaprakasan, Walker et al. 2007; McIlveen, Skull et al. 2007; 
Soldevila, Carreras et al. 2007). There is debate as to which combination of parameters 
has the best predictive value and there is no consensus at present. The relative 
contribution of each individual measure of ovarian reserve is clearer and most authors 
agree that antral follicle counts and serum anti-Müllerian hormone levels have the most 
discriminative potential (van Rooij, Broekmans et al. 2005; Visser, de Jong et al. 2006; 
Nardo, Christodoulou et al. 2007). The total antral follicle count (tAFC), measured using 
ultrasound, appears to perform as well as AMH and each modality has its own advantages 
and disadvantages. Serum measurements of AMH are still relatively expensive and there 
is a definite inter-laboratory variation in the performance of the assay (Visser, de Jong et 
al. 2006). In contrast, antral follicle counts are easy to perform and cheap in comparison 
as all units have access to ultrasound facilities. Follicle counts, as a quantitative measure 
ŽĨŽǀĂƌŝĂŶƌĞƐĞƌǀĞ ?ĂƌĞĂůƐŽƐƵďũĞĐƚ ƚŽ  ‘ĂƐƐĂǇ ?ǀĂƌŝĂƚŝŽŶĚƵĞƚŽ ŝŶƚƌĂ- and inter- observer 
differences and require additional time and manpower to perform (Jayaprakasan, 
Campbell et al. 2008).  
Antral follicle counts are typically performed using real-time, two-dimensional ultrasound 
but may be estimated from three-dimensional ultrasound data. Both methods involve the 
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identification of follicles measuring between 2-10 mm as the observer manipulates the 
ultrasound transducer or scrolls through a stored dataset respectively. These techniques 
take time and are associated with a degree of measurement error as follicles can be 
missed or counted more than once. Automated measurement of the number of antral 
follicles has the potential to address both issues (Raine-Fenning, Jayaprakasan et al. 2007; 
Jayaprakasan, Campbell et al. 2008). 
SonoAVC is a new software program that identifies and quantifies hypo echoic regions 
within a three-dimensional dataset and provides automatic estimation of their absolute 
dimensions, mean diameter, and volume (Raine-Fenning 2008). Each individual volume is 
given a specific color and the automated measurements of its mean diameter (relaxed 
sphere diameter), its maximum dimensions (x, y, z diameters), and its volume are 
displayed in descending order from the largest to the smallest (Raine-Fenning 2008). An 
unlimited number of volumes can theoretically be quantified, which makes it an ideal tool 
for follicle tracking. It also identifies small volumes and can theoretically be used to count 
antral follicles. To date SonoAVC has been used to assess stimulated ovaries only (Raine-
Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008). These studies have shown that 
SonoAVC provides automatic measurements of follicular diameter and volume that are 
more reliable and more accurate than comparable estimations made from 2D data (Raine-
Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008).  
This study is the first to assess the inter- and intra-observer reliability of automated antral 
follicle counts made using SonoAVC and to compare these measures to those made using 
manual 2D and 3D techniques. This study was designed to test the hypothesis that 
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automated measurement of the total AFC using SonoAVC would be more reliable and 
quicker than measures made using conventional 2D and 3D techniques.  
 
3.3 Methods 
 
Experimental Design 
Subjects aged less than 40 years with early follicular phase Follicle Stimulating Hormone 
(FSH) below 15 IU/L, planning to undergo treatment for their sub fertility, were 
prospectively recruited. Ultrasound was performed during the early follicular phase of 
menstrual cycle between days 2-5. The numbers of follicles measuring between 2 to 10 
mm in diameter were counted in each ovary to calculate the total antral follicle count in 
that ovary. Subjects who had had previous ovarian surgery, had one ovary, and those with 
ovarian cysts or follicles measuring more than 10 mm were excluded from the study.  
A sample size of 42 was required if the intraclass correlation coefficient between two 
observations was assumed at 0.80 with Type I error of 0.05 and Type II error of 0.20.  
 
Data acquisition 
All transvaginal ultrasound examinations were performed by a single investigator (J.C) 
using a Voluson Expert 730
TM 
(GE Medical Systems, Zipf, Austria) and 7.5 MHz transvaginal 
transducer. The scan first involved a conventional 2D ultrasound assessment of the pelvis 
to exclude any obvious pathology, followed by visualization of ovaries in their transverse 
and longitudinal planes. This was followed by acquisition of 3D data using the 3D volume 
mode. The 3D volume mode displayed a truncated sector which was adjusted to define 
the area of interest; the sweep angle was set to 90
q 
so as to include the entire ovary and a 
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3D dataset was then acquired using the high quality, slow sweep mode. The resultant 
multiplanar display of the ovary was examined to confirm its inclusion in entirety. 
Datasets of both ovaries from each subject were stored on recordable digital video discs 
for subsequent analysis. The ultrasound settings, both grey scale and Doppler, were 
standardized and identical for all subjects. 
Data measurement  
4D View  (version 7.0, GE Medical Systems) was used for all measurements. The 3D 
dataset was opened and displayed as a single view showing the longitudinal or transverse 
view available with real-time conventional 2D ultrasound. The quality of the image was 
adjusted and optimized in terms of magnification for all datasets. Three different methods 
were then used to measure the number of antral follicles measuring 2-10mm in diameter 
in each ovary. 
Method 1: 2D real-time equivalent (2D RTE) 
The AFC was measured in each ovary using the longitudinal (A plane) and transverse (B 
plane) planes in an identical manner to that what would be done in the way real-time 
antral follicle counts are performed using conventional 2D ultrasound. These two planes 
are available to the observer with conventional 2D ultrasound but cannot be seen 
simultaneously. The investigators were able to scroll through the dataset in these two 
planes simulating a clinical setting of real-time 2D, but were not allowed to rotate the 
image along the x-axis or to see the two images simultaneously as these functions are not 
available with real-time scanning (Jayaprakasan, Walker et al. 2007).  
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Method 2: 3D Multiplanar view (3D MPV) 
The multiplanar view provides the observer with the longitudinal (A) and transverse (B) 
views described above for measurement method 1 but also demonstrates the coronal (C) 
plane which is not available with conventional 2D ultrasound (Jayaprakasan, Walker et al. 
2007). The coronal plane is a reconstructed view of the dataset at 90-degrees to the 
transducer and provides the user with more spatial information. These three sectional 
planes are shown simultaneously and are mutually related so that movement within one 
plane produces geometrically equivalent movements in the other two planes. Method 2 
involved measuring the tAFC using all three perpendicular planes. The investigators had 
the advantage of being able to cross-check the number of follicles in any one plane 
against the two other image planes (Jayaprakasan, Walker et al. 2007).  
Method 3: 3D assisted SonoAVC 
The multiplanar view was used to display the dataset as in method 2. Once the three 
sectional planes were displayed, the render mode was entered to generate a 3D rendered 
view of the ovary. The render box was adjusted to exclude as much extra-ovarian 
information as possible and ensure that the whole ovary was included in the region of 
interest. The threshold settings, which assign transparency associated with fluid to 
opaque voxels, were maintained for all datasets. Once the dataset had been correctly 
positioned, SonoAVC was implemented. The individual follicles were then displayed with a 
specific colour and shown together with their dimensions and relative sizes. The total 
number of follicles initially identified using this technique was recorded as the  ‘^ŽŶŽs-
ĂƵƚŽŵĂƚĞĚĂŶĂůǇƐŝƐ ? ?^ŽŶŽAVC-AA) antral follicle count (Figure 2.2). Preliminary work had 
shown that this initial automated assessment of the ovary missed many follicles, both 
within stimulated and unstimulated ovaries, which were readily evident to any observer. 
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These follicles can be included in the analysis by manually clicking on them. Each 
additional antral follicle identified in this way is given a new colour and its dimensions are 
displayed together with those follicles that were originally identified. The total AFC at the 
end of this process was recorded and referred to as ƚŚĞ  ‘ƐŽŶŽs-ƉŽƐƚ ƉƌŽĐĞƐƐŝŶŐ ?
(SonoAVC-PP) antral follicle count (Figure 2.3). The time required for the initial, 
automated assessment and the additional time required for the manual post-processing 
were recorded separately allowing the total time for measurements to be defined.  
Two investigators (JC and SD) independently counted the total number of antral follicles 
in each dataset using the 2D RTE, 3D MPV, and the SonoAVC (SonoAVC-AA and SonoAVC-
PP) methods. One investigator (SD) measured the datasets twice in no specific order to 
assess the intra observer variation also to reduce the operator dependent bias. When 
comparing the methods, average of the counts made by the two observers for each 
method was considered. The order of measurements and the method used for each 
dataset was randomly determined and different for each investigator. This was achieved 
by allocating a unique number to each dataset and ensuring that each dataset had been 
assessed using each technique. The time taken by each investigator to measure the total 
AFC within both ovaries per subject was recorded to the nearest second for each of the 
three methods. 
Statistical analysis 
Statistical analysis was undertaken using the Statistical Package for the Social Sciences 
(SPSS, version 15.0, Chicago, IL). The total antral follicle count (tAFC) made by adding the 
number of antral follicles in both ovaries per subject was used as a single variable for 
analysis.  
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Interobserver reliability was assessed by two-way mixed Intraclass Correlation 
Coefficients (ICCs) with absolute agreement and their 95% confidence intervals. Limits of 
agreement, as described by Bland and Altman, were used to express inter- and intra 
observer reliability and to compare the different methods (Bland and Altman 1995; Khan 
and Chien 2001). Intraclass correlation coefficient (ICC) is a measure of reliability which 
evaluates the proportion of variance between observations (McGraw 1996). The scale 
from Altman was used in classification of the reliability values (Altman 1999). ICC values 
under 0.20 were considered poor, 0.21- 0.40 fair, 0.41-0.60 moderate, 0.61-0.80 good, 
and 0.81-1.00 very good. Intraclass correlation can give a falsely reassuring impression of 
reliability (Rothwell 2000) and so Bland-Altman plots were also used to estimate the 
agreement between the two observers (Bland and Altman 1986) and because we were 
evaluating and comparing a new method to an established one (Bland and Altman 1999). 
To quantify the inter-observer agreement the differences between the averaged antral 
follicle counts and SDs were calculated, and limits of agreement were constructed (Bland 
and Altman 1986). Limits of agreement are estimated from the mean and standard 
deviation of the differences with 95% of the differences lying within two standard 
deviations either side of mean. These limits, like confidence intervals, give an idea of the 
spread of variance between the methods. The Bland Altman plots were constructed so 
that each observer could be identified and any systematic bias, where one observer 
constantly obtains higher or lower values, identified. No priori definition of the maximum 
width for limits of agreement was done before analyzing the results since there are no 
clinical data to define what an acceptable result would be.  
The distribution of the data was checked using normal probability plots. The mean and 
standard deviation (± SD) are given for normally distributed
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range for non-parametric data. Dependent on the normality of the data, a one-way 
analysis of variance with Wilcoxon Signed Ranks test or a paired student t-test was used 
to examine for differences in the mean AFC between the observers, within one observer, 
and according to the measurement method. A P value of <0.05 was considered to be 
statistically significant. 
3.4 Results 
Of the fifty-five subjects, six were excluded from the study; 3 had follicůĞƐŵĞĂƐƵƌŝŶŐ A?
10mm and another 3 were found to have ovarian cysts. Complete data were available on 
49 subjects therefore and 98 datasets were available for analysis.  
The data were not normally distributed and are expressed, therefore, as median and inter 
quartile ranges. The median tAFC (inter-quartile range, 25
th
 and 75
th
 percentile) measured 
by 2D RTE, 3D MPV, SonoAVC-AA, and SonoAVC-PP were 18 (10.56 and 26.81), 16.5 
(10.25 and 26.75), 5 (3.37 and 9.18), and 15.5 (10.25 and 24.75) respectively (Table 3.1). 
The initial tAFC assessed by SonoAVC-AA missed many follicles which is reflected in a 
significantly lower median tAFC than for all other methods (P<0.001). The median tAFC 
with SonoAVC-PP increased to 15.5 but remained significantly lower than counts made 
with 2D RTE (P=0.006) and 3D MPV (P=0.028).  
The Intraclass Correlation Coefficient (ICC) for 2D RTE, 3D MPV, sAVC-AA, and sAVC-PP 
were 0.979 (95% CI 0.964-0.988), 0.988 (95% CI 0.979-0.993), 0.971 (95% CI 0.949-0.983), 
and 0.997 (95% CI 0.995-0.998) respectively suggesting good inter-observer reliability for 
each method (Table 3.1). 
The intra-observer and inter-observer limits of agreement for the three methods are 
expressed in Table 3.1. The limits of agreement suggest measurements made with 
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SonoAVC (SonoAVC-AA and SonoAVC-PP) are more reliable than those made using the 3D 
MPV and 2D RTE techniques. The limits of agreement between the different methods are 
expressed in Table 3.2 and shown as Bland-Altman plots in Figure 3.1. These data show a 
significant difference in the mean tAFC between sonoAVC-PP, 3D MPV, and 2D RTE. The 
best inter-method agreement was between 3D MPV and 2D RTE. 
 
Table 3.1: Comparison of different methods of measuring antral follicles using mean AFC ± SD, 
median AFC with inter quartile range, inter and intra observer reliability with limits of agreement, 
and inter observer reliability with Intraclass correlation coefficient (ICC). 
Method Median (Inter 
Quartile Range) 
Inter observer upper 
and lower LOA 
Intra observer upper 
and lower LOA 
ICC (95% CI) 
 
2D RTE 
 
18 
(10.56 and 26.81) 
 
7.11 and -4.8 
 
8 and -6.92 
 
0.979 
(0.964 -0.988) 
 
 
3D MPV 
 
16.5 
(10.25 and 26.75) 
 
5.33 and -3.56 
 
5.49 and -3.72 
 
 
0.988 
(0.979 -0.993) 
 
 
sAVC-AA 
 
5 
(3.37 and 9.18) 
 
3.24 and -3.1 
 
3.78 and -3.67 
 
0.971 
(0.949 -0.983) 
 
sAVC-PP 
 
15.5 
(10.25 and 24.75) 
 
1.71 and -2.58 
 
2.51 and -2.59 
 
0.997 
(0.995 -0.998) 
 
  
* 2D RTE (2D real time equivalent), 3D MPV (3D multiplanar view), sAVC-AA (automated analysis with 
SonoAVC), and sAVC-PP (SonoAVC with post-processing) 
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Figure 3.1: Bland WAltman plot showing the intermethod comparison between two-dimensional real-time 
equivalent (2D-RTE), three-dimensional multiplanar view (3D-MPV), and automatic volume count with 
postprocessing (sAVC-PP) using total antral follicle count as the single variable of analysis. The plot shows the 
overall mean difference between the observations made with each method and 95% coverage interval of the 
differences.     3D-MPV vs 2D-RTE;      3D-MPV vs sAVC-PP;       2D-RTE vs.sAVC-PP.  
The mean of antral follicle count and the differences are expressed in numbers (n). 
 
 
 
 
 
  
 
 
 
 
 
 
The time taken for measurements was found to be normally distributed. The mean (± SD) 
time in seconds for measurement of tAFC with 2D RTE, 3D MPV, sAVC-AA, and sAVC-PP 
was 71 ± 18.48, 97 ± 30.38, 26 ± 2.67, and 112 ± 29.86 respectively. Sono AVC with post 
processing (SonoAVC-PP) took the longest time followed by the 3D MPV, 2D RTE, and 
automated mode of Sono AVC (SonoAVC-AA) (Table 3.2). 
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Table 3.2: An inter-method comparison of the different measurement techniques showing the 
difference in time taken to make total antral follicle count (AFC), the difference in the mean AFC, 
limits of agreement, and significance (P) of these variables.  
 
Methods 
compared 
 
Mean 
difference 
in time ± 
SD in 
seconds 
 
Significance 
in time 
(P value) 
 
Mean 
difference 
in tAFC ± 
SD 
 
Significance 
in tAFC 
(P value) 
 
Upper limit 
of 
agreement 
 
Lower 
limit of 
agreement 
 
sAVC-AA vs 
sAVC-PP 
 
 
86.03 ± 
28.78 
 
 
P<0.001 
 
12 ± 7.27 
 
 
P < 0.001 
 
26.08 
 
-2.42 
 
sAVC-PP vs 
3D MPV 
 
14 ± 22.03 
 
 
P=0.020 
 
1 ± 3.91 
 
 
P = 0.006 
 
8.66 
 
-6.66 
 
sAVC-PP vs 
2D RTE 
 
41 ± 23.14 
 
 
P<0.001 
 
0.92 ± 4.07 
 
 
P = 0.028 
 
8.90 
 
-7.06 
 
3D MPV vs 
2D RTE 
 
26 ± 20.48 
 
 
P<0.001 
 
0.08 ± 2.30 
 
 
P = 0.27 
 
4.58 
 
-4.53 
 
 
 
3.5 Discussion  
This is the first study to examine the reliability of automated antral follicle counts made 
using SonoAVC. The intra-observer and inter-observer reliability of antral follicles made 
using SonoAVC was better than measurements made using the 3D multiplanar view or the 
2D real time equivalent technique but only after post processing had been applied. This 
was at the expense of time and therefore negates some of the benefit of the software. 
However, the colour coding provided by sonoAVC ensures follicles are not counted more 
than once and all are identified. This may explain why the mean and median antral follicle 
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counts made with SonoAVC following post processing were significantly lower than those 
made with the 3D multiplanar view and the 2D real time equivalent techniques.  
The software also provides an objective evaluation of each follicle as its diameter and 
volume are calculated. These advantages are specific to the software and have important 
implications for the research setting and for future clinical studies. The total AFC is 
calculated by counting the number of follicles measuring less than 10 mm in diameter in 
both ovaries. This is often done subjectively and even when measurements are made to 
assess the absolute size of the follicle these are often restricted to one or two follicles 
within each ovary to gain an impression of the number of follicles smaller than 10 mm. 
SonoAVC measures the mean diameter and volume of each antral follicle counted, thus 
providing a more accurate measurement of antral follicles, especially those measuring 
between 2-6 mm which are thought to relate more closely to age and other endocrine 
ovarian reserve tests (Haadsma, Bukman et al. 2007).  
The main limitation of the new software was the erroneous low total antral follicle counts. 
The median total antral follicle count based on the initial automated SonoAVC analysis 
(sAVC-AA), was significantly lower than counts made with the 2D real time equivalent (2D 
RTE) and 3D MPV techniques. The follicles missed by sAVC-AA were of random sizes. This 
reflects a current lack of sensitivity of the software to identify all antral follicles as many 
additional follicles not included in the initial automated assessment were readily evident 
in the multiplanar view. sAVC-PP was required in all cases, which made the final total 
antral follicle count more comparable to the other methods. In this study, post processing 
involved the simple identification of individual follicles that had been missed as well as 
those that had been included incorrectly. Post processing can also be performed by 
tracing around follicles to identify them as separate or single entities (Raine-Fenning 
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2008) but this was not required in this study, presumably due to the small volumes being 
studied. 
Previous work by our own group has shown that 3D ultrasound significantly improves the 
interobserver reliability of antral follicle counts (Jayaprakasan, Walker et al. 2007; 
Jayaprakasan, Campbell et al. 2008).  Scheffer et al (Scheffer, Broekmans et al. 2002)
 
showed that both 2D and 3D methods of counting antral follicles were comparable and 
reproducible but raised the possibility of improvement in the use of antral follicle count as 
a clinical test as a consequence to the use of 3D ultrasound. Although time taken to make 
off-line measurements using manual 3D techniques is more than 2D, the duration of the 
actual ultrasound examination and patient exposure is significantly reduced using 3D 
compared with real-time 2D ultrasound (Jayaprakasan, Campbell et al. 2008). SonoAVC 
presents a potential solution to this but at present requires too much manual post-
processing to make it clinically useful and limits the use of the technology at present as it 
is not truly automated. The tradeoff between the ability to measure the total AFC reliably 
and the time required for this must be addressed. The software was designed for the 
assessment of larger follicles within a stimulated ovary and is currently being recalibrated 
for the detection of smaller volumes. This will hopefully reduce the need for post-
processing and the overall time required. The software is probably more appropriate for 
use within the research setting at present and the potential advantage of having a reliable 
assessment of both follicle number and size needs to be addressed in prospective studies.  
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3.6 Conclusions 
The intraobserver and interobserver reliability of automated antral follicle counts made 
with SonoAVC are better than comparable measurements made with manual 2D and 3D 
ultrasound. The initial automated measurements are spuriously low and significantly 
underestimate the true follicle count which requires manual post-processing. This allows 
the identification of missed follicles but at the expense of time and limits the automated 
nature and potential of the software. The software does provide an objective 
measurement of each follicle which has important implications for research as it allows 
investigation into the relative importance of follicles of different sizes.  
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CHAPTER 4. Quantitative analysis of antral follicle number 
and size: a comparison of real-time two-dimensional and 
automated three-dimensional ultrasound techniques  
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4.1 Abstract 
 
Objective: To compare two-dimensional (2D) ultrasound to automated three-dimensional 
(3D) ultrasound for the measurement of antral follicle number and size. 
Methods: 24 subjects aged <40 underwent transvaginal ultrasound (Voluson E8) in the 
early follicular phase of menstrual cycle. A 2D ultrasound scan of both ovaries was 
performed and each antral follicle identified and then measured by taking the mean of 
two diameters. A 3D ultrasound dataset of both ovaries was then acquired and analysed 
ƵƐŝŶŐ  “^ŽŶŽŐƌĂƉŚǇ-ďĂƐĞĚ ƵƚŽŵĂƚĞĚ sŽůƵŵĞ ŽƵŶƚ ?  ?^ŽŶŽs). The time taken to 
measure the size of all antral follicles in both ovaries was recorded in seconds for each 
technique. The antral follicle counts were then grouped into categories according to size: 
2.0 W5.0 mm, 2.0 W6.0 mm, 2.0 W8.0 mm, 2.0 W9.0 mm, and 2.0-10mm. Limits of agreement 
(LOA) and a paired t-test or Wilcoxon signed ranks test was used to analyse the data 
dependent on its distribution.  
Results: The AFC in all the categories was significantly lower with SonoAVC than with 2D 
ultrasound (p<0.05). When antral follicles were compared for every mm size, 2D 
ultrasound measured more follicles measuring 3.0-3.99mm (4.11±3.70 vs 2.63±2.31; 
P=0.019) and 4.0-4.99mm (4.63±4.86 vs 2.68±2.89; P=0.013) than those measured with 
SonoAVC. LOA were widest with follicles measuring 3.0-3.99mm (6.38 and -3.43) and 
4.0-4.99mm (7.99 and -4.09). SonoAVC took significantly lesser time to measure the 
number and size of the antral follicles than 2D ultrasound (132.05±56.23 vs 
324.47±162.22; p<0.001).  
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Conclusion: Fewer antral follicles are evident overall when SonoAVC is used to analyse 
3D ultrasound data. The clinical value of these remains to be determined but the 
automated technique is significantly quicker than measures made using 2D ultrasound 
which may also overestimate the number and size of follicles. 
 
4.2 Introduction 
The antral follicle count is a marker of ovarian reserve and has been shown to be a 
significant predictor of ovarian reserve (Broekmans, Kwee et al. 2006; Jayaprakasan, 
Campbell et al. 2008; Verhagen, Hendriks et al. 2008). The highest production of anti-
Müllerian hormone (AMH) is seen in the granulosa cells of the pre-antral and small antral 
follicles measuring 4 mm or less in diameter with expression gradually reducing as follicles 
become larger (Weenen, Laven et al. 2004). The size of the antral follicle may be more 
important than the total number therefore and more predictive of ovarian reserve and 
outcome following assisted reproduction treatment. Very few studies have considered the 
size of antral follicles other than to define the limits of follicular diameter above and 
below which follicles should not be included in the final count (Chang, Chiang et al. 1998; 
Pellicer, Gaitan et al. 1998; Weenen, Laven et al. 2004). Studies that have considered the 
size of the follicles between and above these extremes suggest that follicles measuring 2-
5mm correlate most strongly with assisted reproduction treatment outcomes (Chang, 
Chiang et al. 1998). Pellicer et al. used 3D ultrasound to assess the population of these 
 ‘ƐĞůĞĐƚĂďůĞ ?ĨŽůůŝĐůĞƐŝŶǇŽƵŶŐ ?ůŽǁƌĞƐƉŽŶĚĞƌƐĂŶĚĨŽƵŶĚƚŚĂƚƚŚĞŶƵŵďĞƌŽĨĂŶƚƌĂůĨŽůůŝĐůĞƐ
measuring 2-5 mm in diameter was significantly lesser than the  age-matched normal 
responders (Pellicer, Ardiles et al. 1998). 
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The standard technique used to the quantify the size of an antral follicle involves 
calculation of the mean diameter from two measurements of the follicular diameter 
(Haadsma, Bukman et al. 2007). No studies have reported on the intra- or inter-observer 
reliability of quantitative antral follicle counts stratified according to the size of the 
follicle. Measurement reliability is likely to be relatively poor as it will depend on both the 
identification and subsequent measurement of each follicle. There is a natural variation in 
determining the total number of antral follicles, both within and between observers and 
once a follicle has been identified there will be further variability in its measurement. Any 
variability is likely to be exaggerated when there are larger numbers of antral follicles as 
more measures are required overall (Scheffer, Broekmans et al. 2002; Jayaprakasan, 
Campbell et al. 2008).  
SonoAVC identifies and quantifies hypo echoic regions within a three-dimensional dataset 
and provides automatic estimation of their absolute dimensions, mean diameter, and 
volume. SonoAVC, when used for follicle tracking during controlled ovarian stimulation, 
provides automatic measurements of follicular diameter and volume that are more 
reliable and more accurate than comparable estimations made from 2D data (Raine-
Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008; Raine-Fenning, Jayaprakasan et al. 
2008). In chapter 3, I have demonstrated how sonoAVC can be used to automatically 
determine the total number of antral follicles and that these measurements are more 
reliable than manual measures of acquired 3D data. This study was specifically designed, 
therefore, to compare automated analysis of 3D data, made using SonoAVC, and real-time 
two-dimensional ultrasound for the assessment of the number and size of antral follicles 
in women undergoing assisted reproduction treatment.  
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4.3 Methodology 
Twenty-four subjects aged less than 40 years planning to undergo assisted reproduction 
treatment for unexplained sub fertility were prospectively recruited. Subjects with a 
history of previous ovarian surgery including ovarian cystectomy, ovarian drilling and 
unilateral oophorectomy were excluded from the study. If the entry criteria were met 
subjects underwent transvaginal ultrasound during the early follicular phase, cycle days 2-
5, in the immediate menstrual cycle prior to treatment. Those subjects found to have 
ovarian cysts or follicles measuring more than 10 mm were excluded at this point.  A total 
sample size of 32 was required to power the study at 0.85 with a difference in total AFC of 
3 between two methods.  
A single investigator (J.C) performed all of the ultrasound scans using a Voluson E8 Expert
 
(GE Medical Systems, Zipf, Austria) and a four-dimensional 5-9 MHz transvaginal 
transducer. The ultrasound assessment involved a conventional real-time 2D ultrasound 
assessment of the pelvis to exclude any obvious pathology, followed by visualization of 
ovaries in their transverse and longitudinal planes. Antral follicle number and size were 
first measured using real-time 2D ultrasound and then, following the acquisition of 3D 
data, with sonoAVC. The ultrasound settings and technique of data acquisition were 
standardized and identical for all subjects: gain, -5; speckle reduction imaging (SRI), 2; 
CrossXBeam CRI (compound resolution imaging), 3; CRI filter, high; enhance, 2; reject, 25; 
and harmonics, high. Once the dataset had been obtained sonoAVC, which was integrated 
in the ultrasound machine, was used to provide an automatic assessment of the follicles 
within each ovary. The precise details of both measurement techniques are detailed 
below: 
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4.3.1 Measurement method 1: Conventional real-time 2D ultrasound 
Figure 4.1: The figure below shows an image of ovary acquired using 2D ultrasound in early 
follicular phase of menstrual cycle. Each antral follicle is measured using 2D imaging in two 
perpendicular diameters 
 
 
This method involved measurement of antral follicles during the conventional real-time 
ultrasound assessment of the ovaries and represents the current standard for this. Once 
the ovary was localized the observer used the transducer to scroll through the ovary in 
two planes, longitudinal and transverse, and observe the antral follicles. Each antral 
follicle was then identified and measured in turn until the whole ovary was analysed. 
Antral follicle size was calculated by taking the mean of two perpendicular diameters, one 
of which represented the largest dimension, of each follicle (Figure 4.1). The same process 
was then repeated for the contra lateral ovary.  
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4.3.2 Measurement method 2:  Automated 3D  ? SonoAVC 
SonoAVC was used on the ultrasound machine (version E8, GE Medical Systems) on the 
dataset which was acquired using 3D and displayed using the multiplanar view, making it 
closer to real time scanning. The image display was optimized and the render mode 
entered to generate a three-dimensional volume of interest (VOI). The render box was 
adjusted to exclude as much extra-ovarian information as possible and ensure that the 
whole ovary was included in the VOI. The threshold settings, which assign transparency 
associated with fluid to opaque voxels, were maintained for all datasets at a default 
ƐĞƚƚŝŶŐ ŽĨ  ‘ůŽǁ ? ? KŶĐĞ ƚŚĞ ĚĂƚĂƐĞƚ ŚĂĚ ďĞĞŶcorrectly positioned, SonoAVC was 
implemented. The individual follicles were then displayed with a specific colour and 
shown together with their dimensions and relative sizes. Post-processing, involving the 
manual identification of follicles not included in the automated analysis, was then used to 
ensure all antral follicles were counted and measured. Each additional antral follicle 
identified in this way was given a new colour and its dimensions displayed together with 
those follicles that were originally identified. The mean diameter of relaxed sphere of 
each antral follicle in both ovaries displayed as d(v) was recorded. 
The antral follicle population for each subject was grouped into five categories based on 
the absolute dimension of the follicles as follows: d 2mm, 2.1 to 4.0mm, 4.1 to 6.0mm, 6.1 
to 8.0mm, and 8.1 to 9.0mm for further analysis. The time taken for the whole process 
was recorded to the nearest second. The clock was started as soon as the baseline scan 
had been conducted and the decision made to assess the antral follicle population. The 
clock was stopped when all antral follicles in both ovaries had been measured and their 
individual sizes recorded. This was a continuous process for both measurement 
techniques and included the process of data acquisition for the 3D method.  
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Statistical analysis 
Statistical analysis was undertaken using the Statistical Package for the Social Sciences 
(SPSS, version 15.0, Chicago, IL). The distribution of the data was checked using normal 
probability plots. The mean and standard deviation (± SD) are given for normally 
distributed data and the median and range for non-parametric data. Dependent on the 
normality of the data, a paired student t-test or one-way analysis of variance with 
Wilcoxon Signed Ranks test was used to examine for differences between the 
measurement methods in the number of antral follicles overall and within each size 
category and in the time taken for the measurements.. A P value of <0.05 was considered 
to be statistically significant. 
 
4.4 Results 
Three subjects were excluded from the study, as they were found to have follicles 
measuring 10 mm or more, and complete data were available, therefore, for 21 subjects 
who had a mean (± SD; range) age of 34.02 (± 4.29; 28.30 to 37.50) years and BMI of 
24.22 (± 2.32; 22.20 to 27.00). The cause for their subfertility related to male factors (8; 
38.09%), tubal disease (2; 9.52%) or was unexplained (11; 52.38%).  
The measurement data and time taken for analysis were both confirmed to be normally 
distributed. The mean time taken for the automated analysis of the 3D ultrasound dataset 
ǁŝƚŚ^ŽŶŽs ?  ? ? ? ? ? ? ?A?  ? ? ? ? ? ƐĞĐŽŶĚƐ ?ǁĂƐ ƐŝŐŶŝĨŝĐĂŶƚůǇ ůĞƐƐĞƌ ƚŚĂŶ ƚŚĂƚƌĞƋƵŝƌĞĚ ĨŽƌ
the 2D ultrasound assessment (324.47 ± 162.22 seconds), respectively (P<0.001). Post 
processing was usĞĚ ŝŶ Ăůů ĐĂƐĞƐ ĂŶĚ ƚŚĞ ƚŝŵĞ ƌĞĐŽƌĚĞĚ ĨŽƌ ^ŽŶŽs ? ŝŶĐůƵĚĞƐ ƚŚĞ
ĂĚĚŝƚŝŽŶĂů ƚŝŵĞ ŶĞĞĚĞĚ ĨŽƌ ƚŚŝƐ ? dŚĞ ŵĞĂŶ ƚŝŵĞ ƚĂŬĞŶ ĨŽƌ ^ŽŶŽs ? ǁŝƚŚŽƵƚ ƉŽƐƚ
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processing was 41.06 ± 11.12 seconds. The mean time required for the post processing 
aspect was 90.99 ± 45.11 secŽŶĚƐ ? ^ŽŶŽs ?ƌĞĐŽƌĚĞĚĂƐŝŐŶŝĨŝĐĂŶƚůǇ ůŽǁĞƌŶƵŵďĞƌŽĨ
antral follicles than 2D ultrasound when the total counts were considered and also when 
the follicles were grouped into the different sub-categories (Table 4.1). The limits of 
agreement between the two methods were wide as well (Table 4.1). A similar trend was 
seen when the number of antral follicles were stratified and analysed to the nearest 
millimeter; a significantly higher number of follicles measuring 3.0 to 3.99 mm (4.11 ± 
3.70 vs 2.63 ± 2.31; P=0.019) and 4.0 to 4.99 mm (4.63 ± 4.86 vs 2.68 ± 2.89; P=0.013) 
were identified with 2D ultrasound than with the automated 3D ultrasound technique 
(Table 4.2). The limits of agreement between the two methods were widest with follicles 
measuring 3.0 to 3.99 mm (6.38 and -3.43) and 4.0 to 4.99 mm (7.99 and -4.09) (Table 
4.2).  
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TABLE 4.1: A comparison of two-dimensional (2D) ultrasound and automated three-dimensional 
 ?^ŽŶŽs ? ? ^ŽŶŽŐƌĂƉŚǇ-based Automated Volume Count) ultrasound techniques for the 
assessment of the total antral follicle count according to the absolute size of the antral follicles. 
The two methods have been compared using limits of agreement and the P value derived using a 
paired samples t test. 
 Real-time 2D 
(Mean ± SD) 
3D SonoAVC 
(Mean ± SD) 
Mean 
difference ± SD 
(95% CI) 
P value Upper 
LOA 
Lower 
LOA 
Time (seconds) 324.47 ± 162.22 132.05 ± 
56.23 
192.42 ± 113.51 
(137.71 to 
247.13) 
<0.001 414.91 -30.06 
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2.0 to 5.0 
mm  
10.95 ± 8.61 8.11 ± 6.22 2.84 ± 4.03 
(0.90 to 4.79) 
0.007 10.74 -5.06 
2.0 to 6.0 
mm  
16.63 ± 10.58 11.37 ± 8.62 5.26 ± 3.19 
(3.72 to 6.80) 
<0.001 11.52 -1.00 
2.0 to 8.0 
mm  
18.26 ± 10.75 15.53 ± 9.51 2.74 ± 2.56 
(1.50 to 3.97) 
0.001 7.75 -2.27 
2.0 to 9.0 
mm  
19.32 ± 10.53 16.79 ± 9.79 2.53 ± 2.27 
(1.43 to 3.62) 
0.001 6.98 -1.92 
2.0 to 
10.0mm  
19.89 ± 10.33 17.16 ± 9.71 2.74 ± 2.40 
(1.58 to 3.89) 
0.001 7.44 -1.97 
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TABLE 4.2: The number of antral follicles stratified by size to the nearest millimeter as measured by 
two-dimensional (2D) ultrasound and automated three-ĚŝŵĞŶƐŝŽŶĂů  ?^ŽŶŽs ? ? ^ŽŶŽŐƌĂƉŚǇ-
based Automated Volume Count) ultrasound. The two methods have been compared using limits 
of agreement and the P value derived using a paired samples t test. 
Antral follicle 
size (n) 
Real-time 2D 
(Mean ± SD) 
SonoAVC 
(Mean ± SD) 
Mean 
difference ± SD 
(95% CI) 
P 
value 
Upper 
LOA 
Lower 
LOA 
2.0 to 2.99 
mm  
2.21 ± 1.96 2.79 ± 1.72 -0.58 ± 2.19 
(-1.64 to 0.48) 
0.265 3.72 -4.88 
3.0 to 3.99 
mm (n) 
4.11 ± 3.70 2.63± 2.31 1.47 ± 2.50 
(0.27 to 2.68) 
0.019 6.38 -3.43 
4.0 to 4.99 
mm  
4.63 ± 4.86 2.68 ± 2.89 1.95 ± 3.08 
(0.46 to 3.43) 
0.013 7.99 -4.09 
5.0 to 5.99 
mm  
3.21 ± 2.30 3.26 ± 2.10 -0.05 ± 1.75 
(-0.89 to 0.79) 
0.897 3.37 -3.48 
6.0 to 6.99 
mm  
2.47 ± 1.07 2.74 ± 1.05 -0.26 ± 1.37 
(-0.92 to 0.40) 
0.413 2.42 -2.94 
7.0 to 7.99 
mm  
1.63 ± 0.96 1.42 ± 1.43 0.21 ± 1.08 
(-0.31 to 0.73) 
0.408 2.34 -1.91 
8.0 to 8.99 
mm  
1.05 ± 0.91 1.26 ± 0.65 -0.21 ± 1.03 
(-0.71 to 0.29) 
0.385 1.81 -2.23 
9.0 to 9.99 
mm  
0.58 ± 0.61 0.37 ± 0.60 0.21 ± 0.79 
(-0.17 to 0.59) 
0.259 1.75 -1.33 
 
 
4.5 Discussion 
This is the ĨŝƌƐƚ ƐƚƵĚǇ ƚŽ ĚĞƐĐƌŝďĞ ƚŚĞ ƵƐĞ ŽĨ ^ŽŶŽs ? ĨŽƌ ƚŚĞ ŝĚĞŶƚŝĨŝĐĂƚŝŽŶ ĂŶĚ
measurement of antral follicle size. Previous work by our own group has shown that the 
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new automated technique provides a more reliable measure of total follicle number than 
2D ultrasound and manual assessment of three-dimensional data both within and 
between observers (Deb, Jayaprakasan et al. 2009)
5
. The current study extends this work 
ĂŶĚŚĂƐƐŚŽǁŶƚŚĂƚ^ŽŶŽs ?ƉƌŽǀŝĚĞƐĚŝĨĨĞƌĞnt results to 2D ultrasound when the size 
ŽĨƚŚĞĨŽůůŝĐůĞŝƐĐŽŶƐŝĚĞƌĞĚ ?tŚŝůƐƚ^ŽŶŽs ?ŝƐĂŶĂƵƚŽŵĂƚĞĚƚĞĐŚŶŝƋƵĞ ?ƉŽƐƚ-processing 
ŽĨ ƚŚĞ ĚĂƚĂ ǁĂƐ ƌĞƋƵŝƌĞĚ ŝŶ Ăůů ĐĂƐĞƐ ? dŚĞ ƚĞĐŚŶŝƋƵĞ ŝƐ ďĞƐƚ ĐŽŶƐŝĚĞƌĞĚ ĂƐ  ‘ƐĞŵŝ-
ĂƵƚŽŵĂƚĞĚ ?ƚŚĞƌĞĨŽƌĞĂŶĚǁŚŝůƐƚƚŚĞĂĚĚŝƚŝŽnal processing adds to the assessment time it 
is straightforward and the overall time required for analysis was still significantly quicker 
than measures made with 2D ultrasound when the size of follicle size was also assessed. 
In both studies we found thaƚ ^ŽŶŽs ? ŝĚĞŶƚŝĨŝĞĚ ĂŶĚ ŵĞĂƐƵƌĞĚ ƐŝŐŶŝĨŝĐĂŶƚůǇ ůĞƐƐ
follicles than 2D ultrasound resulting in a consistently lower total antral follicle count than 
 ? ƵůƚƌĂƐŽƵŶĚ ƌĞŐĂƌĚůĞƐƐ ŽĨ ƚŚĞ ƵƉƉĞƌ ĂŶĚ ůŽǁĞƌ ƐŝǌĞ ůŝŵŝƚƐ ƵƐĞĚ ƚŽ ĚĞĨŝŶĞ ƚŚĞ  ‘ĂŶƚƌĂů
follicle population. This may be a true result or reflect fundamental differences in the 
measurement techniques. An obvious limitation of the current study is the inability to 
confirm the accuracy of these measurements but histological work suggests that the 
automated measures are more valid than those derived using 2D ultrasound imaging. 
Weenen et al. examined the ovaries of 12 regularly cycling subjects aged between 19 and 
44 years who had undergone prophylactic oophorectomy as they were genetically 
predisposed to an increased risk of ovarian cancer or because they had endometriosis 
(Weenen, Laven et al. 2004). Follicles, at all stages of folliculogenesis, were measured in 
two perpendicular planes and the mean measure taken as the diameter of follicle. 
Histologically, an average of 18 follicles measuring 2-6 mm was evident in each ovary. This 
ĐŽŵƉĂƌĞĚŵŽƌĞ ĨĂǀŽƌĂďůǇǁŝƚŚ ƚŚĞŵĞĂƐƵƌĞƐŵĂĚĞǁŝƚŚ^ŽŶŽs ?ǁŚŝĐŚ ŝĚĞŶƚŝĨŝĞĚ  ? ?
such follicles compared to 2D ultrasound which identified 26. A smaller number of follicles 
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measuring 1- ?ŵŵǁĞƌĞĞǀŝĚĞŶƚŚŝƐƚŽůŽŐŝĐĂůůǇ ?ĂƉƉƌŽǆŝŵĂƚĞůǇƐŝǆŝŶĞĂĐŚŽǀĂƌǇ ?^ŽŶŽs ?
identified approximately half this number whilst 2D ultrasound failed to identify any. This 
almost certainly reflects the resolution limits of ultrasound but may have been further 
confounded by the subjective nature of 2D ultrasound imaging. The ability of an observer 
to identify and reliably measure such small structures with 2D ultrasound is likely to be 
time dependent but a degree of measurement inaccuracy would still be expected even if 
more time was allowed for assessment. Whilst the subjects in the study by Weeneen et al. 
may be different from those in the current study with regards to the timing of the 
assessment in the menstrual cycle and in the population studied, who were having 
oophorectomy, the data reported represent the best currently available on the human 
ovary against which ultrasound can be evaluated. There are obvious limitations to the 
current evidence base and future validation studies may provide a stronger evidence base 
against which standards could be set.   
If we accept that the semi-automated 3D ultrasound measures are more valid than those 
made with 2D ultrasound imaging we need to consider why this new technique is better. 
It may relate to the image being displayed in a 3D ultrasound multiplanar view which 
allows cross-checking of each follicle in three different planes, improving spatial 
orientation therefore, but is more likely to reflect the fact that each follicle is colour-
coded which prevents repeat measures of the same follicle (Raine-Fenning, Jayaprakasan 
et al. 2007). As regards the objective assessment of follicle size, the 2D ultrasound 
technique derives the follicular diameter through estimation of the mean of two 
ƉĞƌƉĞŶĚŝĐƵůĂƌ ?ůŝŶĞĂƌŵĞĂƐƵƌĞƐǁŚĞƌĞĂƐ^ŽŶŽs ?ƵƐĞƐǀŽůƵŵĞƚƌŝĐŝŶĨŽƌŵĂƚŝŽŶƚŽ define 
Ă  ‘ƌĞůĂǆĞĚ ƐƉŚĞƌĞ(Raine-Fenning, Jayaprakasan et al. 2007). This might explain the 
differences seen between the two techniques as 2D ultrasound is more likely to disregard 
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small irregularities in the follicles. Volumetric ŵĞĂƐƵƌĞŵĞŶƚƐŵĂĚĞǁŝƚŚ^ŽŶŽs ?ŚĂǀĞ
been shown to provide a a more reliable and valid assessment of the estimated diameter 
of larger follicles than both 2D ultrasound and manual assessment of 3D ultrasound 
datasets regardless of the number of linear measures taken to define the size of the 
follicle (Raine-Fenning, Jayaprakasan et al. 2008; Raine-Fenning, Deb et al. 2009).  
 
4.6 Conclusion 
 
KƵƌƌĞƐƵůƚƐƐŚŽǁƚŚĂƚ^ŽŶŽs ? ?ĚĞƐƉŝƚĞďĞŝŶŐĂƐĞŵŝ-automated method as data post-
processing is invariably required, provides quicker measures of antral follicle size than 2D 
ultrasound. There is least agreement between the two methods with antral follicles 
measuring 3.0 to 4.99 mm. If the size of the follicles contributing to the overall antral 
follicle population is more important than the absolute size of the pool, and the current 
animal and human evidence suggests it is, these findings have important implications for 
the research setting and clinical environment. Further research is required to evaluate the 
biological and clinical importance of quantifying antral follicle size and count. 
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CHAPTER 5. The predictive value of the automated 
quantification of the number and size of small antral follicles 
in women undergoing assisted reproduction treatment.  
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5.1 Abstract 
 
Objective: Sono automatic volume calculation (SonoAVC) automatically identifies and 
measures the dimensions of hypoechogenic areas within datasets acquired using three-
dimensional (3D) ultrasound. The objective of this study was to evaluate the predictive 
value of automated antral follicle counts according to their relative sizes in women 
undergoing assisted reproduction treatment (ART).  
Methods P  ? ? ?ƐƵďũĞĐƚƐĂŐĞĚA? ? ?ǇĞĂƌƐǁŝƚŚĂďĂƐĞůŝŶĞ&^,A? ? ? /hĚƵĞƚŽƵndergo their 
first cycle of ART were prospectively recruited. SonoAVC was used to measure the 
ĚĂƚĂƐĞƚƐ ĂŶĚ ƌĞĐŽƌĚ ƚŚĞ ŶƵŵďĞƌ ŽĨ ĂŶƚƌĂů ĨŽůůŝĐůĞƐŵĞĂƐƵƌŝŶŐ A? ?ŵŵ ŝŶ ĚŝĂŵĞƚĞƌ ? dŚĞƐĞ
ĨŽůůŝĐůĞƐǁĞƌĞƚŚĞŶŐƌŽƵƉĞĚŝŶƚŽƐƵďƐĞƚƐĂĐĐŽƌĚŝŶŐƚŽƚŚĞŝƌƌĞůĂƚŝǀĞƐŝǌĞƐ PA?2.0 mm, 2.1-4.0 
mm, 4.1-6.0 mm, 6.1-8.0 mm, and 8.1-9.0 mm. The primary outcome was viable 
pregnancy confirmed on ultrasound 5 weeks following embryo transfer.  
Results: 142 subjects were included for analysis of primary endpoint. Those subjects who 
conceiǀĞĚŚĂĚƐŝŐŶŝĨŝĐĂŶƚůǇŵŽƌĞĂŶƚƌĂůĨŽůůŝĐůĞƐŵĞĂƐƵƌŝŶŐA? ?ŵŵ ?ƉA? ? ? ? ? ? ?ĂŶĚ ? ? ?-4.0 
mm (p<0.001) than those who had unsuccessful treatment. There were no significant 
differences between the groups in the number of antral follicles measuring 4.1-6.0 mm 
(p=0.191), 6.1-8.0 mm (p=0.203), or 8.1-9.0 mm (p=0.601). Multiple logistic regression 
showed antral follicles measuring 2.1-4.0 mm were an independent predictor of 
pregnancy (Exp(B)=1.234, 95%CI 1.092 and 1.491; p=0.004; AUC=0.693).  
Conclusion: SonoAVC provides automated measures of antral follicle number and size. 
Using this technique, the number of antral follicles measuring 2.1 to 4.0 mm in diameter is 
an independent, significant predictor of pregnancy following IVF treatment.  
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5.2 Introduction 
Ultrasonographic assessment of the total number of antral follicles measuring 2-9 mm is a 
reliable determinant of ovarian reserve (Scheffer, Broekmans et al. 2003; Ng, Chan et al. 
2005; Jayaprakasan, Campbell et al. 2008). The pool of antral follicles comprises pre-antral 
and early antral follicles (0.2  W 2.0 mm) that are largely gonadotrophin-independent, small 
antral follicles (1.0-6.0 mm) selectable due to their responsiveness to gonadotrophins, 
and larger antral follicles (>6.0 mm) that are gonadotrophin-dependent (Gougeon 1989). 
At any given timepoint during the menstrual cycle, the ovaries contain follicles at different 
developmental stages and antral follicle counts must be made during the early follicular 
phase (Gougeon 1998). The total antral follicle count (tAFC) is made by counting the 
number of antral follicles measuring 2 to 10 mm in both ovaries and can be estimated 
using two-dimensional (Scheffer, Broekmans et al. 2002) or three-dimensional ultrasound 
(Jayaprakasan, Campbell et al. 2008). The majority of studies evaluating the value of the 
antral follicle counts only consider the overall number and not the absolute size of the 
follicles, which may be a separate, independent predictor.  
Anti-Müllerian hormone (AMH), also known as Müllerian inhibiting substance, is one of 
the best markers of ovarian reserve (Dehghani-Firouzabadi, Tayebi et al. 2008; Nelson, 
Yates et al. 2009). AMH is largely expressed by the granulosa cells of pre-antral and small 
antral follicles measuring 6.0 mm or less (Modi, Bhartiya et al. 2006). Whilst serum levels 
of AMH correlate with the total number of antral follicles (de Vet, Laven et al. 2002; van 
Rooij, Broekmans et al. 2005; Fanchin, Mendez Lozano et al. 2007), it is likely that these 
smaller antral follicles more accurately reflect ovarian reserve than the total population of 
follicles. The number of small antral follicles is also strongly correlated with other ovarian 
reserve tests, such as AMH, supporting the concept that these smaller follicles represent 
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the functional ovarian reserve (Haadsma, Bukman et al. 2007). There is a linear decline in 
the number of antral follicles with age (Gougeon 1994) and this is more  apparent in the 
smaller antral follicles (<6.0 mm) than the larger ones (>6.0 mm) (Scheffer, Broekmans et 
al. 2003; Haadsma, Bukman et al. 2007) and their total number is, therefore, more 
reflective of the primordial follicle pool. 
Assessment of the antral follicle population is commonly made using two-dimensional 
ultrasound, which is simply used to identify and count the number of small follicles within 
each ovary. The largest follicles should be measured to ensure only follicles measuring 9.0 
mm or less in diameter are included in the total count as larger follicles are more likely to 
be atretic (Khairy, Clough et al. 2008). Assessment of follicle size requires measurement of 
each follicle in two dimensions and calculation of the mean diameter (Haadsma, Bukman 
et al. 2007). This can be very labour intensive and the reliability and validity of such 
measures are likely to be reduced when there are numerous follicles as it is difficult to 
ensure each follicle is only measured once and none are missed. Three-dimensional 
ultrasound allows the user to acquire a volume of information which can be examined off-
line and facilitates the implementation of various software programmes that enhance 
measurement accuracy and both intra- and inter-observer reliability (Raine-Fenning, 
Campbell et al. 2003). The most recent development has seen the introduction of 
automated data analysis where mathematical algorithms allow the definition and 
differentiation of hypo echoic, fluid-filled areas within the acquired volume (Raine-
Fenning, Jayaprakasan et al. 2007). SonoAVC also provides automatic estimation of the 
absolute dimensions of each three-dimensional fluid-filled area (Raine-Fenning, 
Jayaprakasan et al. 2008). Each individual volume is given a specific colour and the 
automated measurements of its mean diameter (relaxed sphere diameter), its maximum 
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dimensions (x, y, z diameters), and its volume are displayed in descending order from the 
largest to the smallest (Raine-Fenning, Jayaprakasan et al. 2008). An unlimited number of 
volumes can theoretically be quantified and the software lends itself, therefore, to the 
examination of follicles within the ovary.  
The aim of this study was to evaluate the value of antral follicles stratified according to 
their size, calculated automatically with SonoAVC, in the prediction of viable pregnancy 5 
weeks following embryo transfer on ultrasound, ovarian response to controlled ovarian 
stimulation with gonadotrophins, and fertilisation and cleavage rates, in women 
undergoing in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) as part of 
their assisted reproduction treatment (ART).  
 
5.3 Methods 
Study design 
Subjects planning to undergo their first treatment cycle of in vitro fertilisation (IVF) were 
prospectively recruited. Inclusion criteria included age less than 40 years, body mass index 
(BMI) of less than 30, regular menstrual cycles of 24-32 days duration, planned first cycle 
of IVF with or without ICSI, and an early follicular phase FSH level of <15IU/L. All subjects 
underwent a pre-treatment ultrasound assessment in the early follicular phase (cycle day 
2-5) of menstrual cycle. Subjects were excluded if they were found to have an ovarian 
follicle or cyst measuring more than 20 mm in diameter. Recruited subjects were 
subsequently excluded if their treatment cycle was cancelled or if they had failed 
fertilisation or embryo cleavage. Subjects wishing to egg share or altruistically donate 
their oocytes were not included. 
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Clinical pregnancy, as confirmed by a transvaginal ultrasound scan performed 5 weeks 
following embryo transfer assessing the fetal viability, was taken as the primary outcome 
measure for analysis. Secondary outcome measures assessed included the number of 
mature oocytes, fertilised oocytes and cleaved embryos. To power the study at 0.8 
incorporating ten predictor variables in the regression model, a sample size of 130 was 
required. 
Data acquisition 
A single investigator (JC) performed all of the transvaginal ultrasound examinations using 
a Voluson Expert 730
TM 
and a four-dimensional, 5-9 MHz transvaginal transducer. A 
preliminary conventional 2D ultrasound assessment of the pelvis was performed to 
exclude any obvious pathology, followed by visualization of ovaries in their transverse and 
longitudinal planes and the subsequent acquisition of 3D data using the volume mode. A 
3D dataset was subsequently acquired using the high quality, slow sweep mode resulting 
in the highest resolution. The resultant multiplanar display of the ovary was examined to 
confirm its inclusion in entirety. Datasets of both ovaries from each subject were stored 
on recordable digital video discs (DVDs) for subsequent analysis.  
Data measurement 
4D View  (version 7.0, GE Medical Systems) was used for offline data analysis. The 3D 
dataset was opened and displayed using the multiplanar view, which shows three 
sectional planes (the A, B, and C plane) simultaneously that are mutually related so that 
movement within one plane produces geometrically equivalent movements in the other 
two planes. These planes can be used to standardize the view of the ovary, or any 3D 
dataset, and for this study we ensured the A plane showed the ovary in its longitudinal 
section with the iliac vessels inferiolaterally and the B plane the transverse image 
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orthogonal to this. This orientation automatically ensures the image presented in the C 
plane demonstrates the coronal view of the ovary. The quality of the image was adjusted 
and optimized, in terms of magnificatiŽŶ ?ĨŽƌĂůůĚĂƚĂƐĞƚƐĂŶĚƚŚĞ ‘ƌĞŶĚĞƌŵŽĚĞ ?ĞŶƚĞƌĞĚ
to generate a 3D rendered view of the ovary. Once the dataset had been correctly 
positioned, SonoAVC was implemented. The individual follicles were then displayed with a 
specific colour and shown together with their dimensions and relative sizes. Post 
processing involved manually clicking on the follicles that were missed as described in 
chapter 3. Each additional antral follicle identified in this way was given a new colour and 
its dimensions displayed together with those follicles that were originally identified. The 
size of the follicles, as measured automatically and displayed with different colour codes 
on the screen, was sub-divided according to the mean follicle sizes into those measuring 
<2 mm, 2.1 to 4.0 mm, 4.1 to 6.0 mm, 6.1 to 8.0 mm, and 8.1 to 9.0 mm. 
Treatment protocol 
A long protocol, involving pituitary suppression with Gonadotrophin Releasing Hormone 
(GnRH) agonists (500 mcg/day of Buserelin; Suprefact®, Aventis Pharma, Kent, UK or 800 
mcg/day of Nafarelin; Synarel®, Pharmacia, Milton Keynes, UK) started in the mid-luteal 
phase of the menstrual cycle, was used in all subjects. Ovarian stimulation was 
commenced once down regulation was confirmed with a daily dose of either 225 IU of 
recombinant Follicle Stimulating Hormone (FSH; Gonal-F; Serono Pharmaceuticals Ltd, 
Feltham, UK) or 225 IU of human menopausal gonadotrophin (hMG; Menopur; Ferring 
Pharmaceuticals Ltd, UK). The response to ovarian stimulation was monitored by 
ultrasound and serum oestradiol levels on an alternate day basis from the fifth day of FSH 
administration and human Chorionic Gonadotrophin (hCG; 6500 IU of Ovitrelle; Serono 
Pharmaceuticals Ltd, Feltham, UK when using recombinant FSH or 5000 IU of Pregnyl; 
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Organon Laboratories Ltd when using Menopur) administered when there were at least 
three follicles measuring 18 mm or more in diameter with transvaginal, ultrasound-guided 
oocyte retrieval scheduled 36 hours later. One or two embryos were replaced according 
to the wishes of the couple and the number of embryos available 48 hours later. From the 
day of embryo transfer, luteal support was provided through the self-administration of 
progestogen pessaries (Cyclogest; Shire Pharmaceuticals Ltd, Basingstoke, Hants, UK). A 
urine pregnancy test was performed 16 days from the day of embryo transfer and 
subjects with positive tests had the viability, position, and growth of their pregnancy 
confirmed by a transvaginal ultrasound scan 3 weeks later at 7 weeks of gestation if the 
date of embryo transfer is considered as the time of implantation.  
Statistical analysis 
The Statistical Package for the Social Sciences (version 15.0; SPSS, Chicago, IL) was used 
for data analysis. The distribution of the data was checked for normality using a normal 
probability plot. An unpaired t-test or Mann-Whitney U test, applied to normally 
distributed and skewed data respectively, were used to examine for significant differences 
in each variable between pregnant and non-pregnant groups. A p-value of <0.05 was 
considered statistically significant and to have not occurred by chance.  
Linear regression analysis was used to assess the value of age and antral follicles, both 
overall and according to their mean diameter, for the prediction of the number of mature 
oocytes retrieved, the number of fertilised oocytes, and the number of embryos at 
cleavage stage. Binary logistic regression analysis was then applied to evaluate the effect 
of the same variables on the prediction of pregnancy. Receiver operating characteristic 
(ROC) curve analysis was performed to quantify the ability of any significant predictors to 
discriminate between pregnant and non-pregnant subjects. Areas under the ROC curves 
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(AUCROC) were compared using the MEDCALC software package (version 9.5.2.0; MedCalc 
Software, Mariakerke, Belgium) (Hanley and McNeil 1983). 
5.4 Results 
Of the 156 subjects recruited, a total of 142 were included in the final analysis of the 
primary endpoint (viable pregnancy on ultrasound scan 5 weeks following embryo 
transfer). Of the 14 subjects excluded from this analysis, 3 were found to have a well 
defined ovarian cyst requiring ovarian cystectomy, 2 failed to down regulate adequately 
requiring cancellation and rescheduling of the treatment cycle, 3 decided to enter the 
egg-share scheme after recruitment, 3 subjects had failed fertilisation, and 3 had failed 
cleavage.  
A total of 151 subjects were included in the final analysis of secondary endpoint including 
the number of mature oocytes. Of the 5 subjects excluded from the study, 3 were found 
to have a well defined ovarian cyst requiring ovarian cystectomy, and 2 failed to down 
regulate adequately requiring cancellation and rescheduling of the treatment cycle. A 
total of 148 subjects were included in the final analysis of secondary endpoint including 
number of fertilised oocytes and cleaved embryos. Of the 8 subjects excluded, 3 were 
found to have a well defined ovarian cyst requiring ovarian cystectomy,  2 failed to down 
regulate adequately requiring cancellation and rescheduling of the treatment cycle, and 3 
decided to enter the egg-share scheme after recruitment.  
The mean (SD; range) age and BMI of the whole study group were 34.30 (4.51; 23.00 - 
39.86 years) and 25.67 (3.24; 22.21 - 28.97 Kg/m2) respectively. 76 (51.35%) subjects had 
standard IVF and the remaining 72 (48.65%) had ICSI to facilitate fertilisation. 52 (35.14%) 
were given hMG as the ovarian stimulant and 96 (64.86%) rFSH. 73 (51.41%) subjects had 
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a viable clinical pregnancy confirmed on transvaginal ultrasound scan 5 weeks following 
embryo transfer, and the remaining 69 (48.59%) had a negative pregnancy outcome, 
which included a negative pregnancy test in 64 subjects and a non viable pregnancy on 
ultrasound in 5 subjects. The pregnant and the non-pregnant groups were compared for 
age, type of treatment (IVF / ICSI), type of gonadotrophin used (rFSH / hMG), size of antral 
follicles, number of total oocytes, number of mature oocytes, number of fertilised 
oocytes, number of cleaved embryos, and grade of embryos using a Mann-Whitney U test 
as they were not normally distributed (Table 5.1). The key findings were that the pregnant 
group were significantly younger (33.38 ± 4.07; 24.25 - 39.86) than their non-pregnant 
counterparts (35.29 ± 4.38; 23.00  W 39.56) and had a significantly higher number of antral 
follicles overall (19.71 ± 10.60; 3 - 48 vs 14.06 ± 8.77; 3 - 43 respectively).  
However, sub-group analysis on the basis of absolute follicle size revealed the differences 
between the groups in the number of antral follicles was restricted to the smaller follicles 
measuring <2.0 mm and 2.1 to 4.0 mm as there were no differences in the number of 
follicles measuring 4.1-6.0 mm, 6.1-8.0 mm, or 8.1 to 9.0 mm. There were also no 
differences between the pregnant and non-pregnant groups in the type of gonadotrophin 
used for ovarian stimulation, the type of treatment employed for fertilisation or in the 
grade of embryos (Table 5.1). 
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Table 5.1: This table shows the differences between the group that achieved a clinical pregnancy 
following ART to the group that did not achieve a clinical pregnancy. Variables examined included 
the age of participant, type of treatment (IVF / ICSI), type of gonadotrophin used, antral follicles 
stratified by size, and ovarian response. 
Variable 
 
Pregnant  
(n=73) 
Non-Pregnant 
(n=69) 
P value 
Age (years) 33.38 (4.07; 24.25-39.86) 35.29 (4.38; 23.00-39.56) 0.006
 
Type of treatment 
IVF  
37 (50.68%) 
ICSI  
36 (49.32%) 
IVF  
35 (50.72%) 
ICSI  
34 (49.28%) 
0.996 
Type of gonadotrophin 
rFSH       
46 (63.01%) 
hMG  
27 (36.99%) 
rFSH  
48 (69.57%) 
hMG  
21 (30.43%) 
0.411 
A
n
tr
a
l 
F
o
ll
ic
le
 C
o
u
n
t 
st
ra
ti
fi
e
d
 b
y
 
m
e
a
n
 f
o
ll
ic
le
 d
ia
m
e
te
r 
Total 19.71 (10.60; 3-48) 14.06 (8.77; 3-43) 0.001 
A? ? ? ?ŵŵ 1.49 (2.07; 0-11) 0.87 (1.16; 0-5) 0.041 
2.1-4.0 mm 6.97 (5.29; 0-26) 3.92 (3.39; 0-14) <0.001 
4.1-6.0 mm 6.62 (4.87; 0-25) 5.39 (4.56; 0-22) 0.069 
6.1-8.0 mm 3.73 (2.66; 0-12) 3.13 (2.28; 0-11) 0.192 
8.1-9.0 mm 0.90 (1.06; 0-4) 0.74 (0.81; 0-3) 0.583 
Total oocytes (n) 12.73 (6.42; 2-35) 10.86 (5.37; 1-26) 0.118 
Mature oocytes (n) 10.73 (5.17; 2-23) 9.04 (4.54; 1-20) 0.081 
Fertilised oocytes (n) 7.26 (3.70; 1-20) 5.81 (4.09; 1-19) 0.028 
Cleaved embryos (n) 6.89 (3.54; 1-19) 5.53 (3.99; 1-18) 0.024 
Mean embryo grade 2.22 (0.61; 1-3) 2.41 (0.55; 1-3) 0.071 
 
Values are presented as mean (SD; range) or as number (percentage). IVF = in vitro fertilisation / ICSI = 
intracytoplasmic sperm injection, rFSH = recombinant Follicle Stimulating Hormone (Gonal-F; Serono 
Pharmaceuticals Ltd, Feltham, UK); hMG = human menopausal gonadotrophins (Menopur; Ferring 
Pharmaceuticals Ltd, UK) 
S h i l p a  D e b   P a g e  | 112 
 
 
Since age is related to number and size of the antral follicles as well as the outcome of 
various ovarian reserve tests (Broekmans, Kwee et al. 2006), linear regression analysis of 
age and the different cohorts of antral follicles, according to their mean diameter, was 
applied individually for the prediction of the number of mature oocytes retrieved, number 
of fertilised oocytes, and the number of embryos reaching cleavage stage (Table 5.2). The 
analysis showed that when regression analysis was applied to each of the variable 
separately, all the variables except for 8.1 to 9.0 mm follicles were significant. However, 
when multiple regression analysis including the age and antral follicle number stratified 
according to their mean diameter was applied, the cohort of antral follicles measuring 2.1 
to 4.0 mm in size were the only significant variable in the prediction of these outcome 
measures of ovarian response (Table 5.3). A significant correlation coefficient (R) was 
found between the antral follicles measuring 2.1 to 4.0 mm and age (R=-0.189; P=0.024), 
number of total oocytes retrieved (R=0.453; P<0.001), number of mature oocytes 
(R=0.431; P<0.001), number of fertilised oocytes (R=0.343; P<0.001), and number of 
embryos at cleavage stage (R=0.347; P<0.001). However, the correlation was not 
significant between 2.1 to 4.0 mm follicles and grade of embryos (R=0.144; P=0.087), and 
total dose of gonadotrophin used for ovarian stimulation (R=-0.084; P=0.303).  
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Table 5.2: Linear regression analysis of each individual predictor variable including age and antral 
follicle number stratified according to their mean diameter, for the prediction of the number of 
mature oocytes, fertilised oocytes, and cleaved embryos. 
R
2
: It is a measure of variability in the outcome due to the predictors (Standardised ß): expresses the number 
of standard deviation that the outcome changes due to a single standard deviation change in the predictor. 
 
Univariate analysis suggested most of the variables were significant predictors of 
pregnancy outcome. However, only the cohort of antral follicles measuring 2.1 to 4.0 mm 
in size remained a significant predictor of clinical pregnancy when logistic regression 
analysis was applied to all of the variables (Table 5.4). ROC curve analysis of the variables 
predictive of pregnancy on univariate analysis also showed a maximum area under curve 
(AUC) for antral follicles measuring 2.1 to 4.0 mm; albeit the AUC for age (0.634), fertilised 
oocytes (0.633), and cleaved embryos (0.632) did not differ significantly. The AUC for 
mature oocytes (0.585) and mean embryo grade (0.577) was significantly lesser than the 
Predictor 
variable 
Number of mature oocytes 
(n=151) 
Number of fertilised 
oocytes 
(n=148) 
Number of cleaved 
embryos 
(n=148) 
 P value R
2 
ß P value R
2 
ß P value R
2 
ß 
Age 0.015 0.099 -0.314 0.075 0.022 -0.147 0.092 0.019 -0.139 
Total antral 
follicles 
<0.001 0.225 0.474 0.001 0.127 0.356 0.001 0.117 0.322 
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(m
m
) A? ? ? ? 0.014 0.040 0.199 0.743 0.001 0.027 0.831 0.001 0.018 
2.1 ?4.0  <0.001 0.249 0.499 <0.001 0.139 0.359 <0.001 0.120 0.346 
4.1-6.0  0.001 0.123 0.351 0.016 0.085 0.292 0.026 0.081 0.284 
6.1-8.0  0.008 0.047 0.217 0.041 0.053 0.181 0.018 0.072 0.219 
8.1-9.0  0.992 0.000 0.001 0.947 0.000 -0.006 0.942 0.000 0.006 
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AUC for 2.1 to 4 mm follicles (Figure 5.1). The sensitivity, specificity, positive and negative 
predictive value, positive likelihood ratio, and post-test probability for the prediction of 
pregnancy at different cut-off levels for the cohort of antral follicles measuring 2.1 to 4.0 
mm are shown in Table 5.5. Whilst the optimum cut-off level, as indicated by the highest 
sum of sensitivity and specificity, was at 3 or more, the post-test probability was highest 
at a cut-off level of 6 or more.  
Table 5.3: Multiple linear regression analysis of model including age and antral follicle number 
stratified according to their mean diameter, for the prediction of the number of mature oocytes, 
fertilised oocytes, and cleaved embryos. 
Predictor 
variable 
Number of mature oocytes 
(n=151); R
2
=0.296 
Number of fertilised 
oocytes 
(n=148); R
2
=0.170 
Number of cleaved 
embryos 
(n=148); R
2
=0.159 
 P value 95% 
CI
 
ß P 
value 
95% 
CI
 
ß P 
value 
95% 
CI
 
ß 
Age 0.064 -0.385 
to 
0.043 
-0.182 0.557 -0.188 
to 
0.102 
-0.048 0.590 -0.179 
to 
0.102 
-0.440 
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) 
A? ? ? ? 0.462 -0.279 
to 
0.611 
0.055 0.165 -0.587 
to 
0.101 
0.088 0.154 -0.578 
to 
0.092 
0.075 
>2.0 ?4.0  <0.001 0.246 
to 
0.626 
0.402 0.001 0.102 
to 
0.418 
0.309 0.002 0.088 
to 
0.397 
0.298 
>4.0-6.0  0.712 -0.165 
to 
0.241 
0.035 0.669 -0.135 
to 
0.210 
0.044 0.647 -0.129 
to 
0.207 
0.047 
>6.0-8.0  0.427 -0.208 
to 
0.490 
0.066 0.088 -0.08 
to 
0.602 
0.128 0.068 -0.15 
to 
0.569 
0.063 
>8.0-9.0  0.637 -1.015 
to 
0.623 
-0.034 0.713 -0.820 
to 
0.562 
-0.029 0.734 -0.789 
to 
0.557 
-0.027 
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Table 5.4: Logistic regression analysis of age, number of antral follicles stratified according to size, 
number of mature oocytes, number of fertilised oocytes, number of cleaved embryos, and mean 
grade of embryos replaced for the prediction of pregnancy following IVF / ICSI treatment. 
Predictor Variable Odds Ratio 95% Confidence Interval P value 
Age 0.987 0.867  W 1.014 0.057 
Total antral follicles 1.072 1.014  W 1.094 0.047 
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A? ? ? ?ŵŵ 0.935 0.644  W 1.082 0.173 
2.1-4.0 mm 1.234 1.092  W 1.491 0.004 
4.1-6.0 mm 1.055 0.951  W 1.172 0.311 
6.1-8.0 mm 1.020 0.853  W 1.219 0.831 
8.1-9.0 mm 0.758 0.497  W 1.154 0.196 
Mature oocytes  1.080 0.949  W 1.229 0.242 
Fertilised oocytes  0.815 0.446  W 1.487 0.505 
Cleaved embryos  1.128 0.623  W 2.045 0.691 
Mean grade of embryos  1.753 0.868  W 3.543 0.118 
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Table 5.5: Receiver operator characteristic curve assessment of the best cut-off level for the 
number of antral follicles measuring 2.1 to 4.0 mm for the prediction of pregnancy following IVF 
with/without ICSI treatment 
2.1-4.0 mm AFC 
Cut-off 
Sensitivity 
(%) 
Specificity 
(%) 
+LR -LR PPV (%) NPV (%) 
>1 87.67 23.19 1.14 0.53 54.70 64.00 
>2 82.19 36.23 1.29 0.49 57.70 65.80 
>3
* 
72.60 59.42 1.79 0.46 65.40 67.20 
>4 61.64 68.12 1.93 0.56 67.20 62.70 
>5 53.42 78.26 2.46 0.60 72.20 61.40 
>6 47.95 84.06 3.01 0.62 76.10 60.40 
>7 38.36 86.96 2.94 0.71 75.70 57.10 
>8 26.03 88.41 2.24 0.84 70.40 53.00 
>9 24.66 89.86 2.43 0.84 72.00 53.00 
>10 19.18 92.75 2.65 0.87 73.70 52.00 
 
* Optimum cut-off level is a level at which an acceptable compromise is achieved between sensitivity, 
specificity, PPV and NPV of the test. 
Positive predictive value (PPV): It is the proportion of subjects with positive test results who are correctly 
diagnosed. It is a critical measure of the performance of a diagnostic method, as it reflects the probability 
that a positive test reflects the underlying condition being tested for.  
Negative predictive value (NPV): It is defined as the proportion of subjects with a negative test result who 
are correctly diagnosed.  
Positive and negative likelihood ratio (+LR and  ?LR): A likelihood ratio of greater than 1 indicates the test 
result is associated with the disease. A likelihood ratio less than 1 indicates that the result is associated 
with absence of the disease.  
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Figure 5.1: Receiver operator characteristic curves of variables predictive of pregnancy 
5.5 Discussion 
This is the first study to evaluate different cohorts of antral follicles, based on their 
absolute size, in the prediction of reproductive outcome in subjects undergoing IVF 
treatment. Our results show that the small antral follicles measuring between 2.1 to 4.0 
mm are a significant predictor of viable pregnancy confirmed on ultrasound 5 weeks 
following embryo transfer, independent of age, the number of mature oocytes obtained, 
fertilisation rates, the number of cleaved embryos, and the grade of embryos transferred.  
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One study  has considered the different sizes of antral follicles and reported that the 
pregnancy rates were higher in women with higher number of 5-10 mm size antral 
follicles (Pohl, Hohlagschwandtner et al. 2000). However, they also included follicles 
ŵĞĂƐƵƌŝŶŐ ƵƉ ƚŽ  ? ? ŵŵ ŝŶ ƚŚĞŝƌ  ‘ƚŽƚĂů ĂŶƚƌĂů ĨŽůůŝĐůĞ ĐŽƵŶƚ ?ĂŶĚ ĨŽƵŶĚ ƚŚĂƚ ĐǇĐůĞ
cancellation due to poor ovarian response was higher in women with a dominant number 
of antral follicles measuring more than 11 mm. Regression analysis, in our study, however 
demonstrated that the small antral follicles, measuring between 2.1 to 4.0 mm, are the 
most significant predictor of the number of mature oocytes retrieved following IVF 
treatment and that this is independent of age and the total number of antral follicles. This 
is in keeping with work by Pellicer et al. who looked at the number of small, selectable 
antral follicles in young, low responders with normal basal FSH levels (Pellicer, Ardiles et 
al. 1998). Those women with an unexpected poor response were found to have a 
significantly lower number of follicles measuring between 2 to 5 mm than age-matched 
controls. In our study, linear regression analysis also revealed a significant predictive 
relationship between follicles measuring 2.1 to 4.0 mm and fertilisation rates and the 
number of cleaved embryos. This supports the notion that the smaller antral follicles are 
the follicles that truly reflect the ovarian potential and are most predictive of response to 
controlled ovarian stimulation during IVF treatment. Several studies suggest, however, 
that the total number of antral follicles is predictive of reproductive response (van Rooij, 
Broekmans et al. 2002; Hendriks, Mol et al. 2005; Muttukrishna, McGarrigle et al. 2005). It 
is possible that the smaller, more responsive follicles comprise the majority of the follicle 
population included in the total count in these individuals and that this masks the 
importance of the smaller follicles.  
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AMH has also been suggested as an important predictor of response to ovarian 
stimulation. Ficicioglu et al., for example, found that levels of AMH predict the number of 
oocytes retrieved with a positive predictive value of 96% (Ficicioglu, Kutlu et al. 2006) and 
other groups have reported a strong correlation between the number of oocytes 
retrieved and both AMH levels and the total number of antral follicles (de Vet, Laven et al. 
2002; van Rooij, Broekmans et al. 2005; Fanchin, Mendez Lozano et al. 2007; Dehghani-
Firouzabadi, Tayebi et al. 2008). AMH is expressed by the granulosa cells of the early 
growing, pre-antral and small antral follicles, which measure less than 6 mm,, but not by 
non-atretic, larger antral follicles or those that have become atretic, and may reflect or 
represent the population of smaller antral follicles more than the overall number 
(Baarends, Hoogerbrugge et al. 1995; Gruijters, Visser et al. 2003; Weenen, Laven et al. 
2004; Skalba, Cygal et al. 2008). Based on our results, further studies evaluating ovarian 
response and reproductive outcome based on the number of small antral follicles and 
AMH levels are warranted. 
The primary outcome measure evaluated in this study was a viable intrauterine pregnancy 
confirmed on a transvaginal ultrasound scan 5 weeks after embryo transfer. Several 
factors are thought to influence the chance of pregnancy after IVF treatment and in this 
study we considered age, the total number of antral follicles and the number of follicles 
within each size cohort, the type of gonadotrophin used, the technique used for 
fertilisation (IVF / ICSI), the number of mature oocytes retrieved, the number of fertilised 
oocytes, the number of cleaved embryos, and the number and grade of embryos 
transferred. Logistic regression revealed that the only variable predictive of clinical 
pregnancy was the number of antral follicles measuring between 2.1 to 4.0 mm 
(Exp(B)=1.221; 95% CI 1.072 and 1.391; p=0.003). Receiver operating characteristic 
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analysis suggested this cohort of follicles provides the most discriminative power to 
differentiate those women likely to conceive (AUC: 0.694) from those whose treatment 
will not be successful; a total count of three providing the optimum sensitivity and 
specificity with a post-test probability of 53%.  
Ovarian ageing is known to influence the ovarian response to stimulation, as measured by 
the oocyte yield at retrieval, and is characterised by the progressive depletion of the 
primordial follicular cohort (Broekmans, Knauff et al. 2007). The antral follicle count is 
positively correlated with the primordial follicular population (Gougeon 1996) and is, 
therefore, a significant predictor of poor ovarian response. Haadsma et al. evaluated 
antral follicles of different sizes and found a decline in the number of small antral follicles 
with increasing age whereas the number of larger follicles remained constant. In our 
study, we further sub-grouped the small and large antral follicles and found a similar 
significant correlation between age and the cohort of follicles measuring 2.1 to 4.0 mm 
(p=0.005) and 4.1 to 6.0 mm (p=0.001). In this study we did not include women above the 
age of 40 who are expected to have a much lower chance of pregnancy as a result of 
impaired oocyte quality, as illustrated by lower implantation rates even when the ovarian 
response is deemed acceptable and when there are an adequate number of embryos 
available for transfer (van Rooij, Bancsi et al. 2003). It would be interesting to examine the 
relative proportions of the different cohorts of antral follicle in these women but one 
would expect a reduction in the smaller follicles.  
The results of our study must be interpreted with caution and are not generally applicable 
as we only included subjects predicted to have a normal response, as assessed by age and 
FSH levels of <15 IU/L, undergoing their first cycle of IVF. Further work is required in 
women who have demonstrated a poor or exaggerated response to ovarian stimulation 
S h i l p a  D e b   P a g e  | 121 
 
 
and the predictive value of the different cohorts of antral follicles compared with other 
markers of ovarian reserve, especially AMH which has emerged as one of the most 
powerful predictors of response and reproductive outcome following assisted 
reproduction treatment (Wunder, Guibourdenche et al. 2008; Nelson, Yates et al. 2009)  
5.6 Conclusion 
SonoAVC allows the quantitative assessment of the number and relative sizes of the 
antral follicle population in women undergoing in vitro fertilisation treatment. Small antral 
follicles, measuring 2.1 to 4.0 mm, appear to be the most significant predictor of the 
number of mature oocytes retrieved, fertilisation rate and the number of embryos 
reaching the cleavage stage. This cohort of follicles also appears to predict pregnancy 
independently of age and the total number of antral follicles. Further work is required in 
women with poor and exaggerated response to treatment and should be undertake in 
conjunction with serum AMH measures. This technique may facilitate prospective studies 
designed to examine the effect of different gonadotrophin preparations and doses and 
treatment protocols.  
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CHAPTER 6. Validation of antral follicle counts of different 
follicle size cohorts made using two- and three-dimensional 
ultrasound  
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6.1 Abstract 
 
Objectives: Three-dimensional (3D) ultrasound assisted sonography-based automated 
volume calculation (SonoAVC) and 2D ultrasound have been described in counting and 
measuring the size of antral follicles. This study was designed in an in vitro setting to 
validate the count and size of antral follicles measured using SonoAVC and 2D against the 
actual size and number of follicles assessed by dissecting the bovine ovaries. 
Methods: 3D Ultrasound scan (Voluson 730 Expert, GE Medical Systems) was performed 
on 22 bovine ovaries. Antral follicles were counted and measured on stored 3D dataset 
using SonoAVC on multiplanar view and 2D real-time equivalent method on longitudinal 
and transverse planes of the dataset. All visible antral follicles were dissected manually 
and measured using a microscope. Ovarian volume calculated using volume displacement 
(VD) method was compared against that measured using Virtual Organ Computer-aided 
ŶĂ>ǇƐŝƐ  ?sK> ? ĂŶĚ  ? ŵĞƚŚŽĚ  ?ǀŽůƵŵĞ ĨŽƌ ĂŶ ĞůůŝƉƐŽŝĚ ? ? ^ƚƵĚĞŶƚ ?Ɛt test, limits of 
agreement (LOA) and Intraclass correlation (ICC) coefficient were used to evaluate the 
variance and agreement between methods.  
Results: The mean ovarian volume calculated by volume displacement (VD) was 
comparable to that using 3D ultrasound (VOCAL) (P=0.338), however significantly larger 
than 2D (P<0.001). Total AFC (2.0-10.0mm) measured by the manual dissection (MD) 
method were significantly higher than SonoAVC (P=0.003) and significantly lower than 2D 
(P<0.001), however LOA between MD and SonoAVC were lower than that between MD 
and 2D.  AFC of follicles measuring 2.0-4.0mm was significantly higher with MD than 
SonoAVC (P<0.001) and significantly lower than 2D (P<0.001). LOA were narrower 
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between MD and SonoAVC than between MD and 2D. Antral follicles measuring >4.0-6.0 
mm and >6.0-10.0mm showed no significant difference between either methods (P<0.05), 
but LOA between MD and SonoAVC were narrower than between MD and 2D.  
Conclusion: SonoAVC with post-processing significantly underestimates and 2D 
overestimates the number of antral follicles measuring 4.0mm or less, but both make 
comparable counts of follicles measuring more than 4.0mm when compared with the 
antral follicles dissected manually. However, the agreement with SonoAVC with post-
processing was more than that with 2D. 
 
6.2 Introduction 
 
Three-dimensional (3D) and two-dimensional (2D) ultrasound have both been used to 
count the total number of antral follicles and measure their dimensions. Many studies 
restrict analysis of size to a few follicles focusing on the largest and smallest follicles and 
then subjectively counting the number between these extremes without measuring their 
individual sizes. This is necessary as the manual identification and measurement of each 
and every follicle is unlikely to be reliable or valid and is clearly not practical in the clinical 
setting. Different authors have suggested different follicle populations should be 
considered with the upper limit of follicle size varying from 8 to 10 mm (Weenen, Laven et 
al. 2004; Allemand, Tummon et al. 2006; Lam and Raine-Fenning 2006; Nardo and 
Gelbaya 2008). Several clinical and laboratory studies have shown that the smaller follicles 
may be more reflective of functional ovarian reserve and follicle quality suggesting there 
is a need for a more detailed analysis of antral follicles by size .  
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Sonography-based automated volume calculation (SonoAVC) is an automated method of 
volume calculation which can be applied on images acquired using three-dimensional (3D) 
ultrasound. Few studies that have used SonoAVC to assess follicles in stimulated ovaries, 
have shown that SonoAVC provides automatic measurements of follicular diameter and 
volume that are more reliable and more accurate than comparable estimations made 
from 2D data (Raine-Fenning, Jayaprakasan et al. 2007; Raine-Fenning 2008; Deutch, 
Joergner et al. 2009). It also identifies small volumes and can theoretically be applied on 
antral follicles as they contain an antrum which is a fluid filled cavity within the follicle. 
Our previous work has shown that the initial automated measurements made by 
SonoAVC are obviously low and significantly underestimate the true follicle count. 
However, the follicles missed can be included in the final count by manually clicking on 
them, making the method semi-automated. Each additional antral follicle identified in this 
way is given a new colour and its dimensions are displayed together with those follicles 
that were originally identified.  SonoAVC with post-processing is a reliable method for 
measuring antral follicles and shows better intra- and inter-observer reliability than 3D 
multiplanar view and two-dimensional (2D) ultrasound (chapter 3). SonoAVC is quicker 
and provides better estimates of small antral follicle number than conventional real-time 
2-D ultrasound. Although time taken by SonoAVC to count the total number of antral 
follicles is more than 2D ultrasound, our results show that SonoAVC, despite being a semi-
automated method as data post-processing is invariably required, provides reliable 
measures of the size of antral follicles more quickly than real-time 2D ultrasound (chapter 
4). This has important implications for both the research setting and clinical environment 
as it allows a quantitative analysis of antral follicle number and size without disturbing 
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workflow. It is a more objective and reliable method than real-time 2D ultrasound and 
takes significantly less time than conventional ultrasound assessments.  
The AFC measured using either 2D or 3D ultrasound has emerged as a single independent 
predictor of ovarian response following in vitro fertilization (IVF) treatment.(verhagen 
2008) SonoAVC has been able to provide reliable and quick measures of antral follicle 
sizes, thus enabling more research in to different size groups of antral follicles. Small 
antral follicles (2.0-6.0mm) could potentially reflect the actual functional or qualitative 
ovarian reserve as it highly correlates with AMH (Jayaprakasan, Deb et al. 2009; van 
Disseldorp, Lambalk et al. 2010) and is also a significant predictor of ovarian response and 
pregnancy outcome following IVF (Jayaprakasan, Campbell et al.; Haadsma, Bukman et al. 
2007; Deb, Batcha et al. 2009; Haadsma, Groen et al. 2009). However, it is not clear 
whether the antral follicles actually seen on ultrasound reflect the true number of antral 
follicles present in the ovary at that time.  This study was therefore designed in an in vitro 
setting to validate the antral follicle counts and the size of antral follicles measured by 
SonoAVC and 2D ultrasound against the actual size and number of follicles assessed by 
dissecting cow ovaries, that resemble human ovaries in terms of numbers and size of 
antral follicles. 
 
6.3 Methods 
Ultrasound scan was performed on bovine ovaries in an in vitro setting. The ovaries were 
dissected from the reproductive tract of the cows and any excess tissue manually 
dissected. A phantom was made out of a latex glove which was filled with water and 
glycerine. The fluid mixture containing 8 parts of water and 2 parts of glycerine 
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constituted a solution of desirable density such that the ovary would neither sink nor float 
in the fluid. The glove was filled to about 60% of its capacity by the fluid mixture and the 
bovine ovary placed in it just before performing the ultrasound scan.  
The ultrasound scans were performed by a single investigator (S.D) using a Voluson E8 
Expert
 
(GE Medical Systems, Zipf, Austria) and a three-dimensional 5-9 MHz transvaginal 
transducer. 3D ultrasound of the ovary was performed which included delineation of the 
ovary with application of a region of interest and the subsequent acquisition of a series of 
2D planes acquired during a high quality slow sweep mode of the ultrasound beam set at 
a 90
0
 angle. This ensured that data from the whole ovary was acquired and also that the 
greatest number of 2D planes were acquired giving the highest degree of resolution when 
the 2D data are reconstructed as a 3D volume. The acquired 3D data were displayed on 
the ultrasound machine (Voluson E8 Expert: General Electric Medical Systems, Zipf, 
Austria) in the multiplanar view. To simulate the 2D ultrasound assessment (2D real-time 
equivalent - 2D RTE), the antral follicles were counted and measured in each ovary using 
the longitudinal (A plane) and transverse (B plane) planes in an identical manner to that 
what would be done when performing real time 2D ultrasound (Figure 6.1). The 
investigators were able to scroll through the dataset in these two planes simulating a 
clinical setting of real-time 2D, but were not allowed to rotate the image along the x-axis 
or to see the two images simultaneously as these functions are not available with real-
time scanning.  
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Figure 6.1: Dataset acquired of bovine ovary in a glove filled with 8:2 of water and glycerine. Each 
antral follicle was measured in two perpendicular planes similar to 2D 
 
For the application of SonoAVC, the acquired 3D data were displayed on the ultrasound 
machine in the multiplanar view (Figure 6.2). The image was optimised and then rendered 
to generate a three-dimensional volume of interest (VOI). The render box was adjusted to 
exclude as much extra-ovarian information as possible and ensure that the whole ovary 
was included in the VOI. The threshold settings, which assign transparency associated 
ǁŝƚŚĨůƵŝĚƚŽŽƉĂƋƵĞǀŽǆĞůƐ ?ǁĞƌĞŵĂŝŶƚĂŝŶĞĚĨŽƌĂůůĚĂƚĂƐĞƚƐĂƚĂĚĞĨĂƵůƚƐĞƚƚŝŶŐŽĨ ‘ůŽǁ ? ?
KŶĐĞ ƚŚĞ ĚĂƚĂƐĞƚ ŚĂĚ ďĞĞŶ ĐŽƌƌĞĐƚůǇ ƉŽƐŝƚŝŽŶĞĚ ?  ? ĂƵƚŽŵĂƚĞĚ ƐŽĨƚǁĂƌĞ ?  ‘ƐŽŶŽŐƌĂƉŚǇ-
ďĂƐĞĚ ĂƵƚŽŵĂƚĞĚ ǀŽůƵŵĞ ĐŽƵŶƚ ?  ?ƐŽŶŽVC: GE Medical Systems) was implemented 
(Raine-Fenning, Jayaprakasan et al. 2008). Post-processing, involving the manual 
identification of follicles, was used to ensure all antral follicles were counted and 
ŵĞĂƐƵƌĞĚ ?dŚĞŵĞĂŶ ‘ƌĞůĂǆĞĚƐƉŚĞƌĞĚŝĂŵĞƚĞƌ ? ?ĚŝƐƉůĂǇĞĚĂƐĚ (V), of each antral follicle 
was recorded and used for data analysis. The antral follicle population for each ovary was 
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recorded to the nearest millimetre, as this reflects the current resolution of the 
ultrasound system, starting from 2.0 mm up to a maximum of 10.0 mm. They were 
analysed and results expressed for follicle size cohorts of 2.0-4.0mm, >4.0-6.0mm, >6.0-
10.0mm and 2.0-10.0mm. 
Figure 6.2: 3D dataset of a bovine ovary in a phantom of glove containing 8:2 of water and 
glycerine. Antral follicles are measured using SonoAVC 
 
Ovarian volume was calculated before performing the scan using the method of volume 
displacement. Virtual Organ Computer-aided AnaLysis (VOCAL imaging programme: GE 
Medical Systems) was used to quantify the ovarian volume. The method has been 
described in detail previously (Raine-Fenning, Campbell et al. 2002) but briefly involved 
display of ovary in 3D multiplanar view followed by delineation of ovarian cortex in B 
plane by manually tracing round the ovary in 30
0 
rotational steps as the dataset was 
rotated through a total of 180
0
, providing six planes for each volume calculation. To 
calculate the volume as one would on 2D ultrasound, three diameters were measured 
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perpendicular to each other on each ovary using the longitudinal (A plane) and transverse 
(B plane) planes in an identical manner to that what would be done when performing 2D 
ultrasound. Formula for calculation of volume of an ellipsoid was applied to derive the 
volume by 2D ultrasound (0.53*length*width*depth) 
Soon after the ultrasound scan, the ovary was transported back to the laboratory in 
normal saline and dissected under a microscope by another investigator (J.A). All visible 
follicles were dissected out using ultra-fine scissors and forceps (Abir, Franks et al. 1997; 
Gilchrist, Wicherek et al. 2001) and measured using the microscope eye piece graticule 
units. Any excess ovarian tissue was gently teased away from the follicles and placed in a 
medium of normal saline on a heated microscope stage. Three perpendicular diameters 
were measured for each follicle, the mean of which was then converted to millimetres 
using the formula,  ?ŵĞĂŶŝŶŐƌĂƚicƵůĞƵŶŝƚƐ ? ? ? ? ? ?.  The investigator dissecting the ovary 
was blinded to the ultrasound measurements and the investigator performing the 
ultrasound was blinded to the findings of the dissected ovary. 
A sample size of 17 was required to power the study at 0.8 with a Type I error of 0.05 and 
Type II error of 0.2. Statistical analysis was undertaken using the Statistical Package for 
the Social Sciences (SPSS, version 17.0, Chicago, IL). The distribution of the data was 
checked using normal probability plots. The mean and standard deviation (± SD) are given 
for normally distributed data and the median and range for non-parametric data. 
Dependent on the normality of the data, a one-way analysis of variance with Wilcoxon 
Signed Ranks test or a paired student t-test was used to examine for differences between 
methods. A P value of <0.05 was considered to be statistically significant. Limits of 
agreement, as described by Bland and Altman, were used to compare the different 
methods (Bland and Altman 1995; Khan and Chien 2001). Limits of agreement are 
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estimated from the mean and standard deviations of the differences with 95% of the 
differences lying within two standard deviations either side of mean (Bland and Altman 
1986; Altman 1999; Bland and Altman 1999). These limits, like confidence intervals, give 
an idea of the spread of variance between the methods Inter-method correlation was 
assessed by two-way mixed Intraclass Correlation Coefficients (ICCs) with absolute 
agreement and their 95% confidence intervals (McGraw 1996).  
 
6.4 Results 
22 bovine ovaries were assessed and included in the final analysis. Table 6.1 shows the 
upper and lower limits of agreement between manual dissection (MD) method, SonoAVC 
with post-processing and 2D, their range of agreements, mean differences between the 
methods and P value derived from these differences. Our results show that the mean 
ovarian volume calculated by the method of volume displacement (VD) was comparable to 
that calculated using 3D ultrasound (VOCAL) (7.68 ± 2.63, 7.86 ± 2.79; P=0.338), however 
significantly larger than that calculated by 2D (7.68 ± 2.63, 6.08 ± 2.50; P<0.001). The mean 
total AFC (2.0-10.0mm) measured by the manual dissection (MD) method was significantly 
higher than that made by SonoAVC (19.27 ± 7.60, 18.18 ± 6.67; P=0.003) and significantly 
lower than that made by 2D (19.27 ± 7.60, 22.86 ± 8.25; P<0.001), however LOA between 
MD and SonoAVC were lower than that between MD and 2D (Table 6.1).  
Mean AFC of follicles measuring 2.0-4.0mm was significantly higher by MD method than 
SonoAVC (12.00 ± 5.75, 11.13 ± 5.35; P<0.001) and significantly lower than 2D (12.00 ± 
5.75, 15.64 ± 6.36; P<0.001). The LOA, however were narrower between MD and SonoAVC 
than between MD and 2D (Table 6.1). Mean AFC of antral follicles measuring >4.0-6.0 mm 
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(MD: 5.14 ± 2.47, SonoAVC: 4.81 ± 2.06, 2D: 5.77 ± 3.38) and >6.0-10.0mm (MD: 1.51 ± 
1.50, SonoAVC: 1.68 ± 1.70, 2D: 1.05 ± 1.96) showed no significant difference between 
either methods (P<0.05). However, more agreement to MD was seen with SonoAVC than 
2D, as reflected by the narrow range between their upper and lower limits of agreement 
(Table 6.1).  
 dŚĞ/ ?ƐƐƵŐŐĞƐƚĞĚĂŶĞǆĐĞůůĞŶƚĐŽƌƌĞůĂƚŝŽŶďĞƚǁĞĞŶŵĞƚŚŽĚƐǁŚĞŶŵĞĂƐƵƌŝŶŐƚŽƚĂů&
of 2.0-10.0mm (0.959, 95% CI: 0.919 to 0.982; P<0.001), AFC of 2.0-4.0mm (0.953, 95% CI: 
0.908 to 0.979; P<0.001) and AFC of 2.0-6.0mm (0.956, 95% CI: 0.914 to 0.981; P<0.001); 
and a moderate correlation when measuring ovarian volume (0.857, 95% CI: 0.735 to 
0.933; P=0.01), AFC of >6.0-10.0mm (0.786, 95% CI: 0.621 to 0.896; P=0.01) and AFC of 
>4.0-6.0mm (0.799, 95% CI: 0.722 to 0.890; P=0.01). 
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TABLE 6.1: Comparison of three different methods (volume displacement, 3D assisted VOCAL and 2D 
for volume calculation; manual dissection of antral follicles, 3D assisted SonoAVC with post 
processing and 2D ultrasound for measuring antral follicle counts) using limits of agreement and 
paired samples t test in calculation of ovarian volume and antral follicles stratified by size. 
 Mean ± SD Mean difference 
± (95% CI) 
P 
value 
Upper and Lower LOA Range 
LOA 
Ovarian volume 
Standard: VD 
7.68 ± 2.63     
VOCAL 7.86 ± 2.79 -0.18 ± 0.87 
(-0.57 to 0.20) 
0.338 -1.53 and -1.90 3.43 
2D 6.08 ± 2.50 1.60 ± 1.67 
(0.87 to 2.34) 
<0.001 4.88 and -1.67 6.55 
AFC 2.0-10.0mm 
Standard: MD 
19.27 ± 7.60     
SonoAVC-PP 18.18 ± 6.67 1.09 ± 1.54 
(0.41 to 1.77) 
0.003 4.11 and -1.93 6.04 
2D 22.86 ± 8.25 -3.59 ± 2.24 
(-4.58 to -2.59) 
<0.001 0.80 and -7.98 8.78 
AFC 2.0-4.0mm 
MD 
12.00 ± 5.75     
SonoAVC-PP 11.14 ± 5.35 0.86 ± 0.94 
(0.45 to 1.28) 
<0.001 2.71 and -0.98 3.69 
2D 15.64 ± 6.36 -3.64 ± 2.13 
(-4.58 to -2.69) 
<0.001 0.53 and -7.81 8.34 
AFC >4.0-6.0mm 
MD 
5.14 ± 2.47     
SonoAVC-PP 4.82 ± 2.06 0.32 ± 1.17 
(-0.20 to 0.84) 
0.216 2.61 and -1.98 4.59 
2D 5.77 ± 3.38 -0.64 ± 1.50 
(-1.96 to 0.69) 
0.331 3.75 and -5.02 8.77 
AFC 2.0-6.0mm 
MD 
17.14 ± 7.17     
SonoAVC-PP 15.95 ± 6.59 1.18 ± 1.37 
(0.57 to 1.79) 
0.001 3.86 and -1.50 5.36 
2D 21.41 ± 8.10 -4.27 ± 2.25 
(-5.27 to -3.27) 
<0.001 0.14 and -8.68 8.82 
AFC >6.0-10.0mm 
MD 
1.50 ± 1.54     
SonoAVC-PP 1.68 ± 1.70 -0.18 ± 0.80 
(-0.53 to 0.17) 
0.296 1.38 and -1.74 3.12 
2D 1.05 ± 1.96 0.45 ± 1.30 
(-0.12 to 1.03) 
0.116 3.00 and -2.09 5.09 
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6.5 Discussion 
This study has validated the antral follicle counts and ovarian volume measured using 3D 
ultrasound assisted SonoAVC and 2D real-time equivalent method against the actual 
number of antral follicles measuring 2.0mm or more that were manually dissected from 
the bovine ovary. The results show that when validating for antral follicles measuring 
more than 4.0mm, both SonoAVC and 2D real-time equivalent made counts comparable 
to the dissection method, but SonoAVC with post processing agreed more than the 2D 
method. However, this was not true for follicles measuring 4.0mm or less. Whilst 
SonoAVC made significantly less counts, 2D made significantly more counts than the 
dissection method, although SonoAVC agreed more with the dissection method than the 
2D method.  
Although it appears that antral follicle counts made using ultrasound are either 
underestimated or overestimated, their predictive value has been validated in studies 
assessing ovarian response following IVF treatment.(Gulekli, Bulbul et al. 1999; Kwee, 
Elting et al. 2003; Chow, Criniti et al. 2004; Elter, Kavak et al. 2005; Muttukrishna, 
McGarrigle et al. 2005; Broekmans, Kwee et al. 2006; Haadsma, Bukman et al. 2007; 
Kwee, Elting et al. 2007; Nardo, Christodoulou et al. 2007; Ireland, Scheetz et al. 2008; 
Verhagen, Hendriks et al. 2008; Deb, Batcha et al. 2009; Haadsma, Groen et al. 2009; 
Maheshwari, Gibreel et al. 2009). The AFC has also been strongly correlated to AMH 
(Jayaprakasan, Campbell et al.; de Vet, Laven et al. 2002; Muttukrishna, McGarrigle et al. 
2005; van Rooij, Broekmans et al. 2005; Fanchin, Mendez Lozano et al. 2007), which is 
another important independent predictor of ovarian reserve and response to controlled 
ovarian stimulation (van Rooij, Broekmans et al. 2002; Hendriks, Mol et al. 2005; 
Muttukrishna, McGarrigle et al. 2005; Lekamge, Barry et al. 2007; Nardo, Christodoulou et 
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al. 2007; Dehghani-Firouzabadi, Tayebi et al. 2008; Riggs, Duran et al. 2008; Verhagen, 
Hendriks et al. 2008; Wunder, Guibourdenche et al. 2008; Nelson, Yates et al. 2009). 
Previous studies have shown that small antral follicles measured using SonoAVC with post 
processing correlate highly to AMH and that they have a significant predictive value in 
predicting ovarian response to controlled ovarian stimulation (Haadsma, Bukman et al. 
2007; Deb, Batcha et al. 2009), poor response (Jayaprakasan, Deb et al. 2009) and 
pregnancy outcome following IVF (Deb, Batcha et al. 2009; Haadsma, Groen et al. 2009). It 
is also known that number of small antral follicles progressively decline with age and have 
been positively correlated to reproductive ageing (Gougeon 1994; Hansen, Morris et al. 
2003; Scheffer, Broekmans et al. 2003; Broekmans, Faddy et al. 2004; Haadsma, Bukman 
et al. 2007; Hansen, Knowlton et al. 2008). This would perhaps make us believe that the 
current understanding of the AFC cut-offs defining normal from poor or hyper-responders 
although not accurate are fair assessment tools of ovarian reserve. However, knowing 
that the current tests for calculating AFC are not accurate, there is a tremendous scope in 
developing the test accuracies in future, especially the small antral follicles, which might 
improve upon the current predictive abilities in assessing ovarian response to IVF and also 
reproductive ageing. 
When using SonoAVC, one could argue that since it underestimates AFC, we must exhibit 
caution with regards to women undergoing first cycle of IVF especially when considering 
cycle cancellation or refusing IVF treatment. On the other hand, when using 2D to 
measure antral follicles, one could argue that since it might overestimate AFC, we must 
consider appropriate dosages when deciding on the amount of gonadotrophin used for 
ovarian stimulation. SonoAVC was shown to have more agreement with dissection 
method than 2D, especially with follicles measuring 4.0mm or less.  Since SonoAVC can 
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reliably measure size of antral follicles, the small antral follicle population must be 
researched further in studies predicting ovarian response to IVF.  
 
6.6 Conclusion 
For antral follicles measuring less than 4.0mm, neither 2D nor 3D assisted SonoAVC 
compare to the actual number in the ovary as measured by manually dissecting them. 
SonoAVC measures significantly less and 2D measures significantly more follicles. 
However there was more agreement seen with SonoAVC than with 2D. With antral 
follicles measuring more than 4.0mm, measures made by both SonoAVC and 2D were 
comparable to the dissection method, however again the agreement seen was more with 
SonoAVC than with 2D. It therefore appears that no current method available to measure 
the count and size of antral follicles is accurate, but SonoAVC with post-processing shows 
the most agreement with the follicles measured following manual dissection.   
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CHAPTER 7. The inter-ovarian variation in three-dimensional 
ultrasound markers of ovarian reserve in women undergoing 
baseline investigation for subfertility 
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7.1 Abstract 
Objective: To evaluate differences in the three-dimensional (3D) ultrasound markers of 
ovarian reserve between the ovaries within an individual undergoing investigation for 
subfertility. 
Methods: This was a prospective observational study conducted at University-based 
Assisted Conception Unit. 270 women undergoing baseline early follicular phase 
ultrasound as an investigation for subfertility were recruited. 3D ultrasound scan in early 
follicular phase between day 2 to 5 of menstrual cycle was performed. The main outcome 
assessed was variations in 3D ultrasound markers of ovarian reserve between the two 
ovaries within same individual. 
Results: 215 subjects were analysed for ovarian volume and antral follicle count (AFC), 
and 205 subjects for 3D power Doppler indices. Significant differences were noted 
(median, range) in the number of antral follicles measuring >6.0mm, and ovarian volume 
(P<0.05). Significant correlation was noted between the two ovaries in antral follicles 
measuring 6.0mm or less, ovarian volume, and 3D power Doppler indices (P<0.05). On 
ƐƚƌĂƚŝĨǇŝŶŐ ƚŚĞ ĂŶƚƌĂů ĨŽůůŝĐůĞƐ ĂĐĐŽƌĚŝŶŐ ƚŽ ƐŝǌĞ ƵƐŝŶŐ  “ƐŽŶŽŐƌĂƉŚǇ ďĂƐĞĚ ĂƵƚŽŵĂƚĞĚ
voůƵŵĞ ĐĂůĐƵůĂƚŝŽŶ ? ǁŝƚŚ ƉŽƐƚ ƉƌŽĐĞƐƐŝŶŐ ? ŵĂǆŝŵƵŵ ǀĂƌŝĂƚŝŽŶ ǁĂƐ ƐĞĞŶ ŝŶ ĨŽůůŝĐůĞƐ
measuring more than 6.0mm as measured using limits of agreement.  
Conclusion: There are significant differences in the antral follicles measuring >6.0mm and 
ovarian volume, as measured using 3D ultrasound, that require consideration when 
comparing the two ovaries within an individual.   
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7.2 Introduction 
 A true ovarian reserve is the number of primordial follicles present in the ovaries which 
can currently only be examined histologically. However, ultrasound and endocrine 
measures of ovarian reserve appear to correlate to this true reserve and have therefore 
been widely accepted as markers of ovarian reserve  
In clinical practice, both ovaries are considered together as a combined unit during 
ovarian stimulation. The endocrine markers such as Follicle Stimulating Hormone (FSH), 
Anti-Müllerian Hormone (AMH), Oestradiol, and Inhibin B provide information on ovarian 
reserve of both ovaries as a combined unit. Ultrasound is the only method so far which 
allows a direct assessment of each ovary as a separate entity; however the numbers and 
sizes of follicles are largely presented either as a mean or total value. Ultrasonographic 
assessment of the total number of antral follicles is an important determinant of ovarian 
reserve (Scheffer, Broekmans et al. 2003; Ng, Chan et al. 2005; Jayaprakasan, Campbell et 
al. 2008). The total antral follicle count (tAFC) is typically made by counting the number of 
follicles measuring 2 to 9 mm (2004; Lam and Raine-Fenning 2006; Nardo and Gelbaya 
2008) or 2 to 10 mm (Scheffer, Broekmans et al. 2003; Klinkert, Broekmans et al. 2005) in 
both ovaries and can be estimated using two-dimensional (Scheffer, Broekmans et al. 
2002) or three-dimensional ultrasound (Jayaprakasan, Campbell et al. 2008). The tAFC 
includes small antral follicles (2.0 - 6.0 mm) that are largely gonadotrophin-independent, 
but selectable due to their responsiveness to gonadotrophins, and larger antral follicles 
(>6.0 mm) that are gonadotrophin-dependent (Gougeon 1989).   
In the assessment of subfertility, both ovaries are included as a single entity when 
predicting ovarian reserve or outcomes following assisted reproduction treatment. 
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However, comparison of one ovary to the other may be warranted in situations such as, 
when examining the effect of pathology or surgery on the ovary.  Ovarian cystectomy has 
been shown to impair ovarian reserve (Loh, Tan et al. 1999; Somigliana, Ragni et al. 2003; 
Candiani, Barbieri et al. 2005; Godinjak, Idrizbegovic et al. 2005; Somigliana, Ragni et al. 
2006) and ovarian response (Loo, Lin et al. 2005; Ragni, Somigliana et al. 2005; Demirol, 
Guven et al. 2006; Esinler, Bozdag et al. 2006; Yazbeck, Madelenat et al. 2006; Kahyaoglu, 
Ertas et al. 2008; Somigliana, Arnoldi et al. 2008) following assisted reproduction 
treatment (ART). However, cystectomy and reduced ovarian reserve does not seem to 
translate into impaired pregnancy outcome (Demirol, Guven et al. 2006; Esinler, Bozdag et 
al. 2006; Somigliana, Ragni et al. 2006; Kahyaoglu, Ertas et al. 2008; Garcia-Velasco and 
Somigliana 2009). Data from few studies suggest that cystectomy might even be 
detrimental to ovarian response when compared to no surgery (Canis, Pouly et al. 2001; 
Marconi, Vilela et al. 2002; Garcia-Velasco, Mahutte et al. 2004; Demirol, Guven et al. 
2006; Alborzi, Ravanbakhsh et al. 2007; Donnez, Lousse et al. 2009; Garcia-Velasco and 
Somigliana 2009). This might be due to inadvertent removal of normal ovarian tissue 
along with the cyst or damage caused by the use of diathermy. Some studies have used 
ultrasound measures including ovarian volume, antral follicle count, and blood flow 
(Somigliana, Ragni et al. 2003; Candiani, Barbieri et al. 2005; Horikawa, Nakagawa et al. 
2008) to compare the operated ovary to the unoperated contra-lateral ovary. Other 
studies have evaluated the effect of surgery by comparing the ovarian response to 
controlled ovarian stimulation during ART in the operated ovary to the contra lateral 
normal ovary (Somigliana, Ragni et al. 2003; Ragni, Somigliana et al. 2005; Esinler, Bozdag 
et al. 2006; Somigliana, Ragni et al. 2006; Alborzi, Ravanbakhsh et al. 2007; Horikawa, 
Nakagawa et al. 2008).  Few studies have shown that the tAFC does not differ significantly 
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between the two ovaries when measured using two-dimensional (2D) ultrasound 
(Scheffer, Broekmans et al. 1999; Baerwald, Adams et al. 2003; Chow, Criniti et al. 2004).  
This study was designed to quantify the 3D ultrasound markers of ovarian reserve within 
an individual and to evaluate the differences in these parameters between two ovaries. 
Our hypotheses were that there is minimal variation between the two ovaries such that 
one could be used as a control for the other, and that an objective assessment of the 
effect of unilateral ovarian surgery can be made by comparing the two ovaries.  
 
 
7.3 Methodology 
 
Study design and population 
Subjects were prospectively recruited from women attending the general gynaecology 
and infertility clinics ĂƚYƵĞĞŶ ?ƐDĞĚŝĐĂůĞŶƚƌĞŝŶNottingham. A sample size of 205 was 
required to power the study at 85%, for an assumed variation of 3 antral follicles between 
the two ovaries and a standard deviation of 2.5.  
270 subjects aged less than or equal to 41 years were prospectively recruited over 
duration of 12 months.  These were women who had been referred for assisted 
reproduction treatment and the ultrasound assessment was performed prior to their 
initial consultation in the assisted conception unit. Subjects were excluded if they had a 
past history of pelvic surgery or had been objectively shown to have endometriosis. 
Subjects meeting the inclusion criteria were scheduled to have a baseline ultrasound 
assessment during the early follicular phase of the menstrual cycle (day 2 to 5). Subjects 
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were excluded at this stage if they were found to have an ovarian cyst or follicle 
measuring more than 10 mm or if a persistent corpus luteum was evident, as it may affect 
the volume or vascularity of the ovary in comparison to the other ovary. 3D ultrasound 
was used throughout the study as it has been shown to provide more reliable and more 
valid measures of ovarian volume and antral follicle numbers than conventional 2D 
ultrasound (Raine-Fenning, Campbell et al. 2003; Raine-Fenning, Campbell et al. 2003; 
Scheffer, Broekmans et al. 2003; Merce, Gomez et al. 2005; Jayaprakasan, Walker et al. 
2007; Jayaprakasan, Campbell et al. 2008; Verhagen, Hendriks et al. 2008). 3D power 
Doppler ultrasonography was used to examine ovarian blood flow as it provides a global 
view of the ovary rather than selected information from a single vessel (Kupesic and 
Kurjak 2002; Pan, Wu et al. 2002; Raine-Fenning, Campbell et al. 2004).  
Data acquisition 
All subjects had a transvaginal ultrasound scan performed by a single investigator (J.C) 
using a Voluson Expert 730
TM
 (GE Medical Systems, Zipf, Austria) and a 7.5-MHz 3D 
transvaginal probe to avoid inter-operator variation in acquisition of 3D data. The 
ultrasound assessment is described in detail in chapter 2. Briefly, it comprised of a 
preliminary conventional 2D ultrasound assessment of the pelvis to exclude any obvious 
pathology, followed by visualization of ovaries in their transverse and longitudinal planes 
and the subsequent acquisition of 3D data using the volume mode. The volume mode, 
which displays a truncated sector, was adjusted to precisely define the area of interest, 
the sweep angle set to 90
0
 and a 3D dataset acquired using the high quality, slow sweep 
mode, which results in the highest resolution. Power Doppler was then applied using 
predefined settings for every patient (Raine-Fenning, Campbell et al. 2002). The same 
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process was repeated for the contra-lateral ovary and the resulting 3D datasets were 
stored on recordable digital videodisc for subsequent off-line analysis. 
Data analysis 
4D View (version 7.0, GE Kretz) software was used for all measurements. 
3D multiplanar view 
The multiplanar view allows simultaneous display of a 3D dataset in three perpendicular 
planes conventionally referred to as the longitudinal (A), transverse (B), and coronal (C) 
planes. These three sectional planes are shown simultaneously and are mutually related 
such that movement within one plane produces geometrically equivalent movements in 
the other two planes. For the purposes of this study the total antral follicle count (tAFC) 
was made by counting the number of antral follicles measuring 2 to 9 mm in each ovary.  
Sonography based automated volume calculation (SonoAVC) 
SonoAVC (GE Medical Systems, Zipf, Austria) was used to automatically measure the size 
of each antral follicle within the grey scale 3D volume. The lower size limit of follicles that 
SonoAVC can detect is 1 to 2 mm. Our technique has been described in detail before but, 
in brief involved the following steps. Firstly, the multiplanar view was used to ensure the 
ovary was centrally placed and the render mode selected to generate a 3D volume of 
interest (VOI) box. Once the dataset had been correctly positioned, SonoAVC was 
implemented. The individual follicles identified were then displayed with a specific colour 
and shown together with their dimensions and relative sizes. Post-processing is required 
in almost all cases to manually identify those antral follicles that have been missed in the 
initial automated analysis. Each additional follicle identified in this way is also given a 
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specific colour and its dimensions presented alongside the other follicles. The total 
number of antral follicles was recorded together with the mean diameter of each follicle 
calculated using the relaxed sphere technique (Raine-Fenning 2008; Raine-Fenning, 
Jayaprakasan et al. 2008). The follicles were categorized into cohorts according to their 
ƌĞůĂƚŝǀĞƐŝǌĞĂƐĨŽůůŽǁƐ PAM ? ? ?ŵŵ ?A? ? ? ?ƚŽ ? ? ?ŵŵ ?AN ? ? ?ƚŽ ?  ?ŵŵ ?AN ? ? ?ƚŽ ? ? ?ŵŵ ?ĂŶĚ
>8.0 to 9.0 mm (Gougeon 1998; Weenen, Laven et al. 2004; Allemand, Tummon et al. 
2006; Lam and Raine-Fenning 2006; Haadsma, Bukman et al. 2007). 
Volume and blood flow analysis 
The volume of each ovary and its vascularity were quantified with the Virtual Organ 
Computer-aided AnaLysis (VOCAL imaging programme; GE Medical Systems). VOCAL was 
used to manually delineate the ovarian cortex in the B plane of multiplanar view as the 3D 
power Doppler dataset was rotated 180
0
, vertically through 9
0
 steps providing 20 planes 
for each volumetric measurement (Raine-Fenning, Campbell et al. 2002). The volume of 
the resultant model was recorded and the histogram facility was then implemented to 
quantify the power Doppler signal within it. The histogram generates three indices of 
vascularity: the Vascularisation Index (VI), the Flow Index (FI), and the Vascularisation 
Flow Index (VFI) (Raine-Fenning, Nordin et al. 2008; Raine-Fenning, Nordin et al. 2008)  
Statistical analysis 
Statistical analysis was undertaken using the Statistical Package for the Social Sciences 
(SPSS, version 15.0, Chicago, IL). One-way analysis of variance was used to examine for 
differences in the tAFC, ovarian volume, and 3D power Doppler indices between the two 
ovaries, and expressed as mean and standard deviation (SD) or median and range 
dependent on the distribution of the data which was checked with a normal probability 
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plot. Limits of agreement (LOA) and interquartile ranges were used to express the degree 
of difference between the two ovaries for each ultrasound variables. Correlation 
coefficient (R) was used to test the correlation between the two ovaries within an 
individual and regression coefficient (R
2
) was used to quantify the variation in one ovary 
due to the other ovary. A P value below 0.05 was considered to be statistically significant.  
 
7.4 Results 
 
Of the 270 subjects recruited in the study, 16 were excluded due to the presence of 
corpus luteum; 18 for an ovarian cyst in either or both ovaries; and 21 excluded because 
of follicle measuring more than 10mm. After exclusion, a final study group of 215 subjects 
were available for analysis of ovarian volume and antral follicle count and diameter of 
follicles. However, a further 10 subjects were excluded from the analysis of ovarian 
vascularity due to either the presence of artefacts in the acquired 3D power Doppler 
dataset or incomplete data, giving a final study group of 205 subjects for the examination 
of ovarian vascularity. 
The data were not normally distributed and therefore presented as median with 
interquartile ranges. The median (IQR) age in years of the study population was 33.23 
(28.43 to 38.20). The total antral follicle count between the right and left ovary was 
significantly different (7, 0 to 22 vs 6, 0 to 26; P=0.015), with LOA ranging between 7.33 
and -7.10 (Table 7.1). However, a significant linear correlation was noted between the 
two ovaries (R: 0.684; P<0.001) with the regression coefficient (R
2
) of 0.468 suggesting 
that 46.8 % of variation in the tAFC in one ovary can be predicted by the tAFC in other 
ovary (Table 7.2).  
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Table 7.1: Comparison of the three-dimensional ultrasound markers of ovarian reserve between the 
two ovaries within an individual with significance levels derived from the Wilcoxon signed rank test, 
and variation expressed as upper and lower limits of agreement (ULOA and LLOA) 
Variable Right Ovary 
 (Median; Range) 
Left Ovary 
 (Median; Range) 
P value ULOA LLOA 
Total AFC (n) 7; 0 to 22 6; 0 to 26 0.015 7.33 -7.10 
&A䜀  ? ? ?ŵŵ ?Ŷ ? 0; 0 to 5 0; 0 to 7 0.117 2.15 -1.88 
AFC >2.0mm-4.0mm 
(n) 
2; 0 to 11 2; 0 to 13 0.852 2.53 -2.64 
AFC >4.0mm-6.0mm 
(n) 
2; 0 to 14 2; 0 to 13 0.169 3.12 -2.65 
AFC >6.0mm-8.0mm 
(n) 
1; 0 to 7 1; 0 to 6 0.027 3.85 -3.27 
AFC >8.0mm-9.0mm 
(n) 
0; 0 to 3 0; 0 to 2 0.028 1.78 -1.49 
Ovarian volume 
(cm
3
) 
6.85; 2.02 to 
15.42 
6.34; 1.22 to 
13.78 
0.001 4.48 -3.24 
Vascularisation 
Index (VI) (%) 
5.85; 0.01 to 
18.98 
6.16; 0.02 to 
22.19 
0.448 9.28 -9.99 
Flow Index (FI) (0-
100) 
36.28; 17.34 to 
51.53 
35.39; 14.88 to 
59.89 
0.327 14.72 -13.37 
Vascularisation Flow 
Index (VFI) (0-100) 
2.15; 0.01 to 8.65 2.24; 0.01 to 
12.34 
0.417 4.22 -4.64 
 
 
The antral follicles were further stratified according to size in each ovary and grouped as 
ĨŽůůŝĐůĞƐ ŵĞĂƐƵƌŝŶŐ AM ?ŵŵ ? A? ? ? ?ŵŵ-4.0mm, >4.0mm-6.0mm, >6.0mm-8.0mm, >8.0mm-
9.0mm. There was no significant difference seen in the number of follicles measuring up 
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to 6.0mm (P>0.05), however the difference was significant with the number of follicles 
measuring >6.0mm (P<0.05) (Table 7.1). The upper and lower LOA between the antral 
follicles of different sizes are shown in Table 1, with widest range between upper and 
ůŽǁĞƌ>KƐĞĞŶǁŝƚŚĂŶƚƌĂůĨŽůůŝĐůĞƐŵĞĂƐƵƌŝŶŐA? ? ? ?ŵŵ-8.0mm.  
Table 7.2: The table shows the correlation coefficient (R) reflecting the linear correlation between 
the two ovaries and the regression coefficient (R
2
) reflecting the ability of one ovary to predict the 
variation in other ovary. P value indicates the significance of correlation between ovaries. 
Variable  R
 
P value  R
2
 
Total AFC in each ovary (n) 0.684 <0.001 0.468 
AFC < 2.0mm (n) 0.210 0.004 0.167 
&A䠀  ? ? ?ŵŵ-4.0mm (n) 0.475 <0.001 0.432 
&A䠀  ? ? ?ŵŵ-6.0mm (n) 0.465 <0.001 0.263 
&A䠀  ? ? ?ŵŵ-8.0mm (n) 0.189 0.069 0.049 
&A䠀  ? ? ?ŵŵ-9.0mm (n) 0.073 0.450 0.003 
Ovarian volume (cm
3
) 0.573 <0.001 0.423 
Vascularisation Index (VI) (%) 0.454 <0.001 0.211 
Flow Index (FI) (0-100) 0.378 0.007 0.129 
Vascularisation Flow Index (VFI) (0-100) 0.450 0.002 0.178 
 
A significant linear correlation was noted in the antral follicles measuring up to 6.0mm 
between the two ovaries, however this correlation became not significant with antral 
S h i l p a  D e b   P a g e  | 148 
 
 
follicles measuring >6.0mm (Table 7.2). The regression coefficients of follicles measuring 
A? ? ? ?ŵŵ  ?A? ? ? ?ŵŵ-4.0mm: R2=0.432; >4.0mm-6.0mm: R2=0.263) was higher than that of 
smaller follicles measuring more than 6.0mm (>6.0mm-8.0mm: R
2
=0.049; >8.0mm-
9.0mm: R
2
=0.003), suggesting that only a small percentage of variation in larger follicles in 
one ovary can be predicted by the follicle counts in the other ovary (Table 7.2).  
The right ovarian volume significantly differed from the left ovarian volume (P=0.001) 
with the upper and lower LOA between the two ovaries were noted at 4.48 and -3.24 
respectively (Table 7.1). A significant linear correlation was seen between the volumes of 
two ovaries (R: 0.573; P<0.001) with the R
2
 of 0.423, suggesting that 42.3% of variation in 
volume in one ovary can be predicted by the other ovary (Table II). There was no 
significant difference seen in the medians of the 3D power Doppler indices between the 
two ovaries (Table 7.1). However, a significant linear correlation was noted in these 
indices between the two ovaries (Table 7.2). Regression analysis showed that 21.1% of 
variation in VI, 12.9% variation in FI and 12.9% variation in VFI in one ovary can be 
predicted by the other ovary. The LOA of these indices between the two ovaries are 
shown in Table 7.1. 
  
7.5 Discussion 
 
This is the first study to compare the three-dimensional ultrasound markers of ovarian 
reserve between the two ovaries within the same individual. Our results suggest that 
there are significant differences in some ultrasound markers of ovarian reserve such as 
ovarian volume, total antral follicle count of each ovary, and antral follicles measuring 
more than 6.0mm. 
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The results of this study bear significance when evaluating the effect of ovarian pathology 
or surgery. Studies evaluating the effect of ovarian cystectomy on ovarian reserve and 
response to ART have either compared the operated ovary to the contra-lateral normal 
ovary (Loh, Tan et al. 1999; Somigliana, Ragni et al. 2003; Candiani, Barbieri et al. 2005; 
Ragni, Somigliana et al. 2005; Somigliana, Infantino et al. 2006; Alborzi, Ravanbakhsh et al. 
2007; Horikawa, Nakagawa et al. 2008) or to the control group (Canis, Pouly et al. 2001; 
Marconi, Vilela et al. 2002; Wong, Gillman et al. 2004; Loo, Lin et al. 2005; Esinler, Bozdag 
et al. 2006; Yazbeck, Madelenat et al. 2006; Nakagawa, Ohgi et al. 2007; Kahyaoglu, Ertas 
et al. 2008). When comparing the operated ovary, majority have evaluated its response to 
controlled stimulation during ART by comparing to the response in contra-lateral ovary. 
Our study shows significant physiological differences in some of the ultrasound markers of 
ovarian reserve between the two ovaries within an individual. Since these markers have 
the capacity to predict ovarian response during ART, these findings should be considered 
when comparing one ovary to another to assess the effects of surgery.  It would appear 
that antral follicle count data, stratified by size, should be considered when the two 
ovaries are compared to quantify the effect of surgery.  
 
The variation in the ultrasound markers of ovarian reserve between the ovaries may 
relate to the effect of ovulation and corpus luteum formation in the preceding cycle or be 
an early indicator of dominance in the current cycle (Baerwald, Adams et al. 2003). This 
potential dynamic process can only be tested by evaluating the ovaries over consecutive 
menstrual cycles and analysing according to ovarian dominance, which was not measured 
or accounted for in this preliminary study. Several studies have shown that anti-Müllerian 
hormone (AMH), an important marker of ovarian reserve is largely expressed by antral 
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follicles measuring less than 6 mm in diameter (Gruijters, Visser et al. 2003; Kevenaar, 
Meerasahib et al. 2006; Fanchin, Mendez Lozano et al. 2007; Nardo, Christodoulou et al. 
2007). The ability to identify and measure these small antral follicles is of emerging 
importance in assessing ovarian reserve as AMH is also thought to play an important role 
in the initiation and cyclic recruitment of ovarian follicles (Durlinger, Gruijters et al. 2001; 
Visser 2006). This cohort of follicles contributes most to the serum AMH level, which is 
known to demonstrate limited intra- and inter-cycle variation, and represents the 
recruitable pool and therefore the functional reserve of the ovary (La Marca, Giulini et al. 
2007; Tsepelidis, Devreker et al. 2007). The variation between the two ovaries is least 
with follicles measuring 6.0mm or less. Their measurement allows the two ovaries to be 
compared ultrasonographically with more confidence.  
The inter-ovarian difference in ovarian volume seen in our study could be either due to 
inherent differences in the two ovaries or due to the number of larger antral follicles. 
There are no similar studies; however one study that used 3D ultrasound and compared 
women with polycystic ovaries (PCO) to normal ovaries reported no difference in ovarian 
volume in spite of significantly higher antral follicle count in PCO group (Jayaprakasan, 
Jayaprakasan et al. 2009). Although 3D ultrasound was used, our study differs in design 
and methodology. In our study, there were no significant differences noted in the 3D 
power Doppler indices between the two ovaries. The ultrasound scans were performed in 
the early follicular phase when the population of follicles in the ovary is predominantly 
antral follicles, and therefore perhaps no difference noted in vascularity (Costello, 
Shrestha et al. 2005). However, this may not be consistent in different phases of the 
menstrual cycle, as the growing follicle and corpus luteum acquire more blood supply 
(Zaidi, Collins et al. 1996). 
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7.6 Conclusion 
 
There are significant differences in the ultrasound markers of ovarian reserve between 
the two ovaries within an individual during the early follicular phase of the menstrual 
cycle as measured using 3D ultrasound. This variation is least evident in the small antral 
follicles, measuring 6 mm or less, which correlate with AMH and more accurately reflect 
the functional reserve of the ovary.  
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CHAPTER 8: The intra-cycle variation in the number of antral 
follicles stratified by size and in the endocrine markers of 
ovarian reserve in women with normal ovulatory menstrual 
cycles  
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8.1 Abstract 
 
Objective: To quantify the intra-cyclical variation in markers of ovarian reserve measured 
by the antral follicle counts stratified by size using three-dimensional (3D) ultrasound and 
anti-Müllerian hormone (AMH) in women with normal ovulatory menstrual cycles.  
Methods: It was a prospective observational study conducted in University-based 
teaching hospital. 38 healthy volunteers with normal menstrual cycles were recruited. 3D 
ultrasound scan and blood test in early (F1) and mid follicular (F2) phase, peri-ovulatory 
(PO) and luteal (LU) phases of one menstrual cycle was performed. The main outcome 
measure was the variation in markers of ovarian reserve in different phases of one 
menstrual cycle. 
Results: 36 volunteers were included in final analysis, of which 34 attended all four visits. 
Repeated measures analysis showed a significant variation in total antral follicle count 
(AFC) (P=0.002). However, on stratifying the antral follicles according to size using 
 “ƐŽŶŽŐƌĂƉŚǇďĂƐĞĚĂƵƚŽŵĂƚĞĚǀŽůƵŵĞĐĂůĐƵůĂƚŝŽŶ ?ǁŝƚŚƉŽƐƚƉƌŽĐĞƐƐŝŶŐ ?ĂŶŽŶ-significant 
variation (P=0.382) was seen in small AFC (A? ?ŵŵ ?ĂŶĚĂƐŝŐŶŝĨŝĐĂŶƚǀĂƌŝĂƚŝŽŶ ?WAM ? ? ? ? ? ?ŝŶ
large AFC (>6mm).  The ovarian volume showed a significant intra-cyclical variation 
(P<0.001). A small but significant intra-cyclical variation was noted in AMH levels 
(P=0.041). A significant variation was seen in levels of serum Follicle stimulating hormone 
(FSH), Lutenising hormone (LH), and oestradiol (P<0.05).  
Conclusion: ^ŵĂůůĂŶƚƌĂůĨŽůůŝĐůĞƐ ?A? ? ? ?ŵŵ ?ŵĞĂƐƵƌĞĚƵƐŝŶŐ ?ƵůƚƌĂƐŽƵŶĚĂŶĚD,ƐŚŽǁ
little intra-cycle variation and perhaps should be evaluated in prediction of ovarian 
reserve independent of menstrual cycle. 
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8.2 Introduction 
 
Ovarian reserve is a widely accepted concept in the field of assisted reproduction and 
describes the quantitative and qualitative potential of the ovaries to respond to 
controlled ovarian stimulation. Of the various tests of ovarian reserve currently available, 
the antral follicle count (AFC) has been shown to be comparable to various multivariate 
models in the prediction of ovarian response to controlled ovarian stimulation during in 
vitro fertilisation (IVF) treatment (Verhagen, Hendriks et al. 2008). It typically involves 
counting the number of antral follicles measuring 2 to 10 mm in both ovaries during the 
early follicular phase of menstrual cycle defined as days 2 to 5 (Chang, Chiang et al. 1998; 
Pellicer, Ardiles et al. 1998; Pellicer, Gaitan et al. 1998; Scheffer, Broekmans et al. 1999; 
Scheffer, Broekmans et al. 2003).  
More recently, anti-Müllerian hormone (AMH) has been shown to be comparable to AFC 
in the prediction of ovarian response (Broer, Mol et al.; van Rooij, Broekmans et al. 2005; 
La Marca, Giulini et al. 2007; Broekmans, Visser et al. 2008; Elgindy, El-Haieg et al. 2008; 
Kwee, Schats et al. 2008). AMH is expressed by the pre-antral and small antral follicles 
measuring up to 6 mm (Weenen, Laven et al. 2004) and is thought to have a role in the 
initial recruitment and subsequent selection of follicular dominance during 
folliculogenesis (Durlinger, Kramer et al. 1999; McGee 2000; Durlinger, Gruijters et al. 
2001). There is a strong positive correlation between the number of small antral follicles 
and AMH in the early follicular phase (Jayaprakasan, Deb et al. 2009) and this follicle 
population might be an important independent predictor of pregnancy following IVF 
treatment (Deb, Batcha et al. 2009).  
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Most of the evidence on the reliability and validity of the various tests of ovarian reserve 
have been based on the tests being performed during the early follicular phase of the 
menstrual cycle. This relatively small window of opportunity is restrictive both to our 
patients and to the hospitals and clinics performing the tests. An ideal test of ovarian 
reserve should not only be reliable but also independent of the menstrual cycle to make 
its application as practical as possible.  
Several groups have suggested that there is no significant variation in the levels of AMH 
throughout the menstrual cycle (Hehenkamp, Looman et al. 2006; La Marca, Stabile et al. 
2006; Tsepelidis, Devreker et al. 2007; van Disseldorp, Lambalk et al. 2010) whilst others 
have shown a presence of significant variation in the levels (Cook, Siow et al. 2000; Eldar-
Geva, Ben-Chetrit et al. 2005; Wunder, Bersinger et al. 2008). As a result AMH is becoming 
the primary test of ovarian reserve as there is no need to standardise the timing of the 
assessment. The cyclical variation in the number of antral follicles, a longstanding proven 
test of ovarian reserve, has received less attention but there are suggestions that there is 
a more profound intra-cycle variation in their number than in AMH levels (van Disseldorp, 
Lambalk et al. 2010). 
 Three-dimensional (3D) ultrasound assessment of the AFC has been shown to have high 
intra- and inter-observer reliability (Scheffer, Broekmans et al. 2002; Jayaprakasan, 
Walker et al. 2007; Jayaprakasan, Campbell et al. 2008). Semi-automated follicle counts 
have recently become available and have also been shown to provide highly reliable 
measures of the total numbers of antral follicles (chapter 3) and their relative sizes 
(chapter 4). Examining the variance in the markers of ovarian reserve will not only inform 
the best time to perform these tests, but also help understand the expression of these 
markers in relation to the menstrual cycle and optimise the use of protocols in assisted 
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reproduction treatment. SonoAVC, shown in previous chapters as a reliable and valid 
method of assessing the size and number of antral follicles was used in this study to 
quantify the number of antral follicles stratified by size.  
This study was designed to quantify the intra-cyclical variations in some of the important 
markers of ovarian reserve including the antral follicle counts of different size cohorts, 
ovarian volume, AMH, follicle stimulating hormone (FSH), Luteinising hormone (LH) and 
Oestradiol in normo-ovulatory healthy volunteers. Our hypothesis was that there is 
minimal intra-cyclical variation in the functional ovarian reserve as measured by the 
number of small antral follicles and AMH. 
 
8.3 Methods 
Study design 
^ƚƵĚǇƉĂƌƚŝĐŝƉĂŶƚƐĚĞƐĐƌŝďĞĚĂƐ ‘ŚĞĂůƚŚǇǀŽůƵŶƚĞĞƌƐ ?ǁĞƌĞƌĞĐƌƵŝƚĞĚƉƌŽƐƉĞĐƚŝǀĞůǇƚŚƌŽƵŐŚ
advertisements on the intranet portal of the University of Nottingham (UoN) website, and 
posters displayed in staff canteens, notice boards and staff library. Further information 
about the study was communicated via email and information leaflets to those who 
expressed interest in participation in the study. Inclusion criteria included age between 18 
to 35 years, body mass index (BMI) between 18 and 26 kg/
 
m
2
, regular menstrual cycles 
with a mean length ranging between 26 to 32 days, no history of ovarian surgery, no 
features suggestive of endocrine disease, and no hormonal contraceptive use within the 
last 6 months. Serial transvaginal ultrasound scans were performed and blood samples 
taken during one menstrual cycle. With the first day of menstruation taken as day 1 of the 
cycle these visits were scheduled for the follicular (days 2-5), peri-ovulatory (days 12-16), 
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and luteal (days 20-26) phases of the menstrual cycle. Early follicular phase involved study 
examinations on day 2 and day 5 of the cycle to ensure the absence of corpus luteum and 
its remnant effect. Peri-ovulatory phase assessment was started on day 12 of the cycle, 
and the day when a dominant follicle of more than 16 mm was noted, was taken as the 
time point to include in the study. Luteal phase assessment was performed 7 days 
following the peri-ovulatory study time point.  A sample size of 32 was required to power 
the study at 0.8 with a type I error of 0.05 and presumed maximum difference of 4 antral 
follicles across 4 levels of analysis. 
 
Data acquisition  
The ultrasound scans were performed by a single investigator (S.D) using a Voluson E8 
Expert
 
(GE Medical Systems, Zipf, Austria) and a three-dimensional, 5-9 MHz, endovaginal 
transducer. The ultrasound assessment involved a two-dimensional (2D) ultrasound 
assessment of the pelvis to exclude any pelvic pathology. Our technique of volume 
ultrasound included delineation of the ovary with application of a region of interest and 
the subsequent acquisition of a series of 2D planes acquired during a high quality, slow 
sweep mode of the ultrasound beam through a predefined 90
0
 angle. This ensured that 
the whole ovary and the greatest number of 2D planes were acquired giving the highest 
degree of resolution when the 2D data were reconstructed as a 3D volume.  
Data analysis  
The acquired 3D data were displayed on the ultrasound machine (Voluson E8 Expert: 
General Electric Medical Systems, Zipf, Austria) in the multiplanar view. The grey-scale 
display of image was optimised and then rendered to generate a three-dimensional 
volume of interest (VOI). The render box was adjusted to exclude as much extra-ovarian 
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information as possible and ensure that the whole ovary was included in the VOI. The 
threshold settings, which assign transparency associated with fluid to opaque voxels, 
were maintained for all datasets at a ĚĞĨĂƵůƚƐĞƚƚŝŶŐŽĨ ‘ůŽǁ ? ?KŶĐĞƚŚĞĚĂƚĂƐĞƚŚĂĚďĞĞŶ
ĐŽƌƌĞĐƚůǇ ƉŽƐŝƚŝŽŶĞĚ ?  ? ĂƵƚŽŵĂƚĞĚ ƐŽĨƚǁĂƌĞ ?  ‘ƐŽŶŽŐƌĂƉŚǇ-based automated volume 
ĐŽƵŶƚ ? ?ƐŽŶŽs P'DĞĚŝĐĂů^ǇƐƚĞŵƐ ?ǁĂƐŝŵƉůĞŵĞŶƚĞĚ(Raine-Fenning, Jayaprakasan et 
al. 2008). The use of sonoAVC with post-processing in counting and measuring the size of 
antral follicles has been previously described in detail (Deb, Jayaprakasan et al. 2009). In 
brief, the dimensions and relative sizes of individual follicles are displayed with a specific 
colour. Post-processing, involving the manual identification of follicles, was then used to 
ĞŶƐƵƌĞ Ăůů ĂŶƚƌĂů ĨŽůůŝĐůĞƐ ǁĞƌĞ ĐŽƵŶƚĞĚ ĂŶĚ ŵĞĂƐƵƌĞĚ ? dŚĞ ŵĞĂŶ  ‘ƌĞůĂǆĞĚ ƐƉŚĞƌĞ
ĚŝĂŵĞƚĞƌ ? ?ĚŝƐƉůĂǇĞĚĂƐĚ ?s ? ?ŽĨĞĂĐŚĂŶƚƌĂůĨŽůůŝĐůĞŝŶďŽƚŚŽǀĂƌŝĞƐǁĂƐƌĞĐŽƌĚĞĚĂŶĚƵƐĞĚ
for data analysis as this has been shown to most accurately reflect the true follicle 
diameter (Raine-Fenning, Jayaprakasan et al. 2009). The antral follicle population for each 
subject was recorded to the nearest millimetre, as this reflects the current resolution of 
the ultrasound system, starting from 2.0 mm up to a maximum of 10.0 mm.  
VOCAL was used to quantify the volume of each ovary. The method, described in detail 
previously (Raine-Fenning, Campbell et al. 2002), involved the manual delineation of the 
ovarian cortex in B plane of the multiplanar view as the dataset was rotated through a 
series of six consecutive 30
0 
steps, and a therefore a total of 180
0
, for each volume 
calculation.  
Hormonal Assays 
Blood samples were centrifuged, within 30 minutes of collection, for 20 min at 4
o
C and 
4000 rpm spin to separate the serum which was then frozen at -20°C and stored for 
subsequent analysis of anti-Müllerian hormone (AMH), follicle stimulating hormone (FSH), 
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luteinising hormone (LH), and Oestradiol (E2) levels. MIS/AMH enzyme-linked 
immunosorbent assay kit (Diagnostic Systems Laboratories, Webster, Texas, USA) was 
used to measure serum AMH levels. The lowest detection limit was 0.006 ng/mL and the 
intra and interassay coefficients of variation below 5% and 8% respectively.  
The Micro particle Enzyme Immunoassay (MEIA) method was used to measure the levels 
of serum FSH, LH, and Oestradiol levels on an AxSYM auto-analyser (AxSYM;
 
Abbott 
Laboratories, Abbott Park, IL). The lowest detection limit for FSH was 0.37 IU/L, with the 
intra- and interassay coefficients of variation were below 5% and above 5% respectively. 
The lowest detection limit for LH was 0.3 IU/L and the intra- and interassay coefficients of 
variation of 3% and 7% respectively. The lowest detection limit for E2 was 8 pmol/L, with 
the intra- and interassay coefficients of variation of 2.9% to 11%, and 4.8% to 15.2% 
respectively.  
Statistical analysis 
The Statistical Package for the Social Sciences (version 17.0; SPSS, Chicago, IL) was used 
for statistical analysis.  General linear model with repeated measures design was used to 
ƉĞƌĨŽƌŵƚŚĞĂŶĂůǇƐŝƐŽĨǀĂƌŝĂŶĐĞ ?dĞƐƚŽĨƐƉŚĞƌŝĐŝƚǇǁĂƐƉĞƌĨŽƌŵĞĚƵƐŝŶŐDĂƵĐŚůǇ ?ƐƚĞƐƚŽŶ
the data. If the assumption of sphericity was violated, Greenhouse-Geisser correction was 
applied to the data and P value derived subsequently. If the P value derived following this 
correction was significant, the significance of the variation was re-confirmed using 
,ŽƚĞůůŝŶŐ ?Ɛ ƚƌĂĐĞ ŵƵůƚŝǀĂƌŝĂƚĞ ƚĞƐƚ ĂŶĚ ƚĞƐƚƐ ŽĨ ǁŝƚŚŝŶ ƐƵďũĞĐƚ ĐŽŶƚƌĂƐƚƐ ?The confidence 
interval was adjusted using Bonferroni correction, which adjusts the observed significance 
level for the fact that multiple (repeated) contrasts are being tested. The contrast was set 
to repeated type to ensure comparison of the mean of each level (except the last) to the 
mean of the subsequent level. A P-value of less than 0.05 was considered statistically 
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significant. Correlation coefficients were used to analyse the significance of correlation of 
the markers between the different cycle phases and intraclass correlation coefficients 
(ICC) were used to evaluate the true intra-individual intra-cycle variation. 
8.4 Results 
38 healthy volunteers were recruited in the study. Two were excluded from the final 
analysis as a dominant follicle was not confirmed during the ultrasound assessments. Of 
the 36 included in final analysis, 34 attended all four visits. One subject did not attend the 
luteal phase visit and the other did not attend the second follicular phase visit. Mean ± SD 
age and BMI of the participants was 28.12 ± 5.75 years and 22.34 ± 3.08 kg/m
2
 
respectively. The mean ± SD of markers of ovarian reserve in different phases of 
menstrual cycle are shown in Table 8.1. The total number of antral follicles measuring 2.0 
to 10.0 mm varied significantly (P=0.002) across the menstrual cycle. Analysis of levels of 
contrasts, showed a significant increase in the count from the first follicular (F1) phase to 
the second follicular phase (F2) (F=27.05, P<0.001) and then a significant drop in the 
count from the peri-ovulatory phase (PO) to the luteal (LU) phase (F=8.21, P=0.007). There 
was no significant difference noted, however, in the total number of follicles measuring 
2.0 to 10.0 mm between the F1 and LU phases of menstrual cycle (P>0.05).   
On stratifying the antral follicles into cohorts of small (2.0 to 4.0mm and >4.0 to 6.0mm) 
and large (>6.0 to 10.0mm) antral follicles, we found that there was no significant intra-
cyclical variation in the small antral follicles measuring up to 6.0mm (P=0.382) but a 
significant variation in the larger follicles measuring more than 6.0mm (P<0.001). The test 
for levels of contrast with large antral follicles showed that the count significantly 
increases from the F2 phase to PO phase (F=36.32, P<0.001) of cycle and then shows a 
S h i l p a  D e b   P a g e  | 161 
 
 
significant drop from PO to LU phase (F=12.168, P=0.001). The small antral follicles 
showed no significant variation at different levels of contrast (P>0.05) (Figure 8.1).  
Figure 8.1: The intra-cycle variation in the mean (error bars of S.E.M) antral follicle counts 
assessed using repeated measures analysis are shown in figure below. P values are marked at 
levels of comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
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Table 8.1: Comparison of the Mean ± SD (95% CI) of the ultrasound and endocrine determinants of 
ovarian reserve measured over one menstrual cycle in healthy volunteers with normal menstrual 
ĐǇĐůĞƐ ?dŚĞWǀĂůƵĞƐŚŽǁŶŝƐĚĞƌŝǀĞĚƵƐŝŶŐ,ŽƚĞůůŝŶŐ ?ƐƚƌĂĐĞŵƵůƚŝǀĂƌŝĂƚĞƚĞƐƚŽĨƌĞƉĞĂƚĞĚŵĞĂƐƵƌĞƐ
analysis. 
 Early follicular 
N=36 
Mid follicular 
N=35 
Peri-ovulatory 
N=36 
Luteal 
N=35 
P value 
 
Total AFC 
2-10mm 
 
 
22.67 ± 9.92 
 
24.14 ± 10.02 
 
24.89 ± 9.88 
 
22.86 ± 9.83 
 
<0.001 
AFC 2-4mm 9.39 ± 4.96 9.17 ± 4.86 9.57 ± 4.98 9.81 ± 5.34 0.041 
AFC >4-6mm 8.25 ± 3.15 8.42 ± 3.42 8.06 ± 3.36 8.19 ± 3.26 0.087 
AFC 2-6 17.64 ± 7.27 17.58 ± 7.40 17.61 ± 7.56 18.00 ± 7.68 0.380 
AFC >6-10mm 5.03 ± 3.50 6.56 ± 3.46 7.28 ± 3.83 4.86 ± 3.57 <0.001 
Volume 6.43 ± 2.19 6.30 ± 2.01 7.28 ± 2.46 7.67 ± 2.64 <0.001 
AMH ng/mL 2.61 ± 1.47 2.60 ± 1.39 2.61 ± 1.42 2.92 ± 1.66 0.035 
FSH IU/L 6.97 ± 2.43 6.54 ± 2.84 8.33 ± 2.91 4.97 ± 1.90 <0.001 
LH IU/L 5.84 ± 2.77 6.18 ± 2.74 20.18 ± 17.05 5.50 ± 3.03 <0.001 
Oestradiol 
pmol/L 
147.72 ± 63.04 165.25 ± 64.32 893.25 ± 68.38 427.78 ± 57.84 <0.001 
 
Two sub-groups of small antral follicles (2.0 to 4.0mm and >4.0 to 6.0mm) were further 
analysed. Whilst >4-6.0mm follicles showed no significant (p=0.335) intra-cyclical 
variation, the 2.0-4.0mm follicles showed a small but significant (P=0.042) intra-cyclical 
variation, and this was noted between the first two follicular phases (F1 and F2) (F=5.091, 
P=0.033) (Figure 8.2) (Tables 8.3 and 8.4 in Appendix). 
The ovarian volume showed a significant intra-cyclical variation (P<0.001). This 
significance was noted due to the increase in ovarian volume between the F2 and PO 
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(F=9.44, P=0.004) phases of menstrual cycle, which was mainly contributed by the ovary 
containing the dominant follicle (Figure 8.2) (Tables 8.3 and 8.4 in appendix). 
Figure 8.2: The intra-cycle variation in the mean (error bars of S.E.M) of small antral follicle counts 
assessed using repeated measures analysis are shown in figure below. P values are marked at 
levels of comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
 
 
 
P = 0.041 
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There was a small but significant intra-cyclical variation noted in serum AMH levels 
(P=0.041). On analysis of levels of within subject contrasts, we found that AMH levels 
significantly increase between the PO and LU (F=11.89, P=0.039) phases of menstrual 
cycle, as shown in Figure 8.3. 
Figure 8.3: The intra-cycle variation in the mean (error bars of S.E.M) AMH levels assessed using 
repeated measures analysis are shown in figure below. P values are marked at levels of comparison 
showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
 
There were expected variations in serum FSH, LH and E2 levels. Serum FSH levels 
increased between the F2 and PO (F=8.78, P=0.005) phases of the menstrual cycle before 
falling between the PO and LU (F=58.10, P<0.001) phases when levels were significantly 
lower (P=0.011) than during the F1 phase of cycle. Serum LH levels showed a similar 
pattern increasing significantly from the F2 to the PO (F=23.98, P<0.001) phase of the 
cycle before falling between the PO and LU (F=33.39, P<0.001) phase, when levels were 
comparable to those seen in the F1 phase of cycle. Oestradiol levels mirrored the 
gonadotrophins increasing from the F1 to F2 (F=115.48, P=0.001) and F2 to PO (F=385.85, 
P<0.001) phases before significantly decreasing between the PO and LU (F=129.59, 
S h i l p a  D e b   P a g e  | 165 
 
 
P<0.001) phases where levels remained significantly higher than those seen during the F1 
phase (Figure 8.4) (Tables 8.3 and 8.4 in appendix).  
Figure 8.4: The intra-cycle variation in the mean (error bars of S.E.M) FSH, LH and Oestradiol 
levels assessed using repeated measures analysis are shown in figure below. P values are marked 
at levels of comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
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Whilst total AFC (2.0-10.0 mm), small (2.0-6.0 mm) and large (>6.0-10.0 mm) antral follicle 
counts, ovarian volume and AMH showed significant correlation (R = 0.948, 0.976, 0.575, 
0.568 and 0.959 respectively), Oestradiol, FSH and LH showed a non-significant 
correlation (R = 0.415, 0.408 and 0.373) between different phases of menstrual cycle. 
AMH, total AFC (2.0-10.0 mm) and small AFC (2.0-6.0 mm) showed excellent ICC of 0.96, 
0.94 and 0.94 respectively, suggesting that majority of the intra-cycle variation seen is due 
to between-subject variation and that the true within-subject variation related to the 
phase of menstrual cycle was only 4%, 6% and 6% respectively. The ICCs for larger antral 
follicles (>6.0-10.0 mm), ovarian volume, FSH, LH and Oestradiol suggested high intra-
individual intra-cycle variation (Table 8.2). 
Table 8.2: The table below shows the Intra-class correlation coefficients (ICC) of ultrasound and 
endocrine markers of ovarian reserve over one menstrual cycle.  
 ICC 95% CI P value 
Total AFC (n) 0.939 0.901  W 0.965 <0.001 
AFC 2.0-4.0mm (n) 0.931 0.890  W 0.961 <0.001 
AFC >4.0-6.0mm (n) 0.898 0.839  W 0.941 <0.001 
AFC 2.0-6.0mm (n) 0.938 0.900  W 0.965 <0.001 
AFC >6.0-10.0mm (n) 0.518 0.353  W 0.681 <0.001 
Ovarian volume (cm
3
) 0.588 0.431  W 0.734 <0.001 
AMH ng/L 0.957 0.931  W 0.976 <0.001 
FSH IU/L 0.301 0.137  W 0.493 0.012 
LH IU/L 0.104 -0.031  W 0.289 0.072 
Oestradiol pmol/L 0.131 -0.019  W 0.320 0.058 
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8.5 Discussion 
 
This is the first study to examine the antral follicles stratified into cohorts of small and 
large antral follicle counts based on their size which was measured using 3D ultrasound 
assisted semi-automated technique, SonoAVC. The results suggest that the cohort of 
small antral follicles measuring 2  W 6 mm do not show significant intra-cycle variation and 
that they show excellent correlation between the different phases of menstrual cycle.  
The total AFC made by including antral follicles of size 2  W 10 mm significantly varied 
across the menstrual cycle. This was predominantly due to a variation in the number of 
larger antral follicles measuring more than 6.0mm and, to a less but still significant extent, 
in the number of follicles measuring 2.0 to 4.0mm. There was no such variation in the 
number of follicles measuring 4.0 to 6.0 mm or in the number of small antral follicles 
measuring 2.0 to 6.0mm as an overall cohort. This latter group of follicles are often 
ƌĞĨĞƌƌĞĚƚŽĂƐƚŚĞ ‘ƐĞůĞĐƚĂďůĞĨŽůůŝĐůĞƐ ?ĂƐƚŚĞǇĂƌĞƌĞƐƉŽŶƐŝǀĞƚŽŐŽŶĂĚŽƚƌŽƉŚŝŶƐďƵƚƵŶůŝŬĞ
the larger antral follicles measuring more than 6.0 mm are not dependent on it (Gougeon 
1989).  
Our results suggest a small but significant intra-cycle variation in serum AMH, mainly 
attributed by the increase in the levels in luteal phase of menstrual cycle. There was a 
high correlation noted in the AMH levels through the menstrual cycle. A high level of 
correlation exist between AMH levels and the small antral follicle population 
(Jayaprakasan, Deb et al. 2009), which is believed to reflect the expression of AMH by this 
follicular cohort (Hansen, Morris et al. 2003; Weenen, Laven et al. 2004). The increase in 
AMH levels seen in the luteal phase of the cycle with no concomitant change in the small 
antral follicle population seen in this study suggests that there might be a new 
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recruitment of pre-antral and early antral follicles in the luteal phase that are also known 
to express AMH (Gougeon 1989; Gougeon 1996; Tsepelidis, Demeestere et al. 2007) but 
that cannot be identified on ultrasound. The increase in AMH we noted in the luteal phase 
has been described in one other study (Hehenkemp 2006). They examined 44 healthy 
volunteers, with an average of 7 visits per participant and described the menstrual cycle 
starting from the mid luteal phase of previous cycle to the luteal phase of next cycle. The 
small significant increase in AMH noticed in the luteal phase might actually reflect the 
levels of subsequent cycle thereby raising the possibility that the number of early and pre-
antral follicles expressing AMH may vary between cycles. The authors however believed 
that the luteal phase increase in AMH levels in their study could be non-significant due to 
the fewer measurements made and a proportional increase in the number of younger 
patients assessed at that visit. In our study we only examined four time points in the 
menstrual cycle and the small but significant increase in luteal phase levels of AMH might 
have become non-significant with more number of visits in each cycle. Wunder et al 
showed a peri-ovulatory increase in the levels of AMH in 36 women with normal 
menstrual cycles (Wunder, Bersinger et al. 2008). They, like in our study, described a 
period between two menstruations as one menstrual cycle. They examined the AMH 
levels every other day and found that it increased in the late follicular phase and mid 
luteal phase of menstrual cycle; and that it decreased in the very early luteal phase 
possibly due to the negative effect of luteinisation on granulosa cells. In our study, we 
have measured the size of antral follicles and shown that the small antral follicles that 
positively correlate with the AMH levels do not vary significantly. However, the luteal 
phase increase in AMH levels in our study and the peri-ovulatory increase in AMH levels 
shown by Wunder et al could be attributed to the much smaller or pre-antral follicles that 
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cannot be seen by ultrasound. It might be possible to explain the new recruitment of 
these follicles in the mid to late luteal phase of cycle when the levels of gonadotrophins 
are low, but difficult to explain the increase in AMH levels seen by Wunder et al in the late 
follicular phase when the high levels of gonadotrophins may have a negative impact on 
the expression of AMH by granulosa cells. Cook et al examined three time points (early 
follicular, peri-ovulatory and luteal) in the menstrual cycle of a much smaller population of 
20 healthy women (Cook, Siow et al. 2000). They found an increase in AMH levels in the 
peri-ovulatory phase (LH surge + 1 day). These results are in contrast to what was found in 
our study and also to that noted by Wunder et al. A small study population with fewer 
time points in the menstrual cycle may explain these findings. 
Several studies have suggested that AMH demonstrates no or minimal variation across 
the menstrual cycle (Hehenkamp, Looman et al. 2006; La Marca, Stabile et al. 2006; 
Tsepelidis, Devreker et al. 2007; van Disseldorp, Lambalk et al. 2010).  These findings 
could be explained by the AMH expression profile. AMH is expressed by the pool of 
growing antral follicles mainly those measuring less than 6 mm, the number of which is 
dependent on the follicular pool i.e. the true ovarian reserve and not the cycle phase 
(Visser, de Jong et al. 2006). This pool of growing follicles is constantly renewed according 
to the follicular reserve, perhaps therefore making the AMH levels constant throughout 
the cycle. Follicles measuring more than 10 mm express negligible to small amounts of 
AMH levels and may be the cause for peri-ovulatory increase in AMH levels seen in some 
studies.    
Only one recent study has examined the intra-cycle variation in AMH along with the antral 
follicle counts made using two-dimensional ultrasound. The authors concluded that the 
variation in AMH during the menstrual cycle is significantly less than that seen in the 
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number of antral follicles and that the AFC is still a cycle-specific test of ovarian reserve. 
Moreover, they showed higher variation in the small antral follicles measuring 2-5 mm 
than those measuring 2-10 mm (van Disseldorp, Lambalk et al. 2010). These results 
contradict to the results from our study, which suggest that the total number of antral 
follicles measuring 2-10 mm show a significant intra-cycle variation and that the small 
antral follicles measuring 2-6 mm do not show significant intra-cycle variation. Moreover, 
the small antral follicles show a high intra-cycle correlation (0.938) comparable to that 
seen with AMH (0.957). The differences in the result may be due to the difference in 
methodology used in our study. In our study, the antral follicles were counted and 
measured using SonoAVC which is a semi-automated 3D assisted method shown to be 
reliable in counting and measuring antral follicles, superior to 2D ultrasound in measuring 
the size of follicles. Also, 2D and other manual methods might over-estimate the size of 
antral follicles (Deb, Jayaprakasan et al. 2009; Deb, Campbell et al. 2010).  The findings 
from our study also compare to the studies showing minimal or no intra-cycle variation in 
AMH levels, confirming that AMH is mainly expressed by the small antral follicles which in 
our study shows a non-significant intra-cycle variation.  
This is the first study that describes the intra-cycle variation in ovarian volume as 
measured using 3D ultrasound in normo-ovulatory healthy women.  It showed significant 
intra-cycle variation, especially an increase in the peri-ovulatory and luteal phase of cycle. 
This could be attributed to the presence of the dominant follicle and the subsequent 
corpus luteum formation. Inter-cycle variation in ovarian volume has been described in 
sub-fertile women using two-dimensional (Elter et al. 2005) and 3D ultrasound 
(Jayaprakasan et al. 2008). Ovarian volume must be assessed in the early follicular phase 
therefore before any significant follicle dominance occurs. 
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FSH and LH, both showed significant intra-cycle variation, mainly due to the increase in 
the peri-ovulatory phase and a subsequent drop in the luteal phase of menstrual cycle. 
This variation is well described (Gougeon 1994) and therefore confirms that these tests 
are also best performed in the early follicular phase. Oestradiol is expressed by the 
granulosa cells of the growing graffian follicle which shows a peak before the LH peak and 
ovulation. Our results confirm this feature and also that Oestradiol levels progressively 
rise till the peri-ovulatory phase and then progressively drop in the luteal phase, although 
still staying higher than the first follicular phase levels. 
 
8.6 Conclusion 
 
The ovarian reserve as measured using small antral follicle count (2.0-6.0mm) and AMH 
show least intra-cycle variation and an excellent within subject correlation. The small but 
significant increase in the luteal phase levels of AMH might suggest a new recruitment of 
early antral and pre-antral follicles and therefore may more adequately predict the actual 
ovarian response, whilst the follicular phase is more likely to reflect the actual pool of 
small antral follicles that is likely to respond to ovarian stimulation. Future studies 
designed to evaluate their ability to predict ovarian response following assisted 
reproduction treatment should consider performing these tests in different phases of 
menstrual cycle. 
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CHAPTER 9: The inter-cycle variation in the number of antral 
follicles stratified by size using three-dimensional ultrasound 
and in the endocrine markers of ovarian reserve in women 
with normal ovulatory menstrual cycles  
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9.1 Abstract 
 
Objective: More often, the assisted reproduction treatment (ART) may not begin soon 
after the test is performed, which raises the question whether the test will be predictive 
enough of the ovarian response and treatment outcome over time. Whilst there are a 
number of tests of ovarian reserve, it appears that AMH and AFC are the most predictive 
tests of ovarian response. The objective of this study was to use 3D ultrasound assisted 
semi-automated method, SonoAVC to quantify the inter cycle variation in AFC stratified 
by follicular size and compare it to AMH and other endocrine markers of ovarian reserve 
over a period of 12 months in normo-ovulatory healthy volunteers.  
Methods: This was a prospective observational study conducted in a university based 
asƐŝƐƚĞĚ ĐŽŶĐĞƉƚŝŽŶ ƵŶŝƚ ? ^ƚƵĚǇ ƉĂƌƚŝĐŝƉĂŶƚƐ ĚĞƐĐƌŝďĞĚ ĂƐ  ‘ŚĞĂůƚŚǇ ǀŽůƵŶƚĞĞƌƐ ? ǁĞƌĞ
recruited prospectively. Serial transvaginal ultrasound scans were performed and blood 
samples taken in the early follicular phase of menstrual cycle (days 2-5) at 0, 1, 3, 6, and 
12 months. The main outcome measure was the variation in the antral follicles stratified 
by size over a period of 12 months. Repeated measures analysis was performed on the 
data. 
Results: The variation in the mean total number of antral follicles measuring 2.0 to 10.0 
mm over 12 months was not significant (P=0.147) with non-significant variation at 
different levels of contrast (P>0.05). Small antral follicles (2.0  W 6.0 mm) and large antral 
follicle (>6.0  W 10.0 mm) both showed a non-significant variation in the number of follicles 
measured over 12 months (P=0.326 and P=0.484 respectively). Both the groups of antral 
follicles again showed a non-significant variation at different levels of contrast (P>0.05). 
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Antral follicle count measuring 2.0-10.0 mm and 2.0-6.0 mm showed excellent correlation 
in their counts across 5 cycles in 12 months examined (0.876, P<0.001 and 0.916, P<0.001 
respectively). Antral follicles measuring >6.0-10mm showed a significant but poorer 
correlation than the smaller antral follicles (0.379, P=0.027). 
Conclusion: The ovarian reserve as measured using small antral follicle count (2.0-6.0mm) 
and AMH show least inter-cycle variation and an excellent within subject correlation. The 
inter-cycle stability of total antral follicle count (2.0-10.0 mm) when performed in the 
early follicular phase of menstrual cycle appears to be comparable to AMH and small AFC. 
 
9.2 Introduction 
  
Ovarian reserve reflects the potential of the ovaries to produce oocytes leading to embryo 
formation and pregnancy. In physiological terms, it is perhaps also a test to predict 
ovarian ageing which has implications on both fertility and menopause (Broekmans, 
Soules et al. 2009). A test of ovarian reserve is primarily aimed at predicting the ovarian 
response to ART and also to inform treatment protocols to prevent unfavourable 
outcomes such as cycle cancellations and ovarian hyper stimulation. More often, the 
assisted reproduction treatment (ART) may not begin soon after the test is performed, 
which raises the question whether the test will be predictive enough of the ovarian 
response and treatment outcome over time. Ageing affects ovarian reserve and therefore 
the tests of ovarian reserve is unlikely to be independent of time. However, an ideal test 
of ovarian reserve should be reliable and predictive of response for at least a few months, 
such that the woman waiting to undergo treatment does not require frequent tests 
before starting treatment. Furthermore, these tests should have minimal variation over 
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time such that they could be reliably used to evaluate the effect of pelvic surgery 
including ovarian cystectomy on ovarian reserve. Generally, a test is thought to be valid 
for up to 6 months before starting treatment. The only subjective data to support such a 
practice would be the population studies on pregnancy and ageing (Poma 1981; Milner, 
Barry-Kinsella et al. 1992; Faddy and Gosden 1996; Gougeon 1998; te Velde and Pearson 
2002; Broekmans, Soules et al. 2009). It would also be important for such a test to be 
reliable showing minimal inter cycle variation. 
Whilst there are a number of tests of ovarian reserve, it appears that AMH and AFC are 
the most predictive tests of ovarian response. Moreover, a good test should show high 
reproducibility and be valid. A moderate degree of inter-observer reliability of both AFCs 
and ovarian volume measurements has been reported with both 2D and 3D ultrasound 
(Scheffer, Broekmans et al. 2002; Merce, Gomez et al. 2005). 3D ultrasound is shown to 
improve reproducibility of measurements of ovarian volume, blood flow indices (Raine-
Fenning, Campbell et al. 2003; Raine-Fenning, Campbell et al. 2003; Raine-Fenning, 
Campbell et al. 2004), and recently that of total antral follicle count (Jayaprakasan, 
Campbell et al. 2008). 3D assisted semi-automated antral follicle counts show further 
improvement in intra and inter observer reproducibility (chapter 3). Also, this technique 
might provide more reliable and valid measurement of size of antral follicles, thereby 
enabling the objective evaluation of small antral follicles (chapter 4, 5 and 6).  
A significant inter-cycle variability has been reported for basal FSH (Scott, Hofmann et al. 
1990) and ovarian volume (Elter, Sismanoglu et al. 2005). Similarly a high degree of 
variation in the number of antral follicles between cycles was demonstrated both in fertile 
(Scheffer, Broekmans et al. 1999) and sub fertile  populations (Elter, Sismanoglu et al. 
2005). A recent study on infertile women has shown more inter-cycle variability with AFC 
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than AMH over four consecutive cycles (van Disseldorp, Lambalk et al. 2010). However, all 
these studies have used 2D ultrasound which is less reliable than 3D ultrasound. AFC 
measured using 3D ultrasound over two consecutive IVF cycles is shown to demonstrate 
lesser inter-cycle variability than ovarian volume and basal FSH levels (Jayaprakasan, 
Campbell et al. 2008). Levels of serum AMH show minimal variation both intra cycle 
(Hehenkamp, Looman et al. 2006; La Marca, Stabile et al. 2006; La Marca, Giulini et al. 
2007; Tsepelidis, Devreker et al. 2007; van Disseldorp, Lambalk et al. 2010) and inter cycle 
(McIlveen, Skull et al. 2007; van Disseldorp, Lambalk et al. 2010) and there is also some 
suggestion that the variation is lower than that seen with AFC (van Disseldorp, Lambalk et 
al. 2010). 
The objective of this study was to use 3D ultrasound assisted semi-automated method, 
SonoAVC to quantify the inter cycle variation in AFC stratified by follicular size using 
SonoAVC and compare it to AMH and other endocrine markers of ovarian reserve over a 
period of 12 months in normo-ovulatory healthy volunteers.  
 
9.3 Methods 
 
Study design 
^ƚƵĚǇƉĂƌƚŝĐŝƉĂŶƚƐĚĞƐĐƌŝďĞĚĂƐ ‘ŚĞĂůƚŚǇǀŽůƵŶƚĞĞƌƐ ?ǁĞƌĞƌĞĐƌƵŝƚĞĚƉƌŽƐƉĞĐƚŝǀĞůǇƚŚƌŽƵŐŚ
advertisements on the intranet portal of the University of Nottingham (UoN) website, and 
posters displayed in staff canteens, notice boards and staff library. Further information 
about the study was communicated via email and information leaflets to those who 
expressed interest in participation in the study. The main inclusion criteria were: age 
between 18 to 35 years, body mass index (BMI) between 18 and 26 kg/
 
m
2
, regular 
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menstrual cycles with a mean length ranging between 26 to 32 days, no history of ovarian 
surgery, no history suggestive of endocrine disease and no use of hormonal 
contraceptives in the last 6 months. Serial transvaginal ultrasound scans were performed 
and blood samples taken in the early follicular phase of menstrual cycle (days 2-5) at 0, 1, 
3, 6, and 12 months. A sample size of 28 was required to power the study at 0.8 with a 
type I error of 0.05 and presumed maximum difference of 0.9 in the mean values across 5 
levels of analysis. 
 
Data acquisition and analysis 
The ultrasound scans were performed by a single investigator (S.D) using a Voluson E8 
Expert
 
(GE Medical Systems, Zipf, Austria) and a three-dimensional 5-9 MHz transvaginal 
transducer. The ultrasound assessment involved a two-dimensional (2D) ultrasound 
assessment of the pelvis to exclude any pelvic pathology followed by acquisition of 3D 
data, similar to that in previous chapters. The acquired 3D data were displayed on the 
ultrasound machine (Voluson E8 Expert) in the multiplanar view. SonoAVC, as described in 
previous chapters was applied to the data and size of each antral follicle measured 
thereby was recorded as d(v). Virtual Organ Computer-aided AnaLysis (VOCAL imaging 
programme: GE Medical Systems) was used to quantify the ovarian volume in each 
individual ovary. The method has been described in detail previously (Raine-Fenning, 
Campbell et al. 2002) but briefly involved display of ovary in multiplanar view followed by 
delineation of ovarian cortex in B plane by manually tracing round the ovary in 30
0 
rotational steps as the dataset was rotated through a total of 180
0
, providing six planes 
for each volume calculation.  
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Hormonal Assays 
The method used was similar to that described in chapter 8.  
Statistical analysis 
The Statistical Package for the Social Sciences (version 17.0; SPSS, Chicago, IL) was used 
for statistical analysis.  Descriptive statistics are displayed as either mean ± SD or median 
with range. General linear model with repeated measures design was used to perform the 
analysis of variance (described in detail in chapter 8). A P-value of less than 0.05 was 
considered statistically significant. Correlation coefficients were used to analyse the 
correlation of the markers over 5 cycles in 12 months and their significance expressed as P 
value. Intraclass correlation coefficients (ICC) were used to assess the inter-cycle variation 
and also between the markers of ovarian reserve. 
 
9.4 Results 
38 healthy volunteers were recruited in the study. Of these, 2 subjects decided to 
commence contraceptive pills and therefore could not be followed up after their visit at 3 
months. A further 6 subjects could not be followed up after their visit at 6 months as 5 
subjects became pregnant and one decided to have an intrauterine contraceptive device. 
30 subjects attended all 5 visits at 0, 1, 3, 6, and 12 months. Mean ± SD age and BMI of 
the participants was 28.12 ± 5.75 years and 22.34 ± 3.08 kg/m
2
 respectively. The mean ± 
SD of markers of ovarian reserve over 12 months are shown in Table 9.1. The mean total 
number of antral follicles measuring 2.0 to 10.0 mm over 12 months did not differ 
(P=0.147) showing a non-significant variation at different levels of contrast (P>0.05) 
(Figure 9.1).  
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Table 9.1: Comparison of the Mean ± SD (95% CI) of the ultrasound determinants of ovarian reserve measured 
in five menstrual cycles at 0, 1, 3, 6, and 12 months in healthy volunteers with normal menstrual cycles. The size 
of antral follicles was measured using 3D assisted SonoAVC and grouped into cohorts of small (2.0-6.0 mm), 
large (>6.0-10.0 mm) and total (2.0- ? ? ? ?ŵŵ ?ĂŶƚƌĂů ĨŽůůŝĐůĞĐŽƵŶƚƐ ?dŚĞWǀĂůƵĞǁĂƐĚĞƌŝǀĞĚƵƐŝŶŐ,ŽƚĞůůŝŶŐ ?Ɛ
trace multivariate test of repeated measures analysis. 
 0 month 
N=38 
1 month 
N=38 
3 months 
N=38 
6 months 
N=36 
12 months 
N=30 
P 
value 
Ovarian 
volume 
6.29 ± 1.76 
(5.69-6.89) 
6.09 ± 1.63 
(5.55-6.65) 
6.21 ± 1.81 
(5.59-6.82) 
6.05 ± 1.52 
(5.54-6.57) 
6.03 ± 1.78 
(5.43-6.64) 
0.434 
Antral follicle counts of both ovaries 
2.0  ? 6.0 
mm (n) 
14.08 ± 5.92 
(12.05-16.12) 
13.51 ± 5.91 
(11.49-15.54) 
14.08 ± 5.92 
(12.05-16.12) 
13.88 ± 5.88 
(11.86-15.91) 
13.51 ± 5.91 
(11.49-15.54) 
0.326 
>6.0  ? 10.0 
mm (n) 
5.97 ± 1.46 
(5.47-6.47) 
5.60 ± 1.83 
(4.97-6.23) 
5.97 ± 1.47 
(5.47-6.47) 
5.89 ± 2.03 
(5.19-6.58) 
5.60 ± 1.83 
(4.97-6.23) 
0.484 
2.0  ? 10.0 
mm (n) 
20.05 ± 6.78 
(17.76-22.35) 
19.08 ± 6.89 
(16.75-21.42) 
20.05 ± 6.78 
(17.76-22.35) 
19.22 ± 7.83 
(16.57-21.87) 
19.08 ± 6.89 
(16.75-21.42) 
0.147 
Antral follicle counts of right ovary 
2.0  ? 6.0 
mm (n) 
7.00 ± 3.05 
(5.95-8.05) 
6.86 ± 2.83 
(5.88-7.83) 
7.00 ± 3.05 
(5.95-8.05) 
6.89 ± 2.86 
(5.90-7.87) 
6.86 ± 2.83 
(5.88-7.83) 
0.870 
>6.0  ? 10.0 
mm (n) 
3.08 ± 1.27 
(2.65-3.52) 
2.74 ± 1.62 
(2.19-3.29) 
3.08 ± 1.27 
(2.65-3.52) 
3.14 ± 1.88 
(2.49-3.79) 
2.74 ± 1.62 
(2.19-3.29) 
0.316 
2.0  ? 10.0 
mm (n) 
10.08 ± 3.90 
(8.76-11.40) 
9.61 ± 3.74 
(8.34-10.88) 
10.08 ± 3.90 
(8.76-11.40) 
9.75 ± 4.38 
(8.27-11.23) 
9.61 ± 3.74 
(8.34-10.88) 
0.870 
Antral follicle counts of left ovary 
2.0  ? 6.0 
mm (n) 
7.08 ± 3.16 
(6.00-8.17) 
6.66 ± 3.35 
(5.50-7.81) 
7.09 ± 3.16 
(6.00-8.17) 
6.66 ± 2.82 
(5.69-7.62) 
6.66 ± 3.35 
(5.51-7.81) 
0.191 
>6.0  ? 10.0 
mm (n) 
2.89 ± 1.08 
(2.52-3.26) 
2.86 ± 1.29 
(2.42-3.30) 
2.88 ± 1.07 
(2.52-3.26) 
2.74 ± 1.34 
(2.28-3.20) 
2.86 ± 1.29 
(2.41-3.30) 
0.885 
2.0  ? 10.0 
mm (n) 
9.97 ± 3.34 
(8.84-11.10) 
9.47 ± 3.67 
(8.23-10.71) 
9.97 ± 3.34 
(8.84-11.10) 
9.14 ± 3.70 
(7.88-10.39) 
9.47 ± 3.67 
(8.23-10.71) 
0.112 
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Figure 9.1: The inter-cycle variation in the mean (error bars of S.E.M) antral follicle counts of both 
and individual ovaries assessed using repeated measures analysis are shown in figure below. P 
values are marked at levels of comparison showing significant change (*=P<0.05; **=P<0.01; 
***=P<0.001). 
 
 
 
P=0.147 
P=0.525 
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Following the stratification of antral follicles based on their size, two main groups of small 
antral follicles (2.0  W 6.0 mm) and large antral follicle (>6.0  W 10.0 mm) were further 
analysed. Both, small and large antral follicle numbers did not differ over 12 months 
(P=0.326 and P=0.484 respectively). Both the groups of antral follicles again did not 
change significantly at different levels of contrast (P>0.05) (Figure 9.1). A similar non-
significant difference was noted when the antral follicle counts of each right and left 
ovaries were analysed (P>0.05) (Figure9.1). Antral follicle count measuring 2.0-10.0 mm 
and 2.0-6.0 mm showed excellent correlation in their counts across 5 cycles in 12 months 
examined (0.876, P<0.001 and 0.916, P<0.001 respectively). Antral follicles measuring 
>6.0-10mm showed a significant but lower correlation than the smaller antral follicles 
(0.379, P=0.027). The ICCs for AFC measuring 2.0-10.0 mm, 2.0-6.0mm, and >6.0-10 mm 
across 5 cycles over 12 months were 0.89 (95% CI, 0.83  W 0.94), 0.95 (95% CI, 0.92  W 0.97) 
and 0.51 (95% CI, 0.35  W 0.67) respectively. 89%, 95% and 51% of variation in AFC 
respectively therefore could be attributed to between-subject variation; and that 11%, 5% 
and 49% respectively could be due to intra-subject variation. 
The inter-cycle change in mean AMH levels over a period of 12 months was not significant 
(P=0.063) with a non-significant change in means at different levels of contrast (P>0.05) 
(Table 9.2 and Figure 9.2). The correlation of AMH levels between cycles was excellent, 
with a correlation coefficient of 0.918 (P<0.001). The ICC for AMH across five cycles over 
12 months was 0.91 (95% CI, 0.85  W 0.95). 91% of variation therefore could be attributed 
to between-subject variation and that only 9% is the intra-individual variation between 
cycles.  
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Mean serum FSH, LH and progesterone levels differed significantly across five cycles over 
a period of 12 months (P=0.027, P=0.033 and P=0.023 respectively). However, Oestradiol 
levels did not show a significant inter-cycle change (P=0.517) (Table 9.2).  
Table 9.2: Comparison of the Mean ± SD (95% CI) of the endocrine determinants of ovarian reserve 
measured in five menstrual cycles at 0, 1, 3, 6, and 12 months in healthy volunteers with normal 
ŵĞŶƐƚƌƵĂů ĐǇĐůĞƐ ? dŚĞ W ǀĂůƵĞ ǁĂƐ ĚĞƌŝǀĞĚ ƵƐŝŶŐ ,ŽƚĞůůŝŶŐ ?Ɛ ƚƌĂĐĞ ŵƵůƚŝǀĂƌŝĂƚĞ ƚĞƐƚ ŽĨ ƌĞƉĞĂƚĞĚ
measures analysis. 
 0 month 
N=38 
1 month 
N=38 
3 months 
N=38 
6 months 
N=36 
12 months 
N=30 
P 
value 
AMH ng/mL 2.76 ± 1.45 
(2.20 W
3.33) 
2.66 ± 1.84 
(1.95-3.38) 
2.88 ± 1.78 
(2.19-3.57) 
3.10 ± 1.68 
(2.45-3.75) 
2.99 ± 1.65 
(2.36-3.64) 
0.053 
FSH IU/L 6.64 ± 2.75 
(5.57-7.70) 
7.81 ± 2.48 
(6.84-8.77) 
6.97 ± 1.76 
(6.29-7.66) 
7.06 ± 3.45 
(5.73-8.40) 
7.84 ± 2.91 
(6.71-8.97) 
0.027 
LH IU/L 5.86 ± 2.45 
(4.91-6.81) 
4.87 ± 1.89 
(4.13-5.60) 
5.71 ± 1.76 
(5.02-6.39) 
5.58 ± 2.02 
(4.79-6.36) 
5.69 ± 2.27 
(4.81-6.58) 
0.033 
Oestradiol 
pmol/L 
149.04 ± 
51.79 
(131.09-
160.30) 
147.05 ± 
42.35 
(136.83-
175.48) 
157.39 ± 
51.39 
(144.10-
183.84) 
159.07 ± 
54.21 
(142.23-
188.23) 
148.36 ± 
42.17 
(138.89-
172.23) 
0.517 
Progesterone 
pmol/L 
1.34 ± 0.67 
(1.12-1.57) 
1.25 ± 0.86 
(0.96-1.54) 
1.03 ± 0.38 
(0.91-1.16) 
1.53 ± 1.27 
(1.10-1.96) 
1.32 ± 0.59 
(1.13-1.52) 
0.023 
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Figure 9.2: The variation in the mean (error bars of S.E.M) levels of endocrine markers of ovarian 
reserve using repeated measures analysis are shown in figure below. P values are marked at levels 
of comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
 
  
  
A significant inter-cycle correlation in FSH levels was seen, with a correlation coefficient of 
0.599 (P=0.042). A poor correlation between cycles was seen in LH, Oestradiol and 
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progesterone levels, with correlation coefficients of 0.433 (P=0.108), 0.446 (P=0.135) and 
0.090 (P=0.618) respectively. The ICCs for FSH, LH, Oestradiol and progesterone were 0.67 
(95% CI, 0.52  W 0.80), 0.50 (95% CI, 0.32  W 0.68), 0.27 (95% CI, 0.11  W 0.48) and 0.19 (95% 
CI, 0.06  W 0.36) respectively. In other words, variation of 67% in FSH, 50% in LH, 27% in 
Oestradiol and 19% in progesterone levels is due to between-subject variation; and that a 
much higher proportion of variation (33%, 50%, 73% and 81% respectively) due to intra-
individual fluctuation of levels between cycles. 
 
9.5 Discussion 
 
This is the first study to quantify markers of ovarian reserve at five time points across a 12 
month period. The results indicate that the small AFC measuring 2.0-6.0 mm showed the 
least variation between five cycles over a period of 12 months followed by serum AMH 
and total AFC measuring 2.0-10.0 mm. A high inter-cycle correlation was observed in 
these markers with significant intra class correlation coefficients suggesting that there is 
only a small intra-individual variation in these markers between cycles.  
A high level of correlation exists between AMH levels and the small antral follicle 
population (Jayaprakasan, Deb et al. 2009), which is believed to reflect the expression of 
AMH by this follicular cohort (Hansen, Morris et al. 2003; Weenen, Laven et al. 2004).The 
larger antral follicles express negligible amounts of AMH and are fewer in number in the 
early follicular phase (mean ± SD: 5.08 ± 1.78) than small AFC measuring 2.0-6.0 mm 
(mean ± SD: 13.82 ± 5.91). The chapter on intra-cycle variation in antral follicle counts 
shows that the number of larger antral follicles significantly increase from the late 
follicular to the peri-ovulatory phase of menstrual cycle and then the numbers drop in the 
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luteal phase to levels comparable to those in the early follicular phase, perhaps indicating 
that this trend persists between cycles showing little inter-cycle change in the early 
follicular phase of the menstrual cycle. The small antral follicles are often referred to as 
ƚŚĞ  ‘ƐĞůĞĐƚĂďůĞ ĨŽůůŝĐůĞƐ ? ĂƐ ƚŚĞǇ ĂƌĞ ƌĞƐƉŽŶƐŝǀĞ ƚŽ ŐŽŶĂĚŽƚƌŽƉŚŝŶƐ ďƵƚ ƵŶůŝŬĞ ƚŚĞ ůĂƌŐĞƌ
antral follicles measuring more than 4.0 mm are not dependent on it (Gougeon 1989). The 
levels of gonadotrophins are low in the early follicular phase and therefore perhaps the 
numbers of larger antral follicles measuring more than 6.0 mm are fewer in this phase of 
menstrual cycle. The total AFC measuring 2-10 mm in the early follicular phase mainly 
comprises of antral follicles less than 6.0mm thereby demonstrating a non-significant 
inter-cycle change in this study. The results from this study in conjunction with those from 
Chapter 8 suggest that to ensure a reliable measure of ovarian reserve, the tests including 
the total AFC (2.0-10.0 mm) and the AFC of larger antral follicles (> 6.0 mm) are best 
measured in the early follicular phase, whereas the small AFC (2.0-6.0 mm) could be 
measured in any phase of menstrual cycle.  
Studies that have looked at inter-cycle variation in the total AFC (2.0-10.0 mm) over more 
than two cycles, showed a non-significant change in the mean counts between cycles, but 
a greater intra-individual variation between cycles when compared to our study (Fanchin, 
Taieb et al. 2005; van Disseldorp, Lambalk et al. 2010). Both groups studied a similar 
group of sub-fertile women who underwent assisted reproduction treatment (ART) 
including intrauterine insemination (IUI) followed by IVF. Fanchin et al examined variation 
over three consecutive cycles and vanDisseldorp et al examined four cycles. They reported 
ICCs of 0.73 and 0.71 respectively for tAFC (2.0-10.0 mm), which suggested significantly 
higher within-subject cycle variation than those observed in our study (ICC 0.89). 
Furthermore, the ICC for small AFC (2.0-6.0 mm) at 0.95 in our study was even better, but 
S h i l p a  D e b   P a g e  | 186 
 
 
unfortunately small antral follicles were not examined in the above two studies. The 
within-subject variation in AMH levels in our study were comparable to those reported in 
these two studies.  The difference in results, in relation to AFC could be attributed to the 
use of 3D ultrasound and SonoAVC; and also that 5 cycles were examined in our study 
over a period of twelve months. SonoAVC is shown to make more reliable and valid 
counts as shown in previous chapters (Deb, Batcha et al. 2009; Deb, Jayaprakasan et al. 
2009; Deb, Campbell et al. 2010). Inter-cycle variability of tAFC (2.0-10.0 mm) alone 
measured using 2D ultrasound  has also been studied previously and shown to be 
moderate in most studies (Scheffer, Broekmans et al. 1999; Hansen, Morris et al. 2003; 
Elter, Sismanoglu et al. 2005). A degree of variation in antral follicle counts and levels of 
AMH might prove desirable when selecting an optimum time for commencing ART 
thereby improving ovarian response and outcome. Future trials designed to look at this 
concept might provide further understanding of physiological variations in the markers of 
ovarian reserve. 
Only one study that used 3D ultrasound to examine the inter-cycle variation between two 
cycles in sub-fertile population, measured tAFC (2.0-10.0) using the manual method of 
counting antral follicles in a multiplanar view (Jayaprakasan, Campbell et al. 2008). They 
reported that the inter-cycle variability in tAFC may mainly be caused by observer 
variability and that the true biological variation may be minimal. In our study, the use of 
SonoAVC by the same experienced observer on the same machine is likely to reduce the 
inter- and intra-observer variation and thereby enable true reflection of within-subject 
inter-cycle variation.  
The current data also suggest a non-significant inter-cycle change in the mean AMH levels; 
and a high correlation between cycles over 12 months duration. The ICC of 0.91 seen in 
S h i l p a  D e b   P a g e  | 187 
 
 
our study was comparable to ICC of 0.89 reported in previous studies (Fanchin, Taieb et al. 
2005; van Disseldorp, Lambalk et al. 2010). Other studies looking at variation between 
two cycles, have reported minimal inter-cycle variation in AMH levels (McIlveen, Skull et 
al. 2007; Streuli, Fraisse et al. 2008). In our study, the inter-cycle stability of AMH (ICC - 
0.91) was comparable to that seen with tAFC (2.0-10.0 mm) (ICC - 0.89) and small AFC 
(2.0-6.0 mm) (ICC - 0.95). 
A significant inter-cycle variation was seen in the mean FSH, LH and progesterone levels; 
however variation in mean oestradiol levels over 12 months was not significant. The 
correlation of LH, progesterone and Oestradiol between cycles was poor; however a 
moderate correlation was seen with FSH between cycles. Since there is no consensus on 
the basal Oestradiol levels that could predict ovarian response and pregnancy outcome 
following ART, Oestradiol is not routinely performed as a test for ovarian reserve 
(Broekmans, Kwee et al. 2006). Although, in our study the mean Oestradiol levels did not 
a show a significant variation between cycles, the correlation was poor and the ICC low at 
0.27, suggesting that the majority of variation seen between cycles is due to intra-
individual fluctuation in levels between cycles.  Elter et al investigated inter-cycle 
variability of FSH, total AFC and ovarian volume in 50 infertile women undergoing ART. 
They found the least inter-cycle variation in FSH levels followed by volume and tAFC 
(Elter, Sismanoglu et al. 2005). In contrast, the results from our study show a significantly 
lower inter-cycle variation in tAFC than FSH (ICC: 0.89 vs 0.67). The difference in these 
findings could be due to the use of 3D ultrasound assisted SonoAVC and the larger 
number of cycles examined in our study.  
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9.6 Conclusion  
The ovarian reserve as measured using small antral follicle count (2.0-6.0mm) and AMH 
show little inter-cycle variation and an excellent within subject correlation. The inter-cycle 
stability of total antral follicle count (2.0-10.0 mm) when performed in the early follicular 
phase of menstrual cycle appears to be comparable to AMH and small AFC. These 
determinants of ovarian reserve demonstrate inter-cycle stability for up to 12 months and 
hence future studies designed to evaluate their ability to predict ovarian response 
following assisted reproduction treatment should consider performing these tests of 
ovarian reserve once in a year, irrespective of the number of ART cycles required. 
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CHAPTER 10: Quantifying the effect of the combined oral 
contraceptive pill on the functional ovarian reserve as 
measured by serum anti-Müllerian hormone and the small 
antral follicle count made using three-dimensional 
ultrasound 
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10.1 Abstract 
 
Objective: Oral contraceptive pills suppress the hypothalomo-pituitary-axis. This can 
affect the ultrasound and endocrine markers used to examine ovarian reserve. The 
objective of this study was to quantify the ultrasound and endocrine markers of functional 
ovarian reserve in women using combined oral contraceptive pill (COCP) for a prolonged 
duration of more than a year.  
Methods: This study is a prospective case-control study on healthy volunteers. 34 subjects 
using COCP with hormone-free-interval (HFI) for more than one year were compared to 
36 normo-ovulatory, age-matched controls that had not used hormonal contraception for 
more than one year. Volunteers taking COCP had a 3D ultrasound scan and blood sample 
within the first 4 days of active pill ingestion and those in the control group had the scan 
and blood test in the early follicular phase (days 2-5) of menstrual cycle. The main 
outcome measure was the differences in antral follicle counts stratified according to size, 
AMH, FSH, LH and oestradiol levels.  
Results: There were no significant differences in the number of small antral follicles 
measuring 2-6mm. The COCP group had significantly lesser antral fŽůůŝĐůĞƐ ŵĞĂƐƵƌŝŶŐ A?
6mm (P<0.001), had significantly smaller ovaries (P<0.001) which also had lower vascular 
indices than the control group (P<0.05). Whilst serum FSH, LH and oestradiol levels were 
significantly lower in COCP group (P<0.05), there was no significant difference in serum 
AMH levels between the two groups.   
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Conclusion: Prolonged use of COCP suppressed pituitary gonadotrophins and antral 
follicle development beyond 6mm but had no effect on levels of serum AMH and small 
antral follicles.  
 
10.2 Introduction 
 
The combined oral contraceptive pill (COCP) is an effective and popular method of 
reversible contraception (2001; Skouby 2004). The contraceptive effect is brought about 
by suppression of the hypothalamo-pituitary-ovarian axis, which inhibits follicular growth, 
maturation of the dominant follicle and ovulation, and as a result of their affect on the 
endometrium and cervical mucus (Mishell, Kletzky et al. 1977; group 2001). The hormone-
free interval (HFI) during which a withdrawal bleed normally occurs in a standard oral 
contraceptive regime, results in some recovery of the pituitary-ovarian axis (Montloin 
1990; van der Spuy, Sohnius et al. 1990), which leads to an increase in the levels of 
gonadotrophins and, eventually, in the resumption of follicle growth and sex steroid 
production (van Heusden and Fauser 1999; Schlaff, Lynch et al. 2004). Some ovarian 
activity, as measured by follicular growth beyond 10 mm, is present without ovulation 
during the pill use (Crosignani, Testa et al. 1996) but a HFI of up to 7 days does not affect 
the contraceptive efficacy of the COCP (Fraser and Jansen 1983; Killick, Bancroft et al. 
1990). It is less clear whether the pituitary-ovarian suppression induced by the COCP or its 
recovery during the HFI has any impact on functional ovarian reserve, which is reflected 
by the number of small antral follicles and serum anti-Müllerian hormone (AMH) levels (La 
Marca, Sighinolfi et al.; Broekmans, Visser et al. 2008; Deb, Batcha et al. 2009; 
Jayaprakasan, Deb et al. 2009).  
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The pool of primordial follicles is finite and folliculogenesis a continuous process that 
depletes this reserve. During the late luteal phase, with the regression of the corpus 
luteum and consequent rise in  follicle stimulating hormone (FSH), the 2 W5 mm antral 
follicles are recruited into a pool of selectable follicles from which the follicle destined to 
ovulate in the subsequent cycle will be selected  (Gougeon and Lefevre 1983). It is not 
known whether suppression of pituitary-ovarian axis by the COCP influences the 
recruitment and growth of these selectable antral follicles.  
This study was therefore designed to quantify the effect of pituitary-ovarian axis 
suppression induced by use of the COCP on functional ovarian reserve as estimated by the 
number of small antral follicles and serum AMH levels. Our hypothesis was that ovarian 
reserve will be affected with the use of COCP. 
 
10.3 Methods 
 
Study design 
The study design was that of a prospective observational nature comparing the 
ĞǆƉĞƌŝŵĞŶƚĂů ŐƌŽƵƉ ƚŽ ĂŐĞ ŵĂƚĐŚĞĚ ĐŽŶƚƌŽůƐ ? ^ƚƵĚǇ ƉĂƌƚŝĐŝƉĂŶƚƐ ĚĞƐĐƌŝďĞĚ ĂƐ  ‘ŚĞĂůƚŚǇ
ǀŽůƵŶƚĞĞƌƐ ? ǁĞƌĞ ƌĞĐƌƵŝƚĞĚ ƚŚƌŽƵŐŚ ĂĚǀĞƌƚŝƐĞŵĞŶƚƐ ŽŶ ƚŚĞ ŝŶƚƌĂŶĞƚ portal of the 
University of Nottingham (UoN) website, and posters displayed in staff canteens, notice 
boards and staff library. Further information about the study was communicated via email 
and information leaflets to those who expressed interest in participation in the study.  
The main inclusion criteria were: age between 18 to 35 years, non-smoker, absence of 
menstrual irregularities, and no past history of ovarian surgery. Those volunteers who had 
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been using COCP containing 30 micrograms of ethinyloestradiol and 150 micrograms of 
levonorgestrel (Microgynon 30, Schering AG, Germany) for more than a year were 
included in the experimental group (COCP group). They had been using the COCP on a 
regular basis and were having monthly withdrawal bleeds during the hormone-free-
interval. Those volunteers who had not used COCP or any other form of hormonal 
contraceptive for more than a year were included in the control group. The main 
exclusion criterion was presence of ovarian pathology such as ovarian cysts identified on a 
baseline ultrasound scan undertaken after recruitment. This scan was conducted during 
the first 4 days of active pill ingestion in the experimental group and during the early 
follicular phase of the menstrual cycle (between days 2-5) in the control group and if the 
patient had no pelvic pathology, venepuncture was undertaken and serum stored for 
subsequent analysis.   
A sample size of 30 was required in each arm to power the study at 0.85, for an assumed 
variation of 4 antral follicles in the total AFC between groups and a standard deviation of 
2.5.   
Data acquisition and analysis 
A single investigator (S.D) performed all of the ultrasound scans using a Voluson E8 Expert
 
(GE Medical Systems, Zipf, Austria) and a three-dimensional 5-9 MHz transvaginal 
transducer. The ultrasound assessment involved a two-dimensional (2D) ultrasound 
assessment of the pelvis to exclude any pelvic pathology, followed by acquisition of 3D 
volume data. The acquired 3D data were displayed on the ultrasound machine (Voluson 
E8 Expert) in the multiplanar view and processed further using SonoAVC and VOCAL to 
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obtain antral follicle sizes and ovarian volume respectively. The technique and method 
used was similar to that used for studies in previous chapters. 
Hormonal Assays 
Blood samples were collected from each subject and centrifuged within 30 min of 
venepuncture for 20 min at 4
o
C and 4000 rpm spin to separate the serum. The processing, 
storage and analysis of the samples was similar to that used for studies in previous 
chapters. 
Statistical analysis 
The Statistical Package for the Social Sciences (version 16.0; SPSS, Chicago, IL) was used 
for statistical analysis. The distribution of the data was checked for normality using a 
normal probability plot. The data are expressed as mean (± SD) or median (± range) and 
ĚŝĨĨĞƌĞŶĐĞƐ ďĞƚǁĞĞŶ ŐƌŽƵƉƐ ǁĞƌĞ ĞǆĂŵŝŶĞĚ ƵƐŝŶŐ ĂŶ ŝŶĚĞƉĞŶĚĞŶƚ ƐƚƵĚĞŶƚ ?Ɛ ƚ ƚĞƐƚ Žƌ
Mann Whitney U test dependent on the distribution of the data. The relationship of each 
follicular cohort, stratified according to the mean diameter of the follicles, with the 
endocrine markers including AMH, FSH, LH , and Oestradiol ǁĂƐĞǀĂůƵĂƚĞĚƵƐŝŶŐWĞĂƌƐŽŶ ?Ɛ
Žƌ ^ƉĞĂƌŵĂŶ ?Ɛ ĐŽƌƌĞůĂƚŝŽŶ ĐŽĞĨĨŝĐŝĞŶƚ  ?ƌ ? ?A P-value of less than 0.05 was considered 
statistically significant. 
 
10.4 Results 
 
34 subjects that were taking combined oral contraceptive pill containing 30 micrograms of 
ethinyloestradiol and 150 micrograms of levonorgestrel (Microgynon 30, Schering AG, 
Germany) for more than one year were evaluated in the experimental group. 36 subjects 
who had not used any form of hormonal contraception for more than one year were 
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evaluated in the control group. There were no differences between the groups in age or 
body mass index. The mean ± SD (range) age of the COCP group was 25.35 ± 4.23 (20  W 
34.6) years and that of control group was 27.16 ± 4.63 (20.30  W 35) years (P=0.137).  The 
mean ± SD (range) BMI of the COCP group was 23.32 ± 3.41 (16.60  W 30.41) and that of 
control group was 23.76 ± 2.70 (18.31  W 29.69) (P=0.599).  
The experimental group had used the COCP for an average of 3.16 years (range: 2.4 to 6 
years). In this group, a significant correlation was seen between AMH and the total 
number of antral follicles measuring 2 to 10 mm (r=0.741, P<0.001). However, on 
evaluating the relationship between AMH and antral follicles stratified into cohorts of 1 
mm, a significant correlation was only seen with the smaller antral follicles that measured 
less than 6 mm (r=0.724, P<0.001). Larger antral follicles, measuring 6 to 10 mm, did not 
correlate with serum AMH levels (r=0.284, P=0.121). There was no significant correlation 
seen between the total antral follicle counts (AFC) or follicles of different sizes and any of 
the other endocrine markers including FSH, LH, and Oestradiol in the experimental group 
using the COCP (Table 10.1).  
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Table 10.1: The correlation between various antral follicle cohorts stratified by size, AMH, FSH, LH, 
and Oestradiol in women using the combined oral contraceptive pill (30 mcg of ethinyl Oestradiol 
and 150 mcg of levonorgesterel) for more than a year. The relationships are presented as the 
WĞĂƌƐŽŶ ?ƐĐŽƌƌĞůĂƚŝŽŶĐŽĞĨĨŝĐŝĞŶƚ ?ƌ ?ĂŶĚŝƚƐůĞǀĞůŽĨƐŝŐŶŝĨŝĐĂŶĐĞ ?WǀĂůƵĞ ? 
Antral follicle size  
(mm) 
AMH  
r (p value) 
FSH 
r (P value) 
LH 
r (P value) 
E2 
r (P value) 
2.0 to 2.99 0.281 (0.126) -0.154 (0.408) -0.074 (0.692) 0.133 (0.475) 
3.0 to 3.99 0.492 (0.010) 0.108 (0.563) -0.184 (0.322) 0.231 (0.211) 
4.0 to 4.99 0.627 (<0.001) -0.023 (0.903) 0.183 (0.324) -0.015 (0.937) 
5.0 to 5.99 0.700 (<0.001) -0.032 (0.866) 0.150 (0.419) 0.246 (0.182) 
6.0 to 6.99 0.302 (0.082) -0.066 (0.723) -0.72 (0.701) 0.303 (0.098) 
7.0 to 7.99 0.284 (0.121) -0.007 (0.968) 0.121 (0.518) -0.007 (0.969) 
8.0 to 8.99 0.320 (0.079) -0.368 (0.042) -0.330 (0.70) -0.103 (0.581) 
9.0 to 9.99 -0.048 (0.800) -0.035 (0.852) 0.002 (0.989) 0.129 (0.488) 
Antral follicle counts     
2.0 to 3.99 (2-4) 0.396 (0.028) -0.159 (0.393) -0.165 (0.375) 0.230 (0.214) 
2.0 to 4.99 (2-5) 0.625 (<0.001) -0.121 (0.518) -0.007 (0.9710 0.147 (0.431) 
2.0 to 5.99 (2-6) 0.724 (<0.001) -0.098 (0.60) 0.056 (0.767) 0.203 (0.274) 
2.0 to 8.99 (2-9) 0.750 (<0.001) -0.115 (0.538) 0.021 (0.910) 0.236 (0.201) 
2.0 to 9.99 (2-10) 0.741 (<0.001) -0.116 (0.535) 0.021 (0.910) 0.241 (0.192) 
6.0 to 9.99 (6-10) 0.284 (0.121) 0.027 (0.782) 0.102 (0.504) 0.098 (0.571) 
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Figure 10.1: Comparison of the antral follicles stratified by size between the experimental group (n 
= 34), who had been using the COCP for more than one year, and the control group (n = 36). 
 
Ŷ  ‘ŝŶĚĞƉĞŶĚĞŶƚ ƐĂŵƉůĞƐ ƚ ƚĞƐƚ ? ĐŽŶĨŝƌŵĞĚ ƚŚĞƌe was no significant difference between 
the experimental group and the control group in the number of small antral follicles 
measuring less than 6 mm (P=0.127). The COCP group, that had used hormonal 
contraceptive for more than a year, had significantly lesser antral follicles measuring 6 to 
10 mm than the control group (2.65 ± 2.93 versus 6.04 ± 3.25; P<0.001). This was 
reflected in the total AFC, which was significantly lower as a result of these differences in 
the COCP group (17.06 ± 8.55 vs 23.42 ± 8.00; P=0.007). The COCP users had significantly 
smaller ovaries (4.38 ± 2.37 vs 7.44 ± 2.66 cm
3
; P<0.001) which were also less vascular 
than the control group (VI: P=0.008; FI: P=0.047; and VFI: P=0.002) (Table 10.2 and Figure 
10.1). Comparison of the endocrine markers, including AMH, FSH, LH, and E2, between 
the two groups is shown in Table 10.3. Whilst there was no significant difference seen in 
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the levels of serum AMH between the two groups, serum FSH, LH, and E2 were all 
significantly lower in the COCP group than the control group (P < 0.05). 
Table 10.2: Comparison of the ultrasound markers of ovarian reserve between the experimental 
group (n = 34), who had been using the COCP for more than one year, and the control group (n = 
36). 
Variable Experimental group: COCP user  
(n=34) 
Control group 
(n=36) 
P 
value 
 Mean ± SD Range Mean ± SD Range  
Antral follicle size (n)      
2.0  ? 2.99 mm 3.87 ± 1.88 1  W 8 4.08 ± 3.35 0  W 13 0.767 
3.0  ? 3.99 mm 3.52 ± 2.23 0  W 9 4.67 ± 2.35 0  W 9 0.070 
4.0  ? 4.99 mm 3.61 ± 2.81 0  W 11 4.42 ± 2.45 1  W 9 0.272 
5.0  ? 5.99 mm 3.42 ± 2.80 0  W 9 4.21 ± 2.21 0  W 10 0.262 
6.0  ? 6.99 mm 1.81 ± 2.09 0  W 10 3.46 ± 2.04 0  W 7 0.005 
7.0  ? 7.99 mm 0.48 ± 0.63 0  W 2 1.25 ± 1.11 0  W 3 0.002 
8.0  ? 8.99 mm 0.19 ± 0.40 0  W 1 1.13 ± 1.15 0  W 3 0.001 
9.0  ? 9.99 mm 0.16 ± 0.45 0  W 2 0.21 ± 0.41 0  W 1 0.694 
Antral follicle counts 
(n) 
     
2 to 4 mm 7.39 ± 3.33 2  W 17 8.75 ± 4.84 2  W 19 0.222 
2 to 5 mm 11 ± 4.93 4  W 23 13.17 ± 6.08 3  W 24 0.156 
2 to 6 mm 14.42 ± 6.97 5  W 32 17.38 ± 7.08 7  W 33 0.127 
2 to 9 mm 16.90 ± 8.47 5  W 36 23.21 ± 7.85 10  W 43 0.007 
2 to 10 mm 17.06 ± 8.55 5  W 36 23.42 ± 8.00 10  W 43 0.007 
6 to 10 mm 2.65 ± 2.93 0  W 14 6.04 ± 3.25 1 - 13 <0.001 
Ovarian volume 
(cm
3
) 
4.38 ± 2.37 1.56  W 11.02 7.44 ± 2.66 3.15  W 14.21 <0.001 
Vascularisation 
Index (VI: %) 
3.46 ± 2.72 0.09  W 13.4 5.58 ± 2.96 0.09  W 13.04 0.008 
Flow Index (FI: 
0_100) 
29.70 ± 5.22 18.12  W 42.87 32.68 ± 5.59 16.95  W 43.17 0.047 
Vascularisation Flow 
Index (VFI: 0_100) 
1.19 ± 1.11 0.03  W 5.36 2.39 ± 1.67 0.03  W 6.32 0.002 
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Table 10.3: Comparison of the endocrine markers of ovarian reserve between the experimental 
group (n = 34), who had been using the COCP for more than one year, and the control group (n = 
36). * Estimated values of AMH in pmol/L using the conversion factor 1 ng/mL = 7.14 pmol/L. 
Variable Experimental group: COCP user 
(n=34) 
Control group 
(n=36) 
P value 
 Mean ± SD Range Mean ± SD Range  
FSH (IU/L) 4.73 ± 3.86  0.44  W 15.39 6.59 ± 0.93 4.99  W 8.33 0.015 
LH (IU/L) 3.46 ± 3.17 0.38  W 10.39 5.76 ± 2.52 1.43  W 11.29 0.005 
Oestradiol (pmol/L) 95.58 ± 56.77 2  W 217 149.58 ± 8.27 84  W 361 0.001 
AMH (ng/mL) 2.75 ± 1.59 0.23  W 6.34 3.06 ± 1.27 1.46  W 5.88 0.440 
AMH (pmol/L)
* 
19.63 ± 11.36 1.65  W 45.30 21.83 ± 9.05 10.45  W 42 0.440 
 
 
10.5 Discussion 
 
This is the first study to quantify the effect of the combined oral contraceptive pill with 
hormone free interval on the small antral follicle counts and AMH using 3D ultrasound 
assisted semi-automated method, SonoAVC. Our results show that despite lower serum 
levels of gonadotrophins in the COCP users, the population of small antral follicles 
measuring 2 to 6 mm and serum AMH levels are comparable to those seen in non-pill 
users. These results are consistent with the fact that the pool of selectable antral follicles 
(2-5 mm) are gonadotrophin responsive but not dependant and that the antral follicles 
measuring more than 6 mm are gonadotrophin dependant (Gougeon and Lefevre 1983).  
S h i l p a  D e b   P a g e  | 200 
 
 
In this study, serum AMH concentrations were the only endocrine marker that was 
comparable between the COCP users and the control group. Further, a significant positive 
correlation was noted between AMH and small antral follicles measuring up to 6mm in 
both the experimental and the control group, but there was no relationship with larger 
antral follicles, FSH, LH and E2 levels. These results are consistent with the observations of 
Weenen et al who have shown that AMH is mainly expressed by the pre antral and small 
antral follicle population up to a diameter of around 4mm (Weenen, Laven et al. 2004). 
Since the majority (70%) of the total antral follicle counts include these small antral 
follicles, a significant positive correlation was also observed between AMH and total AFC 
in the current study and these results are comparable to the correlation seen between 
AMH and antral follicles in normal (van den Berg, van Dulmen-den Broeder et al.; La 
Marca, Stabile et al. 2006) and sub-fertile populations (Weenen, Laven et al. 2004; 
Broekmans, Visser et al. 2008; Haadsma, Groen et al. 2009; Jayaprakasan, Deb et al. 
2009). As with the current study, Jayaprakasan et al also have shown a strong significant 
correlation between AMH and follicles measuring less than 6mm (Jayaprakasan, Campbell 
et al. 2008; Jayaprakasan, Deb et al. 2009). Further, results from chapter 5 have  shown 
that small antral follicles are a significant independent predictor of ovarian response to 
controlled stimulation, and clinical pregnancy rates following IVF treatment and these 
findings are in agreement with those reported by other investigators (Fanchin, Schonauer 
et al. 2003; Eldar-Geva, Ben-Chetrit et al. 2005; Fanchin, Taieb et al. 2005; Penarrubia, 
Fabregues et al. 2005; Fleming, Deshpande et al. 2006). Overall, these findings support 
the interpretation that the number of small antral follicles and circulating AMH 
concentrations more accurately reflect the functional ovarian reserve. Although some 
studies suggest, that the total number of antral follicles is predictive of reproductive 
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response (van Rooij, Broekmans et al. 2002; Hendriks, Mol et al. 2005; Muttukrishna, 
McGarrigle et al. 2005), this can be explained by the fact that the smaller, more 
responsive antral follicles comprise the majority of the follicle population included in the 
total antral follicle count in these individuals.   
Although the HFI has an impact on reversal of the inhibition of pituitary ovarian axis, it is 
interesting to note that the number of antral follicles measuring more than 6mm were 
significantly lower in COCP users when compared to the control group, suggesting that 
the reduction in gonadotrophins in COCP users affects the growth of gonadotrophin 
dependent antral follicles but not the gonadotrophin responsive preantral and small 
antral follicles. It is well established from both in vitro (Spears 1994; Chun, Eisenhauer et 
al. 1996; Newton, Picton et al. 1999; Wright, Hovatta et al. 1999) and in vivo (Hsueh, 
Eisenhauer et al. 1996; McGee, Perlas et al. 1997; Hsueh, McGee et al. 2000; Campbell, 
Telfer et al. 2004) studies that FSH is a major survival factor for preantral and early antral 
follicles, the stage during which a majority of follicle undergo atresia under physiological 
conditions (Gougeon 1996). However, due to the range of approaches and doses used in 
these animal studies, it is difficult to determine the minimum amount of FSH that is 
required to influence the survival of these preantral and small antral follicles. From the 
present study, it is clear that a relatively modest suppression of pituitary gonadotrophins 
in our study did not significantly affect the number of selectable antral follicles but was 
enough to significantly reduce the number of large antral follicles greater than 6mm in 
diameter.  
Surprisingly, there are relatively fewer publications in the literature examining the effect 
of the COCP on ovarian function in women. Van den berg et al. studied 25 women who 
had been taking low dose COCP for an average of 1.8years and followed them for two 
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subsequent natural menstrual cycles after stopping the pill.  They found that FSH and 
inhibin B levels significantly decreased; AMH, total AFC (antral follicles measuring 2 to 
10mm), and ovarian volume significantly increased; and that levels of LH and E2 did not 
significantly change after discontinuation of hormonal contraception (van den Berg, van 
Dulmen-den Broeder et al.). In our study the total AFC was significantly higher in the 
control group which is comparable to the above study, but this was mainly due to the 
large antral follicles. The results of endocrine profile in the above study contrast with 
those of our study. We found that AMH does not significantly differ between the two 
groups, but the FSH, LH, and E2 levels reduce significantly in pill users. These differences 
may perhaps be due to the low dose COCP used in this study or the timing of blood 
samples collected. This interpretation is supported by the results of Somunkiran et al, who 
studied 15 normal women who were given COCP containing 35 mcg of ethinyl oestradiol 
and 2mg cyproterone acetate for 6 months and the endocrine and ultrasound markers of 
ovarian reserve compared pre and post treatment (Somunkiran, Yavuz et al. 2007). They 
found that AMH levels did not change significantly with the use of COCP, but FSH, LH, and 
Oestradiol levels significantly reduced with the use of COCP. Further, a reduction in 
ovarian volume and follicle number following COCP use was found and we have extended 
this observation to show that only the larger antral follicle population measuring 6 mm or 
more was significantly reduced by the use of COCP. We also found that the vascularity of 
the ovaries was significantly lesser in COCP users than the control group. This could be 
attributed to smaller ovaries and lesser number of larger antral follicles than the control 
group.  
The results of the current study are relevant to the use of COCP in assisted reproduction 
treatment, including both IVF and ICSI. Paradoxically, oral contraceptive pills have been 
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used for down-regulation in both poor responders (Fisch, Royburt et al. 1996; al-Mizyen, 
Sabatini et al. 2000; Keltz, Gera et al. 2007) and in women at risk of ovarian hyper 
stimulation syndrome (OHSS) (Damario, Barmat et al. 1997) with beneficial effects having 
been reported in both the groups. In poor responders, the use of COCP prior to using 
GnRH analogue in short protocol in IVF has been shown to blunt the LH flare and it is 
thought that this might reduce the early rise in follicular androgens (Keltz, Gera et al. 
2007), and prevent the rescue of corpus luteum resulting in better follicular recruitment 
and ovarian response (Gelety, Pearlstone et al. 1995; Biljan, Mahutte et al. 1998).  
Conversely, the pre treatment use of COCP in hyper-responders in order to improve the 
outcome and incidence of OHSS following IVF has been attributed to a reduction in LH 
levels leading to a fall in follicular androgens and less FSH-induced granulosa cell 
aromatase activity (Franks and Mason 1991; Damario, Barmat et al. 1997). Our results, 
which show that the functional ovarian reserve as measured by small antral follicles and 
AMH does not change with the COCP use; do not clearly support either of these 
interpretations although the fall in large antral follicles resulting from COCP use might be 
beneficial in patients at risk of OHSS. The benefits, therefore, of using the COCP as part of 
an assisted reproduction treatment cycles are unclear although it is possible that this may  
lead to a homogenous response to controlled ovarian stimulation by influencing the 
recruitment and growth of follicles and the yield and quality of the oocytes harvested. 
This possibility, however, requires evaluation in future trials. 
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10.6 Conclusion  
This study has shown that prolonged use of combined oral contraceptive pill with 
hormone free interval suppressed pituitary gonadotrophins and decreased the volume 
and blood flow within the ovary.  It also suppressed the antral follicle development 
beyond 6 mm but had no effect on the smaller antral follicles measuring less than 6 mm 
or on serum AMH levels both of which are thought to be most reflective of functional 
ovarian reserve.  
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CHAPTER 11: Effect of ovarian cystectomy on ovarian 
reserve as quantified by AMH and antral follicle counts 
measured by SonoAVC  
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11.1 Abstract 
 
Objective: This study was designed to quantify the effect of ovarian cyst per se and that of 
laparoscopic ovarian cystectomy on the markers of ovarian reserve as measured using 
AMH, and 3D ultrasound assisted measures of small antral follicle count and total antral 
follicle count. The hypothesis was that ovarian cystectomy has a significant effect on the 
ovarian reserve. 
Methods: It was a prospective observational study conducted in a university based 
assisted conception unit. Women diagnosed with an ovarian cyst of presumed benign 
nature on ultrasound scan were recruited. Ovarian reserve was evaluated in women with 
unilateral benign ovarian cyst pre operatively and then following laparoscopic cystectomy 
at one, three, and 6 months. AMH, FSH, and 3D assisted software - SonoAVC that made 
semi-automated antral follicle counts were used to quantify ovarian reserve. Repeated 
measures analysis was performed to examine the effect. 
Results: AMH and FSH levels showed a significant decline post-operatively (P<0.05). A 
similar significant decline in antral follicle counts measuring 2.0-10.0mm and 2.0-6.0mm 
was observed in the ovary that underwent cystectomy (P<0.05). These total and small 
& ?Ɛ ? ŚŽǁĞǀĞƌ ƐŚŽǁĞĚ Ă ŶŽŶ-significant decline in the contra-lateral normal ovary 
(P>0.05). A non-significant decline was observed in the number of larger antral follicles 
measuring >6.0 mm in both, the diseased and contra-lateral normal ovaries. Analysis of 
within-subject levels of follow up showed that total AFC and small AFC in the operated 
ovary continued to decline up until 3 months (P<0.05) post-operatively before stabilising 
at 6 months. Levels of serum AMH significantly dropped and that of FSH increased one 
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month post operatively and stayed at those levels 3 and 6 months later. On analysis based 
on cyst types, both endometrioma and dermoid cysts showed a significant drop in ovarian 
reserve which persisted up to 6 months following cystectomy (P<0.05), whereas a simple 
cyst showed a non-significant change (P>0.05). Effect with endometrioma was more 
pronounced than that with dermoid cyst (P<0.05) 
Conclusion: Laparoscopic ovarian cystectomy is associated with a significant loss of 
ovarian reserve measured using AMH and small antral follicle counts, the effect lasting at 
least up to 6 months. Endometrioma itself significantly affects the ovarian reserve of the 
diseased ovary and that removal of endometrioma might cause more damage to ovarian 
reserve than the non-endometriotic cysts.   
 
11.2 Introduction 
 
Benign ovarian cysts commonly occur in premenopausal women and in majority are either 
endometrioma, mature cystic teratomas called dermoid cyst, benign cystadenomas or 
functional ovarian cysts. Endometriosis affects 3 - 10% of women in their reproductive age 
and is the leading cause of sub fertility, seen in about 25-35% of women with infertility 
(Jenkins, Olive et al. 1986; Mahmood and Templeton 1991). Endometriomas are identified 
in 17-44% of women with endometriosis (Chapron, Vercellini et al. 2002).  According to 
the implantation theory, the endometrial implants cause adherence of the ovary to pelvic 
peritoneum and progressively invaginate the ovarian cortex (Hughesdon 1957; Brosens, 
Puttemans et al. 1994). Another theory suggests that endometrioma is formed due to the 
metaplasia of coelomic epithelium which invaginate into the ovarian cortex (Donnez, 
Nisolle et al. 1996). These theories suggest that an endometrioma is perhaps a pseudo 
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cyst. Mature cystic teratomas or dermoids represent more than 10% of all ovarian 
ŶĞŽƉůĂƐŵ ?Ɛ and are the most common benign germ cell tumours of the ovary in women of 
reproductive age.  
 
Laparoscopic cystectomy is usually performed for symptomatic  ovarian cysts as can cause 
further pain and discomfort related to pressure on adjacent structures, torsion, rupture, 
haemorrhage (both within and outside of the cyst), and abnormal uterine bleeding 
(Chapron, Vercellini et al. 2002). In sub fertile women, they are often removed to improve 
chances of conception. Operative laparoscopy compared with laparotomy has been 
established as the gold standard surgical approach in the treatment of ovarian cysts in 
terms of reduced postoperative pain, analgesic requirement, hospitalization, and 
adhesion formation (Pados, Tsolakidis et al. 2006). Potential problems with surgical 
treatment of ovarian cysts are the small risk of post surgical ovarian failure of 2.4% 
especially when dealing with bilateral ovarian cysts (Busacca, Riparini et al. 2006), a 
moderate 30.4% risk of recurrence (Koga, Takemura et al. 2006) and a reduction in 
ovarian reserve. The principle of cystectomy is to either remove or destroy the cyst wall or 
capsule in order to prevent recurrence. The techniques commonly used therefore are 
stripping of the cyst from underlying normal ovarian tissue or drainage of the cyst with 
ablation of cyst wall. Following the excision of the cyst or stripping of the cyst wall from 
the ovarian cortex, it is a normal practice to achieve haemostasis in the cyst bed using 
some form of coagulation, either monopolar, bipolar, laser, or an ultrasonic device. The 
current body of evidence suggests that ovarian cysts, especially endometrioma, can affect 
the function of the adjacent normal ovarian tissue (Maneschi, Marasa et al. 1993), that 
stripping of ovarian cyst is associated with inadvertent loss of normal ovarian tissue 
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attached to it (Hachisuga and Kawarabayashi 2002; Muzii, Bianchi et al. 2002; Roman, 
Tarta et al. 2010), and finally coagulation or ablation achieved using electrical energy, 
laser, or ultrasonics is associated with loss of ovarian reserve (Li, Liu et al. 2009; Tsolakidis, 
Pados et al. 2009; Coric, Barisic et al. 2010). There are some recent studies showing less 
ovarian damage with the use of CO2 laser and with the use of three-stage procedures 
when treating endometriomas (Donnez, Lousse et al. 2010; Pados, Tsolakidis et al. 2010; 
Tsolakidis, Pados et al. 2010). Few studies have suggested that damage to ovarian reserve 
see with removal of endometriomas might be more pronounced than non-endometriotic 
cysts (Maneschi, Marasa et al. 1993; Muzii, Bianchi et al. 2002; Exacoustos, Zupi et al. 
2004; Chang, Han et al. 2010; Iwase, Hirokawa et al. 2011). There is also suggestion that 
inexperience of the surgeon can increase the damage caused to the normal ovarian tissue 
and ovarian reserve thereby (Yu, Huang et al.).  
 
Various methods have been reported to evaluate ovarian reserve following ovarian 
cystectomy. These include ovarian response and / or pregnancy rate in women 
undergoing assisted reproduction treatment (ART); two Wdimensional ultrasound markers 
of ovarian reserve such as volume, vascularity, and AFC (2.0-10.0mm); ovarian volume as 
measured using 3D ultrasound; and endocrine markers of ovarian reserve including AMH 
and FSH. The ovarian reserve in the operated ovary has more commonly been compared 
to either the contra lateral normal ovary or matched controls, and in very few studies to 
itself in a longitudinal study design. Studies that have used outcomes of ovarian response 
to evaluate ovarian reserve have used measures including the duration of ovarian 
stimulation, the number of oocytes collected, fertilisation rate, and clinical pregnancy rate 
when examining the effects of ovarian cystectomy in sub-fertile population undergoing 
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assisted reproduction treatment. They have compared the ovarian response of operated 
ovary either to the contra lateral normal ovary or to the matched case-controls (Loh, Tan 
et al. 1999; Canis, Pouly et al. 2001; Marconi, Vilela et al. 2002; Somigliana, Ragni et al. 
2003; Wong, Gillman et al. 2004; Loo, Lin et al. 2005; Alborzi, Zarei et al. 2006; Esinler, 
Bozdag et al. 2006; Somigliana, Vercellini et al. 2006; Alborzi, Ravanbakhsh et al. 2007; 
Nakagawa, Ohgi et al. 2007; Horikawa, Nakagawa et al. 2008; Kahyaoglu, Ertas et al. 2008; 
Somigliana, Arnoldi et al. 2008; Benaglia, Somigliana et al. 2009; Garcia-Velasco and 
Somigliana 2009; Tsoumpou, Kyrgiou et al. 2009; Benaglia, Somigliana et al. 2010). 
Ovarian cystectomy has been shown to impair ovarian reserve following assisted 
reproduction treatment (ART), but reduced ovarian reserve does not seem to translate 
into impaired pregnancy outcome (Demirol, Guven et al. 2006; Esinler, Bozdag et al. 2006; 
Somigliana, Ragni et al. 2006; Kahyaoglu, Ertas et al. 2008; Garcia-Velasco and Somigliana 
2009). A few studies have reported ovarian volume in conjunction with ovarian response 
and compared to the response in contra lateral ovary (Somigliana, Ragni et al. 2006). 
Other studies have used ultrasound markers such as volume, antral follicle count, and 
stromal blood flow in the operated ovary and compared to the contra lateral ovary 
(Exacoustos, Zupi et al. 2004; Candiani, Barbieri et al. 2005; Benaglia, Somigliana et al. 
2010; Coric, Barisic et al. 2010; Donnez, Lousse et al. 2010).  Very few prospective 
longitudinal studies comparing postoperative ovary to the preoperative ovary have used 
varying combinations of endocrine and ultrasound markers of ovarian reserve with post 
operative follow up of varying number and duration (Candiani, Barbieri et al. 2005; Chang, 
Han et al. 2009; Li, Liu et al. 2009; Tsolakidis, Pados et al. 2009; Chang, Han et al. 2010; 
Pados, Tsolakidis et al. 2010; Iwase, Hirokawa et al. 2011).   
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To further compound the assessment of ovarian reserve following ovarian cystectomy, 
there are inherent physiological variations in some of the markers of ovarian reserve as 
shown in previous chapters. When using ultrasound markers of ovarian reserve, it is 
important to note that there is an inter-ovarian variation in the markers of ovarian 
reserve including the AFC, ovarian volume, vascularity as measured using 3D power 
Doppler indices and pulsed wave Doppler, such that one ovary may not be reliably 
compared to the other contra lateral ovary (chapter 7). The small antral follicles 
measuring less than 6mm show least variation between the two ovaries and hence if the 
two ovaries had to be compared, they would be the most reliable marker of reserve to 
use (chapter 7). Small antral follicles show the least inter-cycle variation and could be 
used reliably in longitudinal studies (chapter 9). There is a significant inter-ovarian, intra-
cyclical and inter-cyclical variation seen with ovarian volume and therefore might not be a 
reliable test to assess the effect of ovarian cystectomy (chapters 7, 8 and 9). Although, 
ovarian volume assessed using 3D ultrasound has been shown to have good intra- and 
inter-observer reliability (Scheffer, Broekmans et al. 2002; Raine-Fenning, Campbell et al. 
2003; Raine-Fenning, Campbell et al. 2003; Merce, Gomez et al. 2005; Merce, Bau et al. 
2006), it shows significant inter-cycle  (Elter, Sismanoglu et al. 2005) and intra- cycle 
variation. A significant inter-cycle variability has been reported for basal FSH (Scott, 
Hofmann et al. 1990) and an expected intra cycle variation as shown in previous chapter 
(chapter). Several studies have confirmed intra- and inter-cycle stability of AMH (La 
Marca, Malmusi et al. 2004; Fanchin, Taieb et al. 2005; Hehenkamp, Looman et al. 2006; 
La Marca, Stabile et al. 2006; Tsepelidis, Devreker et al. 2007; Elgindy, El-Haieg et al. 2008; 
van Disseldorp, Lambalk et al. 2010) Moreover, amongst all the endocrine markers of 
ovarian reserve, AMH is a very good predictor of ovarian response and pregnancy (La 
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Marca, Sighinolfi et al.; Broekmans, Kwee et al. 2006; Dehghani-Firouzabadi, Tayebi et al. 
2008; Verhagen, Hendriks et al. 2008; Maheshwari, Gibreel et al. 2009; Jayaprakasan, 
Campbell et al. 2010).  
It therefore appears that amongst all the ultrasound and endocrine markers of ovarian 
reserve, the small antral follicle  ?A? ? ? ?ŵŵ ?ƉŽƉƵůĂƚŝŽŶĂŶĚD,ĞŵĞƌŐĞĂƐƚŚĞŵĂƌŬĞƌƐŽĨ
choice followed by total antral follicle count (2.0-10.0mm). Bearing in mind the within and 
inter subject variations, it would appear that a longitudinal design of study wherein the 
operated ovary is compared to itself is a desirable method of assessing ovarian reserve 
following cystectomy.  
This study was designed to quantify the effect of ovarian cyst per se and that of 
laparoscopic ovarian cystectomy on the markers of ovarian reserve as measured using 
AMH, and 3D ultrasound assisted measures of small antral follicle count and total antral 
follicle count. The hypothesis was that ovarian cystectomy has a significant effect on the 
ovarian reserve. 
 
11.3 Methods 
 
Study design 
This was a quantitative prospective observation study designed to evaluate ovarian 
reserve in women with unilateral benign ovarian cyst pre operatively and then evaluate 
the effect of laparoscopic cystectomy on ovarian reserve post operatively at one, three, 
and 6 months. AMH, FSH, and 3D assisted software - SonoAVC that made semi-automated 
antral follicle counts were used to quantify ovarian reserve. A sample size of 30 was 
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required to power the study at 0.8 with a type I error of 0.05 and presumed maximum 
difference of 0.8 ng/mL in the mean values of AMH across 5 levels of analysis. 
Study participants were recruited prospectively through advertisements and posters 
displayed in Gynaecology out-patients department, patient toilets, staff canteens and 
notice boards. The main inclusion criteria were: age between 18 to 35 years, body mass 
index (BMI) between 18 and 28 kg/
 
m
2
, regular menstrual cycles with a mean length 
ranging between 26 to 35 days, presence of unilateral benign looking ovarian cyst on 
ultrasound scan, no history of ovarian surgery, no history suggestive of endocrine disease 
and no use of hormonal contraceptives in the last 6 months. On identification of suitable 
participant who met the above inclusion criteria, study information was explained by the 
investigators and information leaflet given to those who expressed interest in 
participation in the study. Subsequently, a consent form was signed and plan made for 
their future visits. A transvaginal ultrasound scan was performed and blood samples taken 
during each patient visit. First visit was arranged preoperatively in the early follicular 
phase of the menstrual cycle and involved performing an ultrasound scan and blood test. 
Subsequent visits were arranged at one month, 3 months, and 6 months following the 
laparoscopic ovarian cystectomy when a TVS was performed and blood test taken.  
Operative technique: 
Laparoscopic pneumoperitoneum was created with CO2, followed by insertion of a sub 
umbilical 10 mm port and two to three 5 mm lateral ports under direct laparoscopic 
observation. Monopolor scissors were used to open the ovarian cortex and identify the 
cyst wall. The cyst was subsequently enucleated from the ovarian cortex by blunt and 
sharp dissection. Every effort was made to excise the cyst in its entirety without spillage 
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of contents. Haemostasis was achieved using bipolar forceps. The cyst was removed in an 
endoscopic bag and sent for histopathological analysis. 
Outcome measures: 
Primary outcome measures were changes in the serum AMH and small antral 
follicle population following the ovarian cystectomy. This was done by comparing 
the post operative levels at 1, 3, and 6 months to the pre operative levels. 
Secondary outcome measures were total AFC and serum FSH levels. These primary 
and secondary measures of ovarian reserve were also applied to the different 
types of cyst on sub group analysis. 
Data acquisition  
The ultrasound scans were performed by a single investigator (S.D) using a Voluson E8 
Expert
 
(GE Medical Systems, Zipf, Austria) and a three-dimensional 5-9 MHz transvaginal 
transducer. The ultrasound assessment involved a two-dimensional (2D) ultrasound 
assessment of the pelvis to confirm the presence of ovarian cyst. Size of the cyst was 
measured by taking the average of three perpendicular diameters measured in 
longitudinal and transverse planes. A wide angle of 180
0
 was set to examine the ovary 
with the cyst in its entirety when required. The technique of volume ultrasound as 
explained in the chapter of methods included delineation of the ovary with application of 
a region of interest and the subsequent acquisition of a series of 2D planes acquired 
during a high quality slow sweep mode of the ultrasound beam set at a 120
0
 angle for the 
ovary with cyst and 90
0
 angle for the normal ovary and the operated ovary. This ensured 
that data from the whole ovary was acquired and also that the greatest number of 2D 
planes were acquired giving the highest degree of resolution when the 2D data are 
reconstructed as a 3D volume.  
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Data analysis  
Multiplanar view was used to display the acquired 3D data (Voluson E8 Expert: General 
Electric Medical Systems, Zipf, Austria). The grey-scale display of image was optimised and 
then rendered to generate a three-dimensional volume of interest (VOI). The render box 
was adjusted to exclude as much extra-ovarian information as possible and ensure that 
the whole ovary was included in the VOI. The threshold settings, which assign 
transparency associated with fluid to opaque voxels, were maintained for all datasets at a 
ĚĞĨĂƵůƚ ƐĞƚƚŝŶŐŽĨ  ‘ůŽǁ ? ? KŶĐĞ ƚŚe dataset had been correctly positioned, 3D automated 
ƐŽĨƚǁĂƌĞ ?  ‘ƐŽŶŽŐƌĂƉŚǇ-ďĂƐĞĚ ĂƵƚŽŵĂƚĞĚ ǀŽůƵŵĞĐŽƵŶƚ ?  ?ƐŽŶŽs P 'DĞĚŝĐĂů ^ǇƐƚĞŵƐ ?
was implemented (Raine-Fenning, Jayaprakasan et al. 2008). The use of sonoAVC with 
post-processing in counting and measuring the size of antral follicles has been described 
in detail in chapters 2 and 3 ?dŚĞŵĞĂŶ ‘ƌĞůĂǆĞĚƐƉŚĞƌĞĚŝĂŵĞƚĞƌ ? ?ĚŝƐƉůĂǇĞĚĂƐĚ ?s ? ?ŽĨ
each antral follicle in both ovaries was recorded and used for data analysis. The antral 
follicle population for each subject was recorded to the nearest millimetre, as this reflects 
the current resolution of the ultrasound system, starting from 2.0 mm up to a maximum 
of 10.0 mm.  
Hormonal Assays 
Within 30 minutes of collection of blood samples, they were centrifuged for 20 min at 4
o
C 
and 4000 rpm spin to separate the serum. The serum sample was frozen at -20°C and 
stored for subsequent analysis of anti-Müllerian hormone (AMH) and follicle stimulating 
hormone (FSH) MIS/AMH enzyme-linked immunosorbent assay kit (Diagnostic Systems 
Laboratories, Webster, Texas, USA) was used to measure the serum AMH levels. The 
lowest detection limit was 0.006 ng/mL and the intra and interassay coefficients of 
variation below 5% and 8% respectively.  
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Micro particle Enzyme Immunoassay (MEIA) method on an AxSYM auto-analyser (AxSYM;
 
Abbott Laboratories, Abbott Park, IL) was used to measure the levels of serum FSH. The 
lowest detection limit for FSH was 0.37 IU/L, with the intra- and interassay coefficients of 
variation were below 5% and above 5% respectively.  
Statistical analysis 
The Statistical Package for the Social Sciences (version 17.0; SPSS, Chicago, IL) was used 
for statistical analysis.  Descriptive statistics are displayed as mean ± SD with 95% CI or as 
median with range. The difference in pre operative and post operative means are also 
expressed in percentages. General linear model with repeated measures design was used 
to perform the analysis of variance. A P-value of less than 0.05 was considered statistically 
significant. In order to examine the effect of cyst on ovarian reserve paired samples t test 
was used to compare the difference in small antral follicles between the diseased and 
contra lateral normal ovary. 
 
11.4 Results 
11.4.1 Overall analysis of all cyst types 
The mean ± SD (95% CI) of the pre operative and post operative levels of serum AMH, 
&^, ?& ?ƐŽĨƚŚĞĚŝƐĞĂƐĞĚŽǀĂƌǇ ?ĐŽŶƚƌĂ-lateral normal ovary  and those of both ovaries 
are shown in Table 11.1. AMH and FSH levels showed a significant decline post-
operatively (P<0.05). A similar significant decline in antral follicle counts measuring 2.0-
10.0mm and 2.0-6.0mm was observed in the ovary that underwent cystectomy (P<0.05). 
dŚĞƐĞ ƚŽƚĂů ĂŶĚ ƐŵĂůů & ?Ɛ ? ŚŽǁĞǀĞƌ ƐŚŽǁĞĚ Ă ŶŽŶ-significant decline in the contra-
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lateral normal ovary (P>0.05). A non-significant decline was observed in the number of 
larger antral follicles measuring >6.0 mm in both, the diseased and contra-lateral normal 
ovaries. The decline in mean AFC including antral follicles measuring 2.0-10.0mm and 2.0-
6.0mm from both ovaries reflected the significant decline observed in the diseased ovary 
(P<0.05), the larger AFC (>6.0-10.0mm) however showed no significant change (P>0.05) 
(Table 11.1). 
Analysis of within-subject levels of follow up showed that total AFC and small AFC in the 
operated ovary continued to decline up until 3 months (P<0.05) post-operatively before 
stabilising at 6 months. Total AFC and small AFC of both ovaries significantly declined at 1 
month (P<0.05) before stabilising at 3 months (P>0.05. The contra lateral normal ovary 
does not appear to compensate as shown by the statistically in significant change in the 
AFC from pre operative to post operative levels in that ovary (Figure 11.1 and 11.2). 
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Table 11.1: Mean ± SD (95% CI) of cohorts of antral follicle counts stratified by size, AMH and FSH before and 
up to 6 months following ovarian cystectomy for benign disease. The table also compares the cohorts of total, 
small and large antral follicle counts in both, the normal and diseased ovary following ovarian cystectomy. 
 Pre operative 
N=38 
1 month 
N=38 
3 months 
N=37 
6 months 
N=34 
P value 
AMH ng/mL 2.71 ± 2.15 
(1.90  W 3.51) 
1.69 ± 1.96 
(1.45  W 2.93) 
2.09 ± 1.88 
(1.63  W 3.04) 
2.29 ± 2.03 
(1.73  W 3.25) 
0.001 
FSH IU/L 6.38 ± 2.13 
(5.58  W 7.17) 
7.72 ± 1.96 
(6.99  W 8.45) 
7.26 ± 2.61 
(6.28  W 8.23) 
7.17 ± 2.76 
(6.14  W 8.20) 
0.024 
Antral Follicle Counts of ovary with cyst  
2.0  ? 6.0 mm 
(n) 
10.33 ± 7.55 
(7.66  W 13.01) 
7.00 ± 6.99 
(4.52  W 9.48) 
7.73 ± 7.5 
(5.06  W 10.39) 
7.30 ± 7.05 
(4.80  W 9.80) 
<0.001 
>6.0  ? 10.0 mm 
(n) 
1.68 ± 1.05 
(1.29  W 2.06) 
1.23 ± 1.02 
(0.85  W 1.60) 
1.32 ± 0.75 
(1.05  W 1.60) 
1.55 ± 1.12 
(1.14  W 1.96) 
0.167 
2.0  ? 10.0 mm 
(n) 
12.03 ± 7.90 
(9.23  W 14.83) 
8.21 ± 7.37 
(5.60  W 10.83) 
9.03 ± 7.69 
(6.31  W 11.76) 
8.76 ± 7.83 
(5.98  W 11.54) 
<0.001 
Antral Follicle Counts of contra lateral normal ovary  
2.0  ? 6.0 mm (n) 11.56 ± 6.66 
(9.24  W 13.88) 
10.59 ± 5.05 
(8.83  W 12.35) 
10.56 ± 4.95 
(8.83  W 12.29) 
9.65 ± 6.48 
(7.39 - 11.91) 
0.062 
>6.0  ? 10.0 mm 
(n) 
1.90 ± 1.56 
(1.33  W 2.47) 
1.58 ± 1.26 
(1.12  W 2.04) 
1.77 ± 1.52 
(1.22  W 2.33) 
1.87 ± 1.02 
(1.49  W 2.25) 
0.464 
2.0  ? 10.0 mm 
(n) 
13.53 ± 7.34 
(10.97  W 16.09) 
12.15 ± 5.42 
(10.26  W 14.04) 
12.29 ± 5.57 
(10.35  W 14.24) 
11.35 ± 7.10 
(8.88  W 13.83) 
0.058 
Total Antral Follicle Counts of both ovaries  
2.0  ? 6.0 mm (n) 22.89 ± 13.46 
(17.45  W 26.84) 
17.14 ± 11.46 
(13.85  W 21.85) 
17.68 ± 10.99 
(14.66  W 22.34) 
16.95 ± 12.35 
(12.43  W 21.04) 
<0.001 
>6.0  ? 10.0 mm 
(n) 
3.58 ± 2.16 
(2.89  W 4.40) 
2.81 ± 1.58 
(2.18  W 3.29) 
3.09 ± 1.66 
(2.45  W 3.61) 
3.42 ± 1.93 
(2.44  W 3.79) 
0.071 
2.0  ? 10.0 mm 
(n) 
26.54 ± 15.04 
(20.70  W 30.89) 
19.93 ± 12.08 
(16.51  W 24.66) 
20.73 ± 12.72 
(17.53  W 25.53) 
20.20 ± 14.05 
(15.15  W 24.55) 
<0.001 
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Figure 11.1:  The variation in the mean (error bars of S.E.M) AFCs in the diseased and contra-lateral 
normal ovary as measured pre-operatively and 1, 3, and 6 months post-operatively. P value was 
derived using repeated measures analysis and are marked at levels of comparison showing 
significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
 
 
P<0.001 
P<0.001 
P=0.167 
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Figure 11.2: The variation in the mean (error bars of S.E.M) AFCs of both ovaries as measured pre-
operatively and 1, 3, and 6 months post-operatively. P value was derived using repeated measures 
analysis and are marked at levels of comparison showing significant change (*=P<0.05; **=P<0.01; 
***=P<0.001). 
 
 
Levels of serum AMH significantly dropped and that of FSH increased one month post 
operatively and stayed at those levels 3 and 6 months later. This suggests an immediate 
effect of cystectomy on ovarian reserve which persisted up to 6 months post operatively 
(Figure 11.3). 
26.54 
19.93*** 
20.73 
20.20 
22.89 
16.9
17.14*** 17.68 
3.58 
2.81* 3.09 3.42 
P<0.001 
P<0.001 
P=0.071 
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Figure 11.3: The variation in the mean (error bars of S.E.M) levels of serum AMH and FSH as 
measured pre-operatively and 1, 3, and 6 months post-operatively. P value was derived using 
repeated measures analysis and are marked at levels of comparison showing significant change 
(*=P<0.05; **=P<0.01; ***=P<0.001). 
 
 
The variation in the levels of AMH, FSH and antral follicle counts was further quantified 
with percent change in post operative levels when compared to pre operative levels. 
1.69*** 
2.09 
2.29 
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There was a significant drop in levels of AMH post operatively at 1 month, 3 months and 6 
months by 38%, 23% and 16% respectively. There was an increase in FSH by 21% at 1 
month, 14% at 3 months and 12% at 6 months noted but not statistically significant. The 
number of small antral follicles in the operated ovary showed a significant drop by 42% at 
1 month, 37% at 3 months and 35 % at 6 months. Total number of antral follicles in the 
operated ovary reduced significantly by 40% at 1 month, 35% at 3 months and 32% at 6 
months. Since the contra lateral normal ovary was not affected by the cystectomy, the 
reduction in total AFC (antral follicles of both ovaries) showed a lesser but significant drop 
by 25% at 1 month, 22% at 3 months and 24% at 6 months. 
Pre operative AMH levels showed higher correlation with total AFC including antral 
follicles in both ovaries (2.0-6.0mm: 0.884, 2.0-10.0mm: 0.841) than with the AFC in the 
ovary with the cyst alone (2.0-6.0mm: 0.742, 2.0-10.0mm: 0.742). One month postop, 
correlation between AMH and tAFC (2.0-6.0mm: 0.862, 2.0-10.0mm: 0.848) were better 
than with operated ovary (2.0-6.0mm: 0.697, 2.0-10.0mm: 0.777). A similar trend was 
noted 3 months post op (with tAFC 2.0-6.0mm and 2.0-10.0mm: 0.873 and 0.857; with 
AFC of operated ovary: 0.721 and 0.645) and 6 months postop (with tAFC 2.0-6.0mm and 
2.0-10.0mm: 0.870 and 0.825; with AFC of operated ovary: 0.761 and 0.620).  
 
11.4.2 Sub group analysis by type of cysts 
Three types of benign cysts were identified histologically, 18 dermoid cysts, 15 
endometriomas, and 5 functional cysts. The average size of dermoid cysts was 72.28 mm, 
that of endometrioma was 62.34 mm and that of simple cyst was 52.45 mm.  
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11.4.2a Dermoid cyst 
The mean ± SD (95% CI) of the pre operative and post operative levels of serum AMH, 
&^, ?& ?ƐŽĨƚŚĞĚŝƐĞĂƐĞĚŽǀĂƌǇ ?ĐŽŶƚƌĂ-lateral normal ovary  and those of both ovaries 
are shown in Table 11.2. AMH levels showed a significant decline post-operatively 
(P<0.05), however the change in FSH levels remained non-significant overall (P>0.05).  A 
significant decline in antral follicle counts measuring 2.0-10.0mm and 2.0-6.0mm was 
ŽďƐĞƌǀĞĚŝŶƚŚĞŽǀĂƌǇƚŚĂƚƵŶĚĞƌǁĞŶƚĐǇƐƚĞĐƚŽŵǇ ?WAM ? ? ? ? ? ?dŚĞƐĞƚŽƚĂůĂŶĚƐŵĂůů& ?Ɛ ?
however showed a non-significant decline in the contra-lateral normal ovary (P>0.05). A 
non-significant decline was observed in the number of larger antral follicles measuring 
>6.0 mm in both, the diseased and contra-lateral normal ovaries. The decline in mean AFC 
including antral follicles measuring 2.0-10.0mm and 2.0-6.0mm from both ovaries 
reflected the significant decline observed in the diseased ovary (P<0.05), the larger AFC 
(>6.0-10.0mm) however showed no significant change (P>0.05) (Table 11.2). 
Analysis of within-subject levels of follow up showed that total AFC and small AFC in the 
operated ovary continued to decline up until 3 months (P<0.05) post-operatively before 
stabilising at 6 months. Total AFC and small AFC of both ovaries significantly declined at 1 
month (P<0.05) before stabilising at 3 months (P>0.05). The contra lateral normal ovary 
does not appear to compensate as shown by the statistically in significant change in the 
AFC from pre- to post operative levels in that ovary (Figure 11.4).  
Levels of serum AMH significantly dropped on the visit at one month post operatively 
(P<0.05), stabilising at 3 months visit but showing a significant recovery at 6 months visit 
post-operatively (P<0.05).  FSH levels significantly increased on the visit at one month 
post operatively (P<0.05) and then stabilising thereafter (Figure 11.5). 
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Table 11.2: Mean ± SD (95% CI) of cohorts of antral follicle counts stratified by size, AMH and FSH 
before and up to 6 months following ovarian cystectomy for dermoid cyst.  
 
Pre operative 
N=18 
1 month 
N=18 
3 months 
N=17 
6 months 
N=16 
P value 
AMH ng/mL 2.84 ± 2.46 
(1.57  W 4.11) 
2.27 ± 2.46 
(1.10  W 3.64) 
2.15 ± 2.25 
(1.39  W 3.71) 
2.22 ± 2.44 
(1.63  W 4.14) 
0.002 
FSH IU/L 6.40 ± 2.11 
(5.32  W 7.49) 
8.18 ± 1.47 
(7.43  W 8.94) 
7.99 ± 1.83 
(7.06  W 8.94) 
7.53 ± 2.59 
(6.19  W 8.86) 
0.021 
Antral Follicle Counts of ovary with cyst  
2.0  ? 6.0 mm 
(n) 
11.50 ± 9.36 
(6.84  W 16.16) 
8.22 ± 8.71 
(3.89  W 12.56) 
9.22 ± 9.29 
(4.60  W 13.84) 
8.56 ± 8.69 
(4.24  W 12.88) 
<0.001 
>6.0  ? 10.0 mm 
(n) 
2.00 ± 0.79 
(1.59  W 2.41) 
1.06 ± 0.66 
(0.72  W 1.39) 
1.53 ± 0.79 
(1.12  W 1.94) 
1.65 ± 1.11 
(1.07  W 2.22) 
0.077 
2.0  ? 10.0 mm 
(n) 
13.39 ± 9.60 
(8.61  W 18.17) 
9.22 ± 9.01 
(4.74  W 13.70) 
10.67 ± 9.48 
(5.95  W 15.38) 
10.11 ± 9.39 
(5.44  W 14.79) 
<0.001 
Antral Follicle Counts of contra lateral normal ovary  
2.0  ? 6.0 mm 
(n) 
12.89 ± 8.15 
(8.97  W 16.82) 
11.79 ± 6.05 
(8.87  W 14.71) 
10.42 ± 5.73 
(7.66  W 13.18) 
9.84 ± 7.57 
(6.19  W 13.49) 
0.065 
>6.0  ? 10.0 mm 
(n) 
2.12 ± 1.62 
(1.28  W 2.95) 
1.53 ± 1.18 
(0.92  W 2.14) 
1.71 ± 1.57 
(0.89  W 2.51) 
1.65 ± 1.17 
(1.05  W 2.25) 
0.693 
2.0  ? 10.0 mm 
(n) 
15.05 ± 8.92 
(10.76  W 19.35) 
13.26 ± 6.36 
(10.19  W 16.33) 
12.11 ± 6.19 
(9.12  W 15.09) 
11.32 ± 8.24 
(7.34  W 15.29) 
0.099 
Total Antral Follicle Counts of both ovaries  
2.0  ? 6.0 mm 
(n) 
24.79 ± 16.62 
(16.78  W 32.79) 
20.42 ± 14.04 
(13.65  W 27.19) 
19.95 ± 13.48 
(13.45  W 26.44) 
17.95 ± 14.93 
(10.75  W 25.14) 
0.002 
>6.0  ? 10.0 mm 
(n) 
4.00 ± 1.79 
(3.13  W 4.86) 
2.42 ± 1.02 
(1.93  W 2.91) 
3.11 ± 1.49 
(2.39  W 3.82) 
2.95 ± 2.04 
(1.96  W 3.93) 
0.078 
2.0  ? 10.0 mm 
(n) 
28.79 ± 17.85 
(20.19  W 37.39) 
22.84 ± 14.08 
(16.06  W 29.63) 
23.05 ± 13.67 
(16.47  W 29.64) 
20.89 ± 15.97 
(13.19  W 28.59) 
0.001 
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 11.4.2b Endometrioma 
The mean ± SD (95% CI) of the pre operative and post operative levels of serum AMH, 
&^, ?& ?ƐŽĨƚŚĞĚŝƐĞĂƐĞĚŽǀĂƌǇ ?ĐŽŶƚƌĂ-lateral normal ovary  and those of both ovaries 
are shown in Table 11.3. AMH levels showed a significant decline post-operatively 
(P<0.05), however the change in FSH levels remained non-significant overall (P>0.05).  A 
significant decline in antral follicle counts measuring 2.0-10.0mm and 2.0-6.0mm was 
observed in the ovary that underwent cystectomy (P<0.05). Unlike the dermoid cysts, the 
small AFC measuring 2.0-6.0mm in the contra-lateral normal ovary showed a significant 
overall variation (P<0.05), however the total AFC (2.0-10.0mm) remained non-significant 
(P>0.05). A non-significant decline was observed in the number of larger antral follicles 
measuring >6.0 mm in both, the diseased and contra-lateral normal ovaries. The decline 
in mean AFC including antral follicles measuring 2.0-10.0mm and 2.0-6.0mm from both 
ovaries reflected the significant decline observed in the diseased ovary (P<0.05), the 
larger AFC (>6.0-10.0mm) however showed no significant change (P>0.05) (Table 11.3). 
Analysis of within-subject levels of follow up showed that total AFC and small AFC in the 
operated ovary continued to decline up until 3 months (P<0.05) post-operatively before 
stabilising at 6 months. Total AFC and small AFC of both ovaries significantly declined up 
until 3 months (P<0.05) before stabilising at 6 months (P>0.05). The overall significant 
variation seen in the contra lateral normal ovary was perhaps due to a compensatory 
increase in the small and total AFC at 3 months post-operatively (P<0.05) (Figure 11.4).  
AMH levels significantly declined up until 3 months post operatively (P<0.05), whilst FSH 
levels stabilised from 0ne month post-operatively (Figure 11.5). 
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Table 11.3: Mean ± SD (95% CI) of cohorts of antral follicle counts stratified by size, AMH and FSH 
before and up to 6 months following ovarian cystectomy for endometrioma.  
 
Pre operative 
N=15 
1 month 
N=15 
3 months 
N=15 
6 months 
N=14 
P value 
AMH ng/mL 2.72 ± 1.96 
(1.09  W 4.36) 
1.58 ± 1.42 
(0.39  W 2.76) 
1.78 ± 1.56 
( 0.48  W 3.08) 
1.71 ± 1.47 
(0.48  W 2.94) 
0.015 
FSH IU/L 7.58 ± 2.16 
(5.78  W 9.39) 
9.53 ± 1.99 
(7.87  W 11.19) 
9.29 ± 1.09 
(8.38  W 10.21) 
9.19 ± 1.47 
(7.96  W 10.42) 
0.134 
Antral Follicle Counts of ovary with cyst  
2.0  ? 6.0 mm 
(n) 
9.50 ± 3.07 
(6.93  W 12.09) 
4.50 ± 1.93 
(2.89  W 6.11) 
5.38 ± 2.07 
(3.65  W 7.10) 
5.38 ± 2.45 
(3.33  W 7. 
0.002 
>6.0  ? 10.0 mm 
(n) 
1.75 ± 1.58 
(0.43  W 3.07) 
1.72 ± 0.89 
(1.01  W 2.49) 
1.38 ± 0.52 
(0.94  W 1.81) 
1.38 ± 0.74 
(0.75  W 1.99) 
0.769 
2.0  ? 10.0 mm 
(n) 
11.25 ± 3.11 
(8.65  W 13.85) 
6.25 ± 2.38 
(4.26  W 8.24) 
6.75 ± 2.12 
(4.98  W 8.52) 
7.13 ± 2.53 
(5.01  W 9.24) 
<0.001 
Antral Follicle Counts of contra lateral normal ovary  
2.0  ? 6.0 mm 
(n) 
10.50 ± 5.04 
(6.28  W 14.72) 
9.00 ± 3.59 
(6.01  W 11.99) 
12.25 ± 4.23 
(8.71  W 15.79) 
10.88 ± 5.06 
(6.65  W 15.10) 
0.007 
>6.0  ? 10.0 mm 
(n) 
2.38 ± 1.77 
(0.89  W 3.85) 
2.13 ± 1.73 
(0.68  W 3.57) 
2.13 ± 1.55 
(0.83  W 3.42) 
2.13 ± 0.64 
(1.59  W 2.66) 
0.068 
2.0  ? 10.0 mm 
(n) 
12.88 ± 5.46 
(8.31  W 17.44) 
11.13 ± 4.76 
(7.14  W 15.11) 
14.37 ± 5.24 
(9.99  W 18.75) 
13.00 ± 5.24 
(8.62  W 17.38) 
0.029 
Total Antral Follicle Counts of both ovaries  
2.0  ? 6.0 mm 
(n) 
20.00 ± 7.69 
(13.57  W 26.43) 
13.50 ± 5.37 
(9.01  W 17.99) 
17.63 ± 6.25 
(12.39  W 22.85) 
16.87 ± 6.17 
(11.71  W 22.03) 
0.034 
>6.0  ? 10.0 mm 
(n) 
4.12 ± 3.14 
(1.50  W 6.75) 
3.87 ± 2.17 
(2.06  W 5.69) 
3.50 ± 1.85 
(1.95  W 5.05) 
3.50 ± 1.19 
(2.50  W 4.49) 
0.639 
2.0  ? 10.0 mm 
(n) 
24.13 ± 8.37 
(17.12  W 31.13 
17.38 ± 6.95 
(11.57  W 23.18) 
21.13 ± 7.24 
(15.07  W 27.17) 
20.38 ± 6.84 
(14.65  W 26.09) 
0.005 
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Figure 11.4: The variation in the mean (error bars of S.E.M) levels of serum AMH and FSH in 
different types of ovarian cysts as measured pre-operatively and 1, 3, and 6 months post-
operatively. P value was derived using repeated measures analysis and are marked at levels of 
comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
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Figure 11.5: The variation in the mean (error bars of S.E.M) of small AFCs in the diseased and 
contra-lateral normal ovary with different type of cyst as measured pre-operatively and 1, 3, and 6 
months post-operatively. P value was derived using repeated measures analysis and are marked at 
levels of comparison showing significant change (*=P<0.05; **=P<0.01; ***=P<0.001). 
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11.4.2c Simple cyst 
Repeated measures analysis of variance showed that none of the markers of ovarian 
reserve in women operated for simple ovarian cyst showed any significant change post 
operatively (P>0.05) (Table 11.4 and Figures 11.4 and 11.5).   
Table 11.4: Mean ± SD (95% CI) of cohorts of antral follicle counts stratified by size, AMH and FSH 
before and up to 6 months following ovarian cystectomy for simple cyst. The table also compares 
the cohorts of total, small and large antral follicle counts in both, the normal and diseased ovary 
following ovarian cystectomy. 
 Pre operative 
N=5 
1 month 
N=5 
3 months 
N=5 
6 months 
N=4 
P value 
AMH ng/mL 1.91 ± 0.98 
(0.66  W 3.16) 
1.91 ± 1.21 
(1.08  W 2.74) 
1.87 ± 1.11 
(0.82  W 2.92) 
1.81 ± 0.88 
(0.80  W 2.82) 
0.156 
FSH IU/L 5.17 ± 2.22 
(4.10  W 6.23) 
5.25 ± 3.32 
(4.31  W 6.18) 
3.72 ± 2.38 
(2.14  W 5.30) 
4.34 ± 2.12 
(3.09  W 5.58) 
0.272 
Antral Follicle Counts of ovary with cyst  
2.0  ? 6.0 mm 
(n) 
8.28 ± 4.22 
(0.15  W 2.13) 
6.71 ± 4.14 
(0.41  W 2.70) 
6.57 ± 5.12 
(0.22  W 1.50) 
6.43 ± 4.88 
(0.03  W 2.83) 
0.245 
2.0  ? 10.0 mm 
(n) 
9.43 ± 7.65 
(3.14  W 15.72) 
7.86 ± 5.55 
(1.69  W 14.03) 
7.43 ± 5.87 
(1.78  W 13.08) 
7.86 ± 4.55 
(1.37  W 14.34) 
0.095 
Antral Follicle Counts of contra lateral normal ovary  
2.0  ? 6.0 mm 
(n) 
9.14 ± 5.15 
(8.15  W 10.13) 
9.14 ± 6.05 
(7.11  W 11.17) 
9.00 ± 4.73 
(6.28  W 11.72) 
8.86 ± 7.57 
(5.77  W 11.94) 
0.324 
2.0  ? 10.0 mm 
(n) 
10.14 ± 7.92 
(8.89  W 11.39) 
10.29 ± 6.36 
(8.38  W 12.19) 
10.43 ± 6.19 
(7.06  W 13.80) 
10.86 ± 7.24 
(7.07  W 14.65) 
0.123 
Total Antral Follicle Counts of both ovaries  
2.0  ? 6.0 mm 
(n) 
17.43 ± 8.97 
(11.25  W 23.61) 
15.86 ± 8.08 
(9.58  W 22.14) 
15.57 ± 9.19 
(8.57  W 22.57) 
15.29 ± 8.18 
(7.41  W 23.16) 
0.256 
2.0  ? 10.0 mm 
(n) 
19.57 ± 8.88 
(12.59  W 26.55) 
18.14 ± 7.26 
(10.81  W 25.47) 
17.86 ± 9.18 
(9.69 -26.03) 
18.71 ± 9.67 
(9.09  W 28.34) 
0.145 
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11.5 Discussion 
 
This is the first study that has evaluated the effects of ovarian cyst and cystectomy on 
ovarian reserve using AMH and a 3D ultrasound assisted novel technique of measuring 
and counting antral follicles (sonoAVC), thereby enabling the use of small antral follicles in 
the measurement of ovarian reserve in a reliable and reproducible manner. The results 
suggest that laparoscopic ovarian cystectomy for a benign cyst is associated with a 
significant loss of ovarian reserve lasting up to at least 6 months post operatively. 
Expectedly, the damage caused is more in the ovary that is operated upon than the other 
normal ovary. The results also suggest that the damage caused by the stripping of 
endometrioma might be more pronounced than the damage caused by stripping of 
dermoid cyst. 
11.5.1 Effect of ovarian cyst per se on the ovarian reserve 
 
This is the first study that has quantified the effect of cyst on the ovary using 3D 
ultrasound. We found that there was no significant difference in the small and total antral 
follicle counts in the ovary with the cyst when compared to the contra lateral normal 
ovary. The limitation of such a comparison is that there are inherent physiological 
differences between the two ovaries within the same individual as shown in chapter 7. 
However, since the small antral follicles measuring up to 6.0 mm show minimal inter-
ovarian variation, and that it has very good correlation with AMH (Jayaprakasan, Deb et 
al. 2009), we would have to conclude that the cyst per se does not affect the ovarian 
reserve as measured by small antral follicle count made by using 3D assisted semi-
automated technique (sonoAVC). On sub group analysis of the type of cysts, we found 
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that there was a significant reduction (P=0.042) in the number of small antral follicles in 
the ovary with endometrioma, but not in the ovary with non-endometriomas when 
compared to their contra lateral normal ovary. These findings are supported by the 
histopathology study done by Maneschi et al where they showed that the presence of 
cyst itself may affect the adjacent normal ovarian tissue (Maneschi, Marasa et al. 1993). 
They examined three types of benign cysts, 13 mature teratomas, 32 endometriomas and 
9 cyst adenomas. The group showed that the ovarian cortex which is stretched and 
thinned by the growth of benign tumour is not altered morphologically in the presence of 
teratomas and benign cyst adenomas, however with endometriomas, there was presence 
of microscopic implants in the stroma and that the follicular number and activity was 
significantly reduced. Recently, Roman et al reported that the size of the endometrioma is 
directly related to the proportional increase in the damage to normal ovarian parenchyma 
at cystectomy (Roman, Tarta et al. 2010). Based on these findings, we could hypothesise 
that increase in the size of endometrioma could directly have an effect on the adjacent 
normal ovarian tissue and ovarian reserve thereby. However, to be able to make such 
assumptions, future trials are warranted where small antral follicle counts could be used 
to examine the effect of cyst when comparing to contra lateral normal ovary; and where 
oophorectomy is required, no opportunity is lost in examining the adjacent ovarian 
parenchyma histologically. 
We still retain the comment made in a recent review article that there is insufficient data 
to suggest whether endometrioma related damage to ovarian reserve precedes or follows 
surgery (Garcia-Velasco and Somigliana 2009). We believe that perhaps the damage to 
ovarian reserve is two-fold with endometriotic cyst, one caused by the presence of cyst 
per se as shown in this study and supported by some histological data, and the other 
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related to cystectomy. Unless histology available, perhaps the best tool to assess ovarian 
reserve in these women would be to use the small antral follicle count and compare it to 
the contra lateral normal ovary. 
 
11.5.2  Ovarian cystectomy and damage assessed histologically 
Few studies have quantified histologically the amount of normal ovarian tissue removed 
at the time of cystectomy. It would be reasonable to presume that this would have an 
impact on the quantitative ovarian reserve; however whether it has an impact on the 
qualiƚĂƚŝǀĞĂƐƉĞĐƚŽĨĂǁŽŵĂŶ ?ƐůŝĨĞŝŶƚĞƌŵƐŽĨƉƌĞŐŶĂŶĐǇĂŶĚƉƌĞŵĂƚƵƌĞŵĞŶŽƉĂƵƐĞŝƐ
uncertain.  
Muzii et al examined 42 benign cysts removed laparoscopically by the stripping technique, 
of which 26 were endometriomas, 6 dermoids, 7 serous and 3 mucinous cystadenomas. 
They showed that in 36% of the cysts, normal ovarian tissue is excised together with the 
cyst wall. On sub group analysis, this was more pronounced with endometriomas than 
with non-endometriomas (54% vs. 6%) (Muzii, Bianchi et al. 2002). These results are 
comparable to our study. There was a 52% reduction noted in the small antral follicle 
count in the ovary that was operated upon for an endometrioma. These findings may 
further emphasise the reliability of using small antral follicle count as a marker of ovarian 
reserve when evaluating ovarian cysts. Muzii et al later evaluated the laparoscopic 
technique of stripping endometriotic ovarian cyst and the associated inadvertent removal 
of normal ovarian tissue. 48 women were randomised to two consecutive independent 
randomised trials. One trial evaluated the technique of circular excision and subsequent 
stripping versus immediate stripping at the initial adhesion site. The other trial evaluated 
the technique of stripping versus coagulating and cutting at the ovarian hilus. They 
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concluded that ovarian tissue is inadvertently excised along with the endometrioma in 
most cases irrespective of the technique used, although the excised tissue is at normal 
functional developmental stage (primary and secondary follicles) only at the hilus and the 
rest of the tissue contained primordial follicles alone. (Muzii, Bellati et al. 2005). 
Hachisuga et al histologically examined 72 women that underwent laparoscopic 
cystectomy for ovarian endometrioma. They divided them into two groups, one where 
the cyst was easily stripped and the other where stripping of the cyst was difficult. They 
found that easy stripping of the cyst was associated with more loss of follicles and ovarian 
stroma. (Hachisuga and Kawarabayashi 2002). Roman et al in their recent study 
demonstrated that adjacent ovarian parenchyma was present in 97% of cysts removed 
and that the thickness of ovarian tissue removed increases proportionally with cyst 
diameter (Roman, Tarta et al.; Roman, Tarta et al. 2010). There is also a possibility that 
with endometriotic cysts more amount of normal ovarian tissue is inadvertently removed 
due to the difficulty in stripping the cyst leading to bleeding and extensive use of bipolar 
diathermy as compared to non-endometriotic cysts (Exacoustos, Zupi et al. 2004). 
The results from our study and those reported in the studies above confirm that there is a 
significant loss of normal ovarian parenchyma when stripping the ovarian cysts, more so 
in the hilar area and that the small antral follicle count correlates with the loss of ovarian 
tissue quantified histologically when removing endometriomas. 
 
11.5.3  Ovarian cystectomy and clinical data on ovarian reserve 
The technique of cystectomy used in our study has been described in the past and is a 
method commonly used. Laparoscopic cystectomy has been shown to have many 
advantages over conventional laparotomy and suturing of the ovary following removal of 
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cyst, including lesser recurrence, reduced morbidity, shorter hospital stay, fewer 
adhesions, and faster recovery (Yuen, Yu et al. 1997; Saleh and Tulandi 1999; Alborzi, 
Zarei et al. 2006). In comparison with traditional surgery by laparotomy and suturing of 
ovarian cortex, laparoscopic cystectomy is currently considered the treatment of choice 
for benign ovarian cysts (Chapron, Fauconnier et al. 2002; Chapron, Vercellini et al. 2002; 
Alborzi, Zarei et al. 2006). There are largely two ways of dealing with an ovarian cyst of 
endometriotic origin. One method is to strip the cyst from normal ovarian parenchyma 
and the other method is to drain the cyst and coagulate the endometrial lining of the cyst. 
The main outcome measure following the treatment of cyst is a reduction in the 
symptoms of pain and reduction in the incidence of recurrence (Saleh and Tulandi 1999). 
According to the recently published Cochrane review (Hart, Hickey et al. 2008), only three 
randomized controlled trials have been conducted comparing cystectomy to drainage 
with ablation by electrosurgery (Beretta, Franchi et al. 1998; Alborzi, Momtahan et al. 
2004; Alborzi, Ravanbakhsh et al. 2007). Beretta et al randomised 64 patients to either 
have a cystectomy or drainage with ablation of endometrial lining, and evaluated the 
outcome measures of pain and pregnancy rate. They found a statistically significant 
favourable outcome in women who underwent cystectomy (Beretta, Franchi et al. 1998). 
Another RCT randomised 100 sub fertile patients to the above two techniques and found 
lower recurrence rate, lesser pain and better cumulative pregnancy rates with cystectomy 
than drainage and coagulation (Alborzi, Momtahan et al. 2004). One trial comparing the 
two techniques showed that there was no difference noted in the ovarian response to 
controlled ovarian stimulation (Alborzi, Ravanbakhsh et al. 2007). These findings suggest 
that it would be appropriate to consider the technique of cystectomy when outcomes of 
pain relief and recurrence were considered. Few cohort studies have shown favourable 
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outcome following ablation of endometrial capsule but they used laser to coagulate the 
capsule (Bellina, Fick et al. 1984; Bellina, Voros et al. 1984; Donnez 1987; Sutton and Jones 
2002; Azem, Hasson et al. 2009) 
One prospective study of 191 women comparing bipolar coagulation, coagulation with 
ultrasonic harmonic scalpel and suturing of the ovarian cortex (Li, Liu et al. 2009) showed 
that electrocoagulation causes damage to healthy ovarian parenchyma leading to reduced 
ovarian reserve as measured using FSH, AFC (3-10mm) and blood flow. One study looking 
at the effect of bilateral cystectomy with and without electrocoagulation for 
endometrioma showed that bilateral stripping of the endometrioma  decreased the 
ovarian reserve as measured by FSH and AFC and that it was even more with electro 
coagulation (Zhang, Zhou et al. 2009). These studies suggest a detrimental effect of 
electro coagulation on ovarian reserve as measured using FSH, AFC and blood flow 
indices, however these markers especially FSH and blood flow indices show a significant 
within and inter-subject variation. Moreover, they are less reliable tests of ovarian reserve 
(Broekmans, Kwee et al. 2006).  
The introduction of CO2 laser in the laparoscopic management of endometriomas has 
been well established as an alternative, safe, and effective modality (Bellina, Fick et al. 
1984; Bellina, Voros et al. 1984; Donnez 1987; Sutton and Jones 2002; Azem, Hasson et al. 
2009). It is claimed to provide precise tissue dissection and ablation, controlled 
penetration, and tissue thermal damage. These advantages justify the reason why lasers 
may be potentially more tissue sparing than other sources of energy. Another study 
confirmed that destruction of the filmy superficial internal lining of endometriomas was a 
safe and effective approach for the treatment of endometriotic cysts without sacrificing 
the adjacent healthy ovarian cortex (Brosens, Van Ballaer et al. 1996). Donnez et al 
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published a large series of 814 women with endometriomas treated with a three step 
procedure (drainage followed by GnRh analogues followed by laser ablation) and showed 
a postoperative cumulative PR of 51% and the recurrence rate of 8% for a follow-up of 2 W
11 years (Donnez, Nisolle et al. 1996). Few studies have questioned laparoscopic stripping 
as an ideal surgical approach for endometriomas because it is associated with excessive 
removal of ovarian tissue and loss of ovarian follicles with subsequent reduction of 
ovarian reserve (Candiani, Barbieri et al. 2005; Busacca, Riparini et al. 2006; Busacca and 
Vignali 2009). A recent study by Donnez et al showed that stripping a large part of the cyst 
wall and coagulating the remaining 10-20% of cyst around the hilus with Co2 laser was not 
deleterious to the ovary. Normal ovarian tissue adjacent to cyst was found in only 2% of 
cases with a recurrence of small endometrioma in 2% (Donnez, Lousse et al. 2010). 
However, they used ovarian volume and AFC (2-10mm) as markers of ovarian reserve and 
compared it to that of the contra lateral normal ovary. Both these markers show 
significant inter ovarian variation as shown in chapter 7. Two recent studies have 
compared the three step procedure to cystectomy, showing a lesser damage to ovarian 
reserve as measured with AMH and AFC (2-9mm) in the 3 step procedure (Pados, 
Tsolakidis et al. 2010; Tsolakidis, Pados et al. 2010). The results from these two trials 
suggest that CO2 laser may cause lesser damage to ovarian reserve than bipolar 
electrocoagulation and also that 3 stage procedure might have a favourable impact on 
ovarian reserve. However, it means the patient will require two operative laparoscopies 
and an interim 3 months of GnRh analogues, the risks of which would have to be balanced 
against the advantages of the procedure. Also, as shown in the previous chapters, the use 
of small antral follicles in assessment of ovarian reserve may be ideal in combination with 
AMH in future trials. 
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11.5.4  Ovarian cystectomy and subfertility 
In sub fertile women undergoing ART, it is unclear whether removal of cyst improves the 
fertilisation and pregnancy rates; however it is shown that the ovarian response is 
reduced as evident by the increase in gonadotophins used, reduction in the number of 
follicles stimulated and the number of oocytes collected. Some believe that the presence 
of an endometrioma may affect the quality of oocytes collected, but a RCT has shown no 
difference in fertilisation, pregnancy and implantation rates between surgery versus 
conservative management of cysts (Demirol, Guven et al. 2006). Several studies have 
associated ovarian cystectomy with impaired ovarian reserve (Loh, Tan et al. 1999; 
Somigliana, Ragni et al. 2003; Candiani, Barbieri et al. 2005; Godinjak, Idrizbegovic et al. 
2005; Somigliana, Ragni et al. 2006) and ovarian response following assisted reproduction 
treatment (ART) (Loo, Lin et al. 2005; Ragni, Somigliana et al. 2005; Demirol, Guven et al. 
2006; Esinler, Bozdag et al. 2006; Yazbeck, Madelenat et al. 2006; Kahyaoglu, Ertas et al. 
2008; Somigliana, Arnoldi et al. 2008).  However, recent meta-analysis (Tsoumpou, 
Kyrgiou et al. 2009) of studies comparing surgical treatment with no treatment of 
endometrioma before IVF showed no significant difference in ovarian response and 
pregnancy rates. 
The results from our study confirm the damage caused to ovarian reserve following 
cystectomy when using the technique of stripping the cyst from normal ovarian 
parenchyma. However, they cannot be directly compared to majority of the studies in the 
literature as comparisons are made with either the contra lateral ovary or a matched 
control. Only a few studies have used a longitudinal design where the ovarian reserve is 
compared pre and post operatively (Li, Liu et al. 2009; Chang, Han et al. 2010; Pados, 
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Tsolakidis et al. 2010; Tsolakidis, Pados et al. 2010; Iwase, Hirokawa et al. 2011). Chang et 
al evaluated ovarian reserve with AMH and ovarian volume measured using 3D ultrasound 
in 20 women who had undergone cystectomy (13 endometrioma, 6 dermoid and 1 cyst 
adenoma). They assessed women up to 3 months showing that the reserve reduced 
immediately post op (1 week) but restored to 65% at 3 months (Chang, Han et al. 2010). 
Our results are comparable to the immediate post operative drop but in our series we 
found that the effect persisted up to at least 6 months and that with endometrioma there 
was no significant recovery in ovarian reserve noted. This might be due to the use of AFC 
especially the small AFC and also that our sample size was larger than this study. Iwase et 
al assessed ovarian reserve in 51 patients (29 endometrioma and 21 non-endometrioma) 
using AMH and FSH. They examined women pre and one month post operatively. They 
found that AMH levels significantly reduced in all cysts but was more with endometrioma. 
Although these results are comparable to our study, we believe that our study is superior 
with regards to a longer follow up of 6 months and that small antral follicle counts were 
used in the assessment of ovarian reserve.  
 
11.6 Conclusions 
 
In conclusion, laparoscopic ovarian cystectomy is associated with a significant loss of 
ovarian reserve measured using AMH, and small antral follicle counts, the effect lasting at 
least up to 6 months. Endometrioma itself significantly affects the ovarian reserve of the 
diseased ovary and that removal of endometrioma might cause more damage to ovarian 
reserve than the non-endometriotic cysts.  Counting of antral follicles enables assessment 
of ovarian reserve in individual ovary and therefore provides more accurate assessment of 
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the damage caused to the operated ovary which otherwise could only be quantified using 
histological data.  Small antral follicles measuring 2.0-6.0 mm provide more reliable, 
accurate and comparable assessment of ovarian reserve. The longitudinal prospective 
nature of the study enables assessment of ovaries pre and post operatively which we 
believe is a more reliable method of assessing ovarian reserve following cystectomy. 
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CHAPTER 12: General Discussion 
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In this thesis, I have examined the ultrasound and endocrine markers of ovarian reserve in 
order to establish an optimum method of evaluating the effect of ovarian cystectomy on 
ovarian reserve. In this process, I studied a semi-automated 3D ultrasound assisted 
method, SonoAVC to measure the size and number of antral follicles and found that it 
made more reliable measures than other methods of measuring antral follicles, thereby 
defining a reliable and valid method of measuring small antral follicles. I then studied the 
physiological variation in these small antral follicles and also in other markers of ovarian 
reserve.  Since the small antral follicle population showed the least variation, I used it as a 
marker of ovarian reserve along with AMH in the evaluation of ovarian cysts and 
cystectomy. I also examined the effect of COCP on the markers of ovarian reserve as the 
study population that I planned to study might wish to use them for contraception during 
the study period. 
 
12.1 Summary of Research Findings 
I have shown that the intra-observer and inter-observer reliability of antral follicles made 
using SonoAVC was better than measurements made using the 3D multiplanar view or the 
2D real time equivalent technique but only after post processing had been applied. 
Furthermore, measurement of the size of antral follicles was quicker and reliable with 
sonoAVC than with 2D ultrasound. In vitro validation study using bovine ovaries confirmed 
more agreement with sonoAVC than with 2D ultrasound. I further showed that the small 
antral follicle count as measured using sonoAVC was an independent significant predictor 
of pregnancy following in vitro fertilization. Having confirmed the reliability and validity of 
small antral follicle counts, I showed that there was minimal inter-ovarian, intra-cycle and 
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inter cycle variation in these follicles. I also went on to show that combined oral 
contraceptive pills did not affect the small antral follicle count and serum AMH levels. 
Finally, but not the least, I have shown that the benign ovarian cyst, especially 
endometriotic cyst and laparoscopic ovarian cystectomy of endometriotic and dermoid 
cyst using the stripping technique cause damage to the ovarian reserve as measured using 
AMH and small antral follicle count.    
 
I began my research by examining the reliability of automated antral follicle counts made 
using 3D ultrasound. Sonography based automated volume counts is new software that 
can only be applied on data acquired using 3D ultrasound. Here, I found that the AFC 
calculated by the software in its complete automated format erroneously missed antral 
follicles of random sizes. TŚŝƐĐŽƵůĚďĞĐŽƌƌĞĐƚĞĚďǇĂƉƉůŝĐĂƚŝŽŶŽĨĂĨĞĂƚƵƌĞĐĂůůĞĚ ‘ƉŽƐƚ-
ƉƌŽĐĞƐƐŝŶŐ ? ?ǁŚŝĐŚĂůůŽǁĞĚŝŶĐůƵƐŝŽŶŽĨƚŚĞŵŝƐƐĞĚĨŽůůŝĐůĞƐďǇŵĂŶƵĂůůǇĐůŝĐŬŝŶŐŽŶƚŚĞŵ ?
This made the technique semi-automated and increased the time taken to measure antral 
follicle count. However, the colour coding provided by sonoAVC ensured that follicles 
were not counted more than once and that all were identified. In chapter 3, I have 
therefore reported reliability on four methods of counting antral follicles: automated 
sonoAVC (sAVC-AA), semi-automated sAVC (sAVC-PP), 3D multiplanar view which has 
mainly been the method of counting antral follicles using 3D ultrasound, and 2D 
ultrasound. The intra-observer and inter-observer reliability of antral follicles made using 
SonoAVC with post processing i.e. semi automated method was better than 
measurements made using the 3D multiplanar view or the 2D real time equivalent 
technique.  
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The main limitation of this software was the erroneously low total antral follicle counts 
made in its automated format which was overcome by post processing but at the expense 
of time and making the technique semi-automated. The main advantage of the software 
is its ability to measure diameter and volume of each follicle objectively and provide a 
unique colour to each follicle measured. This allowed accurate measurement of antral 
follicles, especially the small antral follicles. The potential advantage of having a reliable 
assessment of both follicle number and size as suggested in this study informed the work 
done in the next few chapters. 
 
Having established that antral follicle count made using sonoAVC with post processing 
was more reliable than 2D and 3D multiplanar view methods, in chapter 4, I have 
compared its ability to measure the size of antral follicles to that made using 2D 
ultrasound. No such study has been reported in the literature.  The relaxed sphere 
diameter, as used in this study to define the follicle diameter, was closely correlated to 
the follicular volume (Raine-Fenning 2008). I found that sonoAVC identified and measured 
significantly less number of total antral follicles than 2D ultrasound. This may relate to the 
image being displayed in a 3D multiplanar view which allows crosschecking of each follicle 
in three different planes and improves spatial orientation but is more likely to reflect the 
fact that each follicle is colour-coded preventing repeated measures of the same follicle. 
When stratified according to size, the main differences between the two techniques were 
between the follicle sizes less than 2 mm and more than 6 mm. Another difference was 
the time taken by 2D ultrasound to measure each antral follicle, which was significantly 
more than that taken by sonoAVC with post processing. The results from this study 
suggested that sonoAVC, despite being a semi-automated method as data post-processing 
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is invariably required, provides reliable and objective measures of the size of antral 
follicles more quickly than 2D ultrasound. This has important implications for both the 
research setting and clinical environment as it allows a quantitative analysis of antral 
follicle number and size without disturbing workflow.  
 
Having shown that sonoAVC was reliable in measuring and counting the antral follicles 
and that it was quicker in measuring the size of follicles than 2D ultrasound, it was 
important to assess its ability as a test of ovarian reserve. Chapter 5 is about the study 
that I conducted to evaluate different cohorts of antral follicles, based on their absolute 
sizes measured using sonoAVC, in the prediction of reproductive outcome in subjects 
undergoing IVF treatment. The results showed that the small antral follicles, especially 
those measuring between 2.1 to 4.0 mm are a significant predictor of pregnancy 
independent of age, the number of mature oocytes obtained, fertilisation rates, the 
number of cleaved embryos, and the grade of embryos transferred. The primary outcome 
measure evaluated in this study was a viable intrauterine pregnancy confirmed on a 
transvaginal ultrasound scan 5 weeks after embryo transfer. Taking into account age, total 
number of antral follicles and the number of follicles within each size cohort, type of 
gonadotrophin used, technique used for fertilisation (IVF / ICSI), number of mature 
oocytes retrieved, number of fertilised oocytes, number of cleaved embryos, and the 
number and grade of embryos transferred, Logistic regression revealed that the only 
variable predictive of clinical pregnancy was the number of antral follicles measuring 
between 2.0 to 4.0 mm (Exp(B)=1.221; 95% CI 1.072 and 1.391; p=0.003). Receiver 
operating characteristic analysis suggested this cohort of follicles provided the most 
discriminative power to differentiate those women likely to conceive (AUC: 0.694) from 
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those whose treatment will not be successful; a total count of three providing the 
optimum sensitivity and specificity with a post-test probability of 53%. There was also a 
significant correlation found between age and the cohort of follicles measuring 2.1 to 4.0 
mm (p=0.005) and 4.1 to 6.0 mm (p=0.001). These results further support the results from 
a study by Haadasma et al that the small antral follicles decline in number with increasing 
age and larger antral follicles remain constant. Linear regression analysis showed 
significant predictive relationship between small antral follicles and fertilisation rates and 
the number of cleaved embryos. This supports the notion that the smaller antral follicles 
are the follicles that truly reflect the ovarian potential and are most predictive of response 
to controlled ovarian stimulation during IVF treatment. Several studies suggest, however, 
that the total number of antral follicles is predictive of reproductive response (van Rooij, 
Broekmans et al. 2002; Hendriks, Mol et al. 2005; Muttukrishna, McGarrigle et al. 2005). It 
is possible that the smaller, more responsive follicles comprise the majority of the follicle 
population included in the total count in these individuals and that this masks the 
importance of the smaller follicles.  
One limitation of this study was that only women predicted to have a normal response, as 
assessed by age and FSH levels of <15 IU/L, undergoing their first cycle of IVF were 
ŝŶĐůƵĚĞĚŝŶƚŚŝƐƐƚƵĚǇ ?tŽŵĞŶĂďŽǀĞƚŚĞĂŐĞŽĨ ? ?ŽƌǁŝƚŚ&^,A? ? ?/h ?>ƚŚĂƚĂƌĞůŝŬĞůǇƚŽ
have an unfavourable outcome following IVF were not included in our study. Further work 
is required in women with poor and exaggerated response to treatment and would be 
ideal to undertake in conjunction with serum AMH measures. 
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Having established that small antral follicle counts measured using sonoAVC was reliable 
and predictive of ovarian response and pregnancy, it was important to establish that it 
was a true reflection of the existing follicles in the ovary. Study in chapter 6 was therefore 
designed to validate the counts made by 3D ultrasound assisted SonoAVC and 2D against 
the antral follicles manually dissected from the bovine ovary. The results showed that 
when validating for antral follicles measuring more than 4.0mm, both SonoAVC and 2D 
real-time equivalent made counts comparable to the dissection method, but SonoAVC 
with post processing agreed more than the 2D method. However, this was not true for 
follicles measuring 4.0mm or less. Whilst SonoAVC made significantly fewer counts, 2D 
made significantly greater counts than the dissection method, although SonoAVC agreed 
more with the dissection method than the 2D method. It therefore appears that no 
current method available to measure the count and size of antral follicles is accurate, but 
SonoAVC with post-processing shows the most agreement with the follicles measured 
following manual dissection.   
Several studies have reported good predictive value of antral follicle counts in assessing 
response following IVF treatment, their strong correlation to AMH and finally ovarian 
ageing. This would perhaps make one believe that the current understanding of the AFC 
cut-offs defining normal from poor or hyper-responders although not accurate are fair 
assessment tools of ovarian reserve. However, knowing that the current tests for 
calculating AFC are not accurate, there is a tremendous scope in developing the test 
accuracies in future, especially the small antral follicles, which might improve upon the 
current predictive abilities in assessing ovarian response to IVF and also reproductive 
ageing. When using SonoAVC, one could argue that since it underestimates AFC, we must 
exhibit caution with regards to women undergoing first cycle of IVF especially when 
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considering cycle cancellation or refusing IVF treatment. On the other hand, when using 
2D to measure antral follicles, one could argue that since it might overestimate AFC, we 
must consider appropriate dosages when deciding on the amount of gonadotrophin used 
for ovarian stimulation. SonoAVC was shown to have more agreement with dissection 
method than 2D, especially with follicles measuring 4.0mm or less.  Since SonoAVC can 
reliably measure size of antral follicles, the small antral follicle population must be 
researched further in studies predicting ovarian response to IVF.  
 
When evaluating the effects of ovarian cystectomy, several studies have used the contra 
lateral ovary as a control. The study in chapter 7 was therefore designed to compare the 
three-dimensional ultrasound markers of ovarian reserve between the two ovaries within 
the same individual. Our results suggest that there are significant differences in the 
ultrasound markers of ovarian reserve between the two ovaries within an individual 
during the early follicular phase of the menstrual cycle as measured using 3D ultrasound. 
Ovarian volume, total antral follicle count of each ovary and antral follicles measuring 
more than 6 mm showed significant differences; however this variation was least evident 
in the small antral follicles, measuring 6 mm or less. These results would have to be 
considered when evaluating the effect of ovarian pathology or surgery. Moreover, since 
these ultrasound markers have the capacity to predict ovarian response during ART, these 
findings should be considered when comparing one ovary to another to assess the effects 
of surgery.  The results suggested that antral follicle count data, stratified by size, be 
considered when the two ovaries are compared to quantify the effect of surgery. The 
variation in the ultrasound markers of ovarian reserve between the ovaries may relate to 
the effect of ovulation and corpus luteum formation in the preceding cycle or be an early 
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indicator of dominance in the current cycle (Baerwald, Adams et al. 2003). The inter-
ovarian difference in ovarian volume seen could be either due to inherent differences in 
the two ovaries or due to the number of larger antral follicles. There were no significant 
differences noted in the 3D power Doppler indices between the two ovaries. The 
ultrasound scans were performed in the early follicular phase when the population of 
follicles in the ovary is predominantly antral follicles, and therefore perhaps no difference 
noted in vascularity (Costello, Shrestha et al. 2005). However, this may not be consistent 
in different phases of the menstrual cycle, as the growing follicle and corpus luteum 
acquire more blood supply (Zaidi, Collins et al. 1996). 
 
The study in chapter 8 was designed to examine the variation in the 3D ultrasound 
markers of ovarian reserve and the endocrine markers including serum AMH, FSH, LH and 
Oestradiol in one menstrual cycle. The results suggest that there is a small but significant 
intra-cyclical variation in serum AMH, which is mainly due to the increase in levels in the 
luteal phase of the menstrual cycle. The total AFC significantly varied intra-cyclically, 
however this was mainly contributed to by the large antral follicles measuring more than 
6.0mm, and to a smaller but significant extent by the 2.0 to 4.0mm follicles. Overall, the 
small antral follicles measuring 2.0 to 6.0mm did not show a significant intra-cyclical 
variation. At any given time point during the menstrual cycle, the ovaries contain follicles 
at different developmental stages (Gougeon 1998). This explains why a significant intra-
cyclical variation in the number of large antral follicles was noted in our study, especially 
the increase in the number from follicular to peri-ovulatory phase of cycle and then a 
decrease in number in the luteal phase. 
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The increase in AMH levels in the luteal phase of the cycle with no change in the small 
antral follicle count confirming that there exists a continuous recruitment of pre-antral 
and very small antral follicles that are also known to produce AMH (Gougeon 1989; 
Gougeon 1996; Tsepelidis, Demeestere et al. 2007) but that cannot be identified on 
ultrasound. Alternatively, this may be due to the small sample size, albeit we chose a 
targeted study population that were young normal healthy women with normal ovulatory 
cycles. Several studies have reported intra-cycle stability of AMH and that it might even 
show lower variation than total AFC. Significant variation seen in ovarian volume was 
mainly due to an increase in the peri-ovulatory and luteal phase of cycle and could be 
attributed to the presence of the dominant follicle and the subsequent corpus luteum 
formation. FSH and LH, both showed significant intra-cycle variation, mainly due to the 
increase in the peri-ovulatory phase and a subsequent drop in the luteal phase of 
menstrual cycle. This variation is well described (Gougeon 1994) and therefore confirms 
that these tests are best performed in the early follicular phase. Oestradiol levels 
expectedly showed significant variation. 
The results from this study suggested that small antral follicles and AMH showed least 
intra-cycle variation and an excellent within subject correlation. The main advantage of 
this study was the objective and reliable assessment of the size of antral follicles using 3D 
ultrasound and examining the variation in both small and large antral follicles.  
 
Study in chapter 9 was designed to evaluate the inter-cycle variation in the 3D ultrasound 
and endocrine determinants of ovarian reserve, such that the best test of ovarian reserve 
could be used when examining the effect of ovarian cystectomy. The small AFC measuring 
2.0-6.0 mm showed the least variation between five cycles over a period of 12 months 
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followed by serum AMH and total AFC measuring 2.0-10.0 mm. A high inter-cycle 
correlation was observed in these markers with significant intra class correlation 
coefficient suggesting a small non-significant intra-individual variation between cycles. 
The results from this study in conjunction with those from Chapter (intra-cycle variation) 
suggest that to ensure a reliable measure of ovarian reserve, the tests including the total 
AFC (2.0-10.0 mm) and the AFC of larger antral follicles (> 6.0 mm) are best measured in 
the early follicular phase, whereas the small AFC (2.0-6.0 mm) could be measured in any 
phase of menstrual cycle. In our study, the inter-cycle stability of AMH (ICC - 0.91) was 
comparable to that seen with tAFC (2.0-10.0 mm) (ICC - 0.89) and small AFC (2.0-6.0 mm) 
(ICC - 0.95). A significant inter-cycle change in the mean FSH, LH and progesterone levels 
was noted; however a non-significant change in oestradiol levels over 12 months. The 
inter-cycle stability of total antral follicle count (2.0-10.0 mm) when performed in the 
early follicular phase of menstrual cycle appears to be comparable to AMH and small AFC. 
These determinants of ovarian reserve demonstrate inter-cycle stability for up to 12 
months and hence future studies designed to evaluate their ability to predict ovarian 
response following assisted reproduction treatment should consider performing these 
tests of ovarian reserve once in a year irrespective of the number of ART cycles required. 
 
Study in chapter 10 was designed to further evaluate the effect of combined oral 
contraceptive pills on ovarian reserve. The results suggested that despite lower serum 
levels of gonadotrophins in the COCP users, the population of small antral follicles 
measuring 2 to 6 mm and serum AMH levels were comparable to those seen in non-pill 
users; however growth of antral follicles beyond 6 mm was significantly reduced in pill 
users. These results are consistent with the fact that the pool of selectable antral follicles 
S h i l p a  D e b   P a g e  | 251 
 
 
(2-5 mm) are gonadotrophin responsive but not dependant and that the antral follicles 
measuring more than 6 mm are gonadotrophin dependant (Gougeon and Lefevre 1983). 
Overall, these findings support the interpretation that the number of small antral follicles 
and circulating AMH concentrations more accurately reflect the functional ovarian 
reserve. Although some studies suggest, that the total number of antral follicles is 
predictive of reproductive response (van Rooij, Broekmans et al. 2002; Hendriks, Mol et 
al. 2005; Muttukrishna, McGarrigle et al. 2005) this can be explained by the fact that the 
smaller, more responsive antral follicles comprise the majority of the follicle population 
included in the total antral follicle count in these individuals.  FSH is considered to be a 
major survival factor for gonadotrophin responsive follicles, the stage during which a 
majority of follicles undergo atresia under physiological conditions (Gougeon and Busso 
2000). However, due to the range of approaches and doses used in these animal studies, 
it is difficult to determine the minimum amount of FSH that is required to influence the 
survival of these gonadotrophin responsive antral follicles. From the present study, it is 
clear that a relatively modest suppression of pituitary gonadotrophins in our study did not 
significantly affect the number of selectable antral follicles. The reduction in ovarian 
volume may be due to the combined effect of a lower number of large antral follicles and 
reduced vascularity as shown by 3D power Doppler indices.  The results of the current 
study are relevant to the use of COCP in assisted reproduction treatment, including both 
IVF and ICSI. The benefits of using the COCP as part of an assisted reproduction treatment 
cycles are unclear although it is possible that this may lead to a homogenous response to 
controlled ovarian stimulation by influencing the recruitment and growth of follicles and 
the yield and quality of the oocytes harvested. This possibility, however, requires 
evaluation in future trials. 
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Having confirmed the functional role of small antral follicles in assessment of ovarian 
reserve, and its reliability and validity in evaluating ovarian reserve, they were then used 
in examining the effects of ovarian cyst and cystectomy along with serum AMH in the 
study in chapter 11. The results suggest that laparoscopic ovarian cystectomy for a benign 
cyst is associated with a significant loss of ovarian reserve lasting up to at least 6 months 
post operatively. The damage caused is more in the ovary that is operated upon than the 
other normal ovary. The results also suggest that the damage caused by the stripping of 
endometrioma is more pronounced than the damage caused by stripping of dermoid cyst.  
The positive aspects of this study were that it used 3D ultrasound assisted sonoAVC to 
measure and count antral follicles and AMH to assess ovarian reserve in a prospective 
longitudinal observational design. Use of small antral follicles enabled comparison of 
diseased ovary to the contra lateral ovary thus quantifying the effect of cyst on the 
affected ovary. Only endometriotic cysts per se affected the ovarian reserve of the ovary 
containing the cyst. These findings were comparable to some of the histological studies 
reported emphasising the value of these small follicles in assessing the damage caused by 
cyst itself. Few studies have quantified histologically the amount of normal ovarian tissue 
removed at the time of cystectomy. It would be reasonable to presume that this would 
have an impact on the quantitative ovarian reserve; however whether it has an impact on 
ƚŚĞƋƵĂůŝƚĂƚŝǀĞĂƐƉĞĐƚŽĨĂǁŽŵĂŶ ?ƐůŝĨĞŝŶƚĞƌŵƐŽĨƉƌĞŐŶĂŶĐǇĂŶĚƉƌĞŵĂƚƵƌĞŵĞŶŽƉĂƵƐĞ
is uncertain. The results from our study and those reported in the past confirm that there 
is a significant loss of normal ovarian parenchyma when stripping the ovarian cysts, more 
so in the hilar area and that the small antral follicle count correlates with the loss of 
ovarian tissue quantified histologically when removing endometriomas. In sub fertile 
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women undergoing ART, it is unclear whether removal of cysts improves the fertilisation 
and pregnancy rates; however it is shown that the ovarian response is reduced as evident 
by the increase in gonadotophins used, reduction in the number of follicles stimulated 
and the number of oocytes collected. Some believe that the presence of an 
endometrioma may affect the quality of oocytes collected, but recent meta-analysis of 
studies has shown no difference in fertilisation, pregnancy and implantation rates 
between surgery versus conservative management of cysts (Tsoumpou, Kyrgiou et al. 
2009). The results of our study confirm the damage caused to ovarian reserve following 
cystectomy when using the technique of stripping the cyst from normal ovarian 
parenchyma. However, they cannot be directly compared to majority of the studies in the 
literature as comparisons are made with either the contra lateral ovary or a matched 
control. Only a few studies have used a longitudinal design where the ovarian reserve is 
compared pre and post operatively; however our study differs in the use of small antral 
follicle count and 3D ultrasound. The main limitation of this study has been a small sample 
size and a post operative follow up of up to 6 months only, albeit a better design and a 
longer follow up than what has been reported in the literature so far.  
 
12.2 New findings in relation to ovarian reserve assessment and its 
application in assessment of ovarian cysts 
 
Several new findings relating to ovarian reserve assessment and prediction of ovarian 
response, particularly when ovarian parameters are defined by 3D ultrasound, have been 
made in this thesis.  
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I have evaluated the role of small antral follicles in assessment of ovarian reserve and 
shown that these follicles are significant predictors of ovarian response and pregnancy 
following in vitro fertilisation. I have confirmed one of the presumptions that AMH is 
expressed by pre antral and small antral follicles by demonstrating an excellent 
correlation between the two (Deb, Batcha et al. 2009). 
This thesis evaluates the role of 3D assisted technique of measuring and counting antral 
ĨŽůůŝĐůĞƐĐĂůůĞĚƚŚĞ ‘ƐŽŶŽŐƌĂƉŚǇďĂƐĞĚĂƵƚŽŵĂƚĞĚǀŽůƵŵĞĐĂůĐƵůĂƚŝŽŶ ? ?/ŚĂǀĞĐŽŶƚƌŝďƵƚĞĚ
towards its application in the assessment of antral follicles by demonstrating the 
limitations of completely automated version of sonoAVC whereby it erroneously missed 
antral follicles of random sizes in the analysis. To overcome these limitations, I have 
applied the feature of post processing and then evaluated its application in clinical 
practice. I have shown that sonoAVC with post processing had an excellent intra- and 
inter-observer reliability in measuring antral follicles (Deb, Jayaprakasan et al. 2009). 
Furthermore, I have shown that antral follicles measured by sonoAVC take much lesser 
time than those measured by 2D ultrasound (Deb, Campbell et al. 2010). There was good 
agreement between the two methods when measuring antral follicles between 2 and 6 
mm, however lesser agreement when measuring more than 6 mm and less than 2mm size 
follicles (Deb, Campbell et al. 2010). With the help of in vitro study on bovine ovaries, I 
have shown that sonoAVC perhaps underestimates and 2D overestimates the antral 
follicles measuring less than 4mm, albeit sonoAVC shows more agreement with the 
manually dissected follicles from the ovary. The two methods compared well with the 
actual number of follicles when considering follicles measuring more than 4 mm. These 
findings will further help in its evolution as a test of ovarian reserve. 
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I have contributed to the current understanding of inter ovarian, intra cycle and inter 
cycle variations in the small antral follicles when compared to larger antral follicles, total 
antral follicle count, AMH, and FSH (Deb, Kannamannadiar et al.). Small antral follicles 
along with AMH show the least physiological variation. This finding makes these two tests 
reliable in the assessment of ovarian reserve. I have also contributed to the understanding 
of partial suppression of pituitary ovarian axis following prolonged use of COCP with HFI 
and its effect on antral follicles, AMH and gonadotrophins (Submitted to journal of 
Ultrasound Obstet Gynecol). The work from this thesis has shown that COCP does not 
affect the small antral follicles and AMH. 
Finally, I have demonstrated a new objective, reliable and valid method of assessing 
ovarian reserve following ovarian cystectomy and also a potential method of assessing 
effect of ovarian cyst per se on ovarian reserve. 
 
12.3 Future suggested direction of work 
 
This study has shown the potential benefits of using a semi-automated 3D method 
(SonoAVC with post processing) for the identification and measurement of antral follicles. 
It is a more objective and reliable method than real-time 2D ultrasound and takes 
significantly less time than conventional ultrasound assessments. Further research is 
required to evaluate the biological and clinical importance of quantifying antral follicle 
size. Knowing that the current tests for calculating AFC are not accurate, there is a 
tremendous scope in developing the test accuracies in future, especially the small antral 
follicles, which might improve upon the current predictive abilities in assessing ovarian 
response to IVF and also reproductive ageing. 
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The small antral follicle count appears to predict pregnancy independently of age and the 
total number of antral follicles. Further work is required in women with poor and 
exaggerated response to treatment and should be undertake in conjunction with serum 
AMH measures. This technique may facilitate prospective studies designed to examine the 
effect of different gonadotrophin preparations and doses and treatment protocols.  
The functional ovarian reserve as measured using small antral follicle count (2.0-6.0mm) 
and AMH show least intra-cycle variation and an excellent within subject correlation. 
Future studies designed to evaluate their ability to predict ovarian response following 
assisted reproduction treatment should consider performing these tests in various time-
points in the menstrual cycle.  
The benefits of using the COCP as part of an assisted reproduction treatment cycles are 
unclear although it is possible that this may lead to a homogenous response to controlled 
ovarian stimulation by influencing the recruitment and growth of follicles and the yield 
and quality of the oocytes harvested. This possibility, however, requires evaluation in 
future trials. 
Future trials evaluating the effect of ovarian cystectomy should be designed to look at 
standardised techniques of cystectomy on specific types of ovarian cyst using small antral 
follicle count and AMH in a longitudinal fashion over a longer period of follow up. Whilst 
examining the quantitative loss of ovarian reserve, qualitative measures such as 
pregnancy should be considered in the outcome measures.  
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